@article{lewis.etal_2024,
  title = {Triazole Antifungal Drug Interactions---Practical Considerations for Excellent Prescribing},
  author = {Lewis, Russell and {Niazi-Ali}, Saarah and McIvor, Andrew and Kanj, Souha S and Maertens, Johan and Bassetti, Matteo and Levine, Deborah and Groll, Andreas H and Denning, David W},
  year = {2024},
  month = apr,
  journal = {Journal of Antimicrobial Chemotherapy},
  pages = {dkae103},
  issn = {0305-7453},
  doi = {10.1093/jac/dkae103},
  urldate = {2024-05-17},
  abstract = {Systemic antifungal therapy is critical for reducing the mortality from many invasive and chronic fungal infections. Triazole antifungals are the most frequently prescribed antifungals but require attention to dosing and drug interactions. Nearly 600 severe drug--drug interactions and over 1100 moderate interactions requiring dose modifications are described or anticipated with systemic antifungal agents (see https://www.aspergillus.org.uk/antifungal-drug-interactions/). In this article, we address the common and less common, but serious, drug interactions observed in clinical practice with triazole antifungals, including a group of drugs that cannot be prescribed with all or most triazole antifungals (ivabradine, ranolazine, eplerenone, fentanyl, apomorphine, quetiapine, bedaquiline, rifampicin, rifabutin, sirolimus, phenytoin and carbamazepine). We highlight interactions with drugs used in children and new agents introduced for the treatment of haematological malignancies or graft versus host disease (midostaurin, ibrutinib, ruxolitinib and venetoclax). We also summarize the multiple interactions between oral and inhaled corticosteroids and triazole antifungals, and the strategies needed to optimize the therapeutic benefits of triazole antifungal therapy while minimizing potential harm to patients.},
  file = {/Users/russelllewis/Zotero/storage/P3ELTCRI/7647009.html}
}

Systemic antifungal therapy is critical for reducing the mortality from many invasive and chronic fungal infections. Triazole antifungals are the most frequently prescribed antifungals but require attention to dosing and drug interactions. Nearly 600 severe drug–drug interactions and over 1100 moderate interactions requiring dose modifications are described or anticipated with systemic antifungal agents (see https://www.aspergillus.org.uk/antifungal-drug-interactions/). In this article, we address the common and less common, but serious, drug interactions observed in clinical practice with triazole antifungals, including a group of drugs that cannot be prescribed with all or most triazole antifungals (ivabradine, ranolazine, eplerenone, fentanyl, apomorphine, quetiapine, bedaquiline, rifampicin, rifabutin, sirolimus, phenytoin and carbamazepine). We highlight interactions with drugs used in children and new agents introduced for the treatment of haematological malignancies or graft versus host disease (midostaurin, ibrutinib, ruxolitinib and venetoclax). We also summarize the multiple interactions between oral and inhaled corticosteroids and triazole antifungals, and the strategies needed to optimize the therapeutic benefits of triazole antifungal therapy while minimizing potential harm to patients.

@article{matsuo.etal_2024a,
  title = {Invasive Fusariosis in Patients with Leukaemia in the Era of Mould-Active Azoles: Increasing Incidence, Frequent Breakthrough Infections and Lack of Improved Outcomes},
  shorttitle = {Invasive Fusariosis in Patients with Leukaemia in the Era of Mould-Active Azoles},
  author = {Matsuo, Takahiro and Wurster, Sebastian and Jiang, Ying and Sasaki, Koji and Tarrand, Jeffrey and Lewis, Russell E and Kontoyiannis, Dimitrios P},
  year = {2024},
  month = feb,
  journal = {Journal of Antimicrobial Chemotherapy},
  volume = {79},
  number = {2},
  pages = {297--306},
  issn = {0305-7453},
  doi = {10.1093/jac/dkad377},
  urldate = {2024-05-17},
  abstract = {Historically, patients with leukaemia and invasive fusariosis (IF) have experienced poor outcomes in the setting of persistent immunosuppression. Herein, we retrospectively reviewed the incidence, presentation and outcomes of IF that are scarcely studied in contemporary cohorts of leukaemia patients.We identified adult leukaemia patients with proven or probable IF at MD Anderson Cancer Center during 2009--21. Independent risk factors for 42 day mortality after IF diagnosis were determined using a multivariable logistic regression model. Combined with historical data, the annual IF incidence density over the past 23 years was estimated using Poisson regression analysis.Among 140 leukaemia patients with IF (114 proven), 118 patients (84\%) had relapsed/refractory leukaemia and 124 (89\%) had neutropenia at IF diagnosis. One hundred patients (71\%) had pulmonary IF, 88 (63\%) had disseminated IF and 48 (34\%) had fungaemia. Coinfections were common (55\%). Eighty-nine patients (64\%) had breakthrough IF to mould-active triazoles. Most patients (84\%) received combination antifungal therapy. Neutrophil recovery [adjusted OR (aOR), 0.04; 95\% CI, 0.01--0.14; P{$\mkern1mu\&$}lt;{$\mkern1mu$}0.0001], pulmonary IF (aOR, 3.28; 95\% CI, 1.11--9.70; P{$\mkern1mu$}={$\mkern1mu$}0.032) and high SOFA score (aOR, 1.91 per 1-point increase; 95\% CI, 1.47--2.50; P{$\mkern1mu\&$}lt;{$\mkern1mu$}0.0001) were independent predictors of 42 day mortality outcomes. From 1998 to 2021, IF incidence density increased significantly at an annual ratio of 1.03 (95\% CI, 1.01--1.06; P{$\mkern1mu$}={$\mkern1mu$}0.04).IF is predominantly seen in patients with relapsed/refractory leukaemia and increasingly seen as a breakthrough infection to mould-active triazoles. Despite frequent combination antifungal therapy, high mortality rates have persisted in patients with lasting neutropenia.},
  file = {/Users/russelllewis/Zotero/storage/46X52WY5/7468707.html}
}

Historically, patients with leukaemia and invasive fusariosis (IF) have experienced poor outcomes in the setting of persistent immunosuppression. Herein, we retrospectively reviewed the incidence, presentation and outcomes of IF that are scarcely studied in contemporary cohorts of leukaemia patients.We identified adult leukaemia patients with proven or probable IF at MD Anderson Cancer Center during 2009–21. Independent risk factors for 42 day mortality after IF diagnosis were determined using a multivariable logistic regression model. Combined with historical data, the annual IF incidence density over the past 23 years was estimated using Poisson regression analysis.Among 140 leukaemia patients with IF (114 proven), 118 patients (84%) had relapsed/refractory leukaemia and 124 (89%) had neutropenia at IF diagnosis. One hundred patients (71%) had pulmonary IF, 88 (63%) had disseminated IF and 48 (34%) had fungaemia. Coinfections were common (55%). Eighty-nine patients (64%) had breakthrough IF to mould-active triazoles. Most patients (84%) received combination antifungal therapy. Neutrophil recovery [adjusted OR (aOR), 0.04; 95% CI, 0.01–0.14; P$ &$lt;$ $0.0001], pulmonary IF (aOR, 3.28; 95% CI, 1.11–9.70; P$ $=$ $0.032) and high SOFA score (aOR, 1.91 per 1-point increase; 95% CI, 1.47–2.50; P$ &$lt;$ $0.0001) were independent predictors of 42 day mortality outcomes. From 1998 to 2021, IF incidence density increased significantly at an annual ratio of 1.03 (95% CI, 1.01–1.06; P$ $=$ $0.04).IF is predominantly seen in patients with relapsed/refractory leukaemia and increasingly seen as a breakthrough infection to mould-active triazoles. Despite frequent combination antifungal therapy, high mortality rates have persisted in patients with lasting neutropenia.

@article{lewis.etal_2023b,
  title = {Radiology-Based Diagnosis of Fungal Pulmonary Infections in High-Risk Hematology Patients: Are We Making Progress?},
  shorttitle = {Radiology-Based Diagnosis of Fungal Pulmonary Infections in High-Risk Hematology Patients},
  author = {Lewis, R.E. and Stanzani, M. and Morana, G. and Sassi, C.},
  year = {2023},
  journal = {Current Opinion in Infectious Diseases},
  volume = {36},
  number = {4},
  pages = {250--256},
  issn = {0951-7375},
  doi = {10.1097/QCO.0000000000000937},
  abstract = {Purpose of reviewIn patients with hematological malignancies, high-resolution computed tomography (CT) is the recommended imaging approach for diagnosis, staging and monitoring of invasive fungal disease (IFD) but lacks specificity. We examined the status of current imaging modalities for IFD and possibilities for more effective applications of current technology for improving the specificity of IFD diagnosis.Recent findingsAlthough CT imaging recommendations for IFD are largely unchanged in the last 20 years, improvements in CT scanner technology and image processing algorithms now allow for technically adequate examinations at much lower radiation doses. CT pulmonary angiography can improve both the sensitivity and specificity of CT imaging for angioinvasive molds in both neutropenic and nonneutropenic patients, through detection of the vessel occlusion sign (VOS). MRI-based approaches also show promise not only for early detection of small nodules and alveolar hemorrhage but can also be used to detect pulmonary vascular occlusion without radiation and iodinated contrast media. 18F-fluorodeoxyglucose (FDG) PET/computed tomography (FDG-PET/CT) is increasingly used to monitor long-term treatment response for IFD, but could become a more powerful diagnostic tool with the development of fungal-specific antibody imaging tracers.SummaryHigh-risk hematology patients have a considerable medical need for more sensitive and specific imaging approaches for IFD. This need may be addressable, in part, by better exploiting recent progress in CT/MRI imaging technology and algorithms to improve the specificity of radiological diagnosis for IFD. {\copyright} 2023 Wolters Kluwer Health, Inc. All rights reserved.},
  langid = {english},
  keywords = {angiography,computed tomography,invasive aspergillosis,invasive fungal disease,MRI,mucormycosis,PET},
  note = {Cited By :5},
  file = {/Users/russelllewis/Zotero/storage/TL3AGBXV/Lewis et al. - 2023 - Radiology-based diagnosis of fungal pulmonary infections in high-risk hematology patients are we ma.pdf;/Users/russelllewis/Zotero/storage/4Z4RB6CJ/display.html}
}

Purpose of reviewIn patients with hematological malignancies, high-resolution computed tomography (CT) is the recommended imaging approach for diagnosis, staging and monitoring of invasive fungal disease (IFD) but lacks specificity. We examined the status of current imaging modalities for IFD and possibilities for more effective applications of current technology for improving the specificity of IFD diagnosis.Recent findingsAlthough CT imaging recommendations for IFD are largely unchanged in the last 20 years, improvements in CT scanner technology and image processing algorithms now allow for technically adequate examinations at much lower radiation doses. CT pulmonary angiography can improve both the sensitivity and specificity of CT imaging for angioinvasive molds in both neutropenic and nonneutropenic patients, through detection of the vessel occlusion sign (VOS). MRI-based approaches also show promise not only for early detection of small nodules and alveolar hemorrhage but can also be used to detect pulmonary vascular occlusion without radiation and iodinated contrast media. 18F-fluorodeoxyglucose (FDG) PET/computed tomography (FDG-PET/CT) is increasingly used to monitor long-term treatment response for IFD, but could become a more powerful diagnostic tool with the development of fungal-specific antibody imaging tracers.SummaryHigh-risk hematology patients have a considerable medical need for more sensitive and specific imaging approaches for IFD. This need may be addressable, in part, by better exploiting recent progress in CT/MRI imaging technology and algorithms to improve the specificity of radiological diagnosis for IFD. © 2023 Wolters Kluwer Health, Inc. All rights reserved.

@article{lewis.stanzani_2023,
  title = {Antifungal {{Prophylaxis}} in the {{Era}} of {{Targeted Chemotherapy}} for {{Acute Myelogenous Leukemia}}},
  author = {Lewis, R.E. and Stanzani, M.},
  year = {2023},
  journal = {Current Fungal Infection Reports},
  volume = {17},
  number = {3},
  pages = {250--261},
  issn = {1936-3761},
  doi = {10.1007/s12281-023-00474-0},
  abstract = {Purpose of Review: This review will provide an overview of the potential drug-drug interactions (DDIs) that may occur when using small-molecule kinase inhibitors (SMKIs) for the treatment of acute myeloid leukemia (AML) with triazole antifungals. We aim to discuss the management strategies for these interactions, including the assessment of invasive fungal disease (IFD) risks, alternative antifungal treatments, and dosage adjustments of SMKI therapy. Recent Findings: Recent advances in molecular and cell biology have led to the approval of several SMKIs for the treatment of AML. These targeted therapies, while more tolerable than traditional cytotoxic chemotherapy regimens, are metabolized via the cytochrome P450 3A4 pathway, making them susceptible to potential DDIs with triazole antifungals. Managing these interactions requires a tailored approach, taking into consideration the patient's specific IFD risks, treatment status, and comorbidities. While specific dosing guidance is available for using venetoclax or ivosidenib with triazole antifungals, recommendations for other SMKIs are less certain. Summary: The use of SMKIs in AML treatment has revolutionized patient care by providing more targeted and tolerable therapies. However, the potential for DDIs, particularly with triazole antifungals, necessitates careful management. Clinicians must carefully assess the specific IFD risks associated with SMKI therapies, evaluate the limitations of current and future antifungal treatments, and consider evidence supporting dosage adjustments when co-administering SMKIs with triazoles. Ongoing research in model-informed precision dosing and therapeutic drug monitoring holds promise for improving the safety and efficacy of managing drug interactions with SMKI therapy. {\copyright} 2023, The Author(s).},
  langid = {english},
  keywords = {Acute myeloid leukemia,Antifungal prophylaxis,Invasive aspergillosis,Targeted therapy},
  file = {/Users/russelllewis/Zotero/storage/5U4TQUFT/Lewis and Stanzani - 2023 - Antifungal Prophylaxis in the Era of Targeted Chemotherapy for Acute Myelogenous Leukemia.pdf;/Users/russelllewis/Zotero/storage/EZUPXNW8/display.html}
}

Purpose of Review: This review will provide an overview of the potential drug-drug interactions (DDIs) that may occur when using small-molecule kinase inhibitors (SMKIs) for the treatment of acute myeloid leukemia (AML) with triazole antifungals. We aim to discuss the management strategies for these interactions, including the assessment of invasive fungal disease (IFD) risks, alternative antifungal treatments, and dosage adjustments of SMKI therapy. Recent Findings: Recent advances in molecular and cell biology have led to the approval of several SMKIs for the treatment of AML. These targeted therapies, while more tolerable than traditional cytotoxic chemotherapy regimens, are metabolized via the cytochrome P450 3A4 pathway, making them susceptible to potential DDIs with triazole antifungals. Managing these interactions requires a tailored approach, taking into consideration the patient's specific IFD risks, treatment status, and comorbidities. While specific dosing guidance is available for using venetoclax or ivosidenib with triazole antifungals, recommendations for other SMKIs are less certain. Summary: The use of SMKIs in AML treatment has revolutionized patient care by providing more targeted and tolerable therapies. However, the potential for DDIs, particularly with triazole antifungals, necessitates careful management. Clinicians must carefully assess the specific IFD risks associated with SMKI therapies, evaluate the limitations of current and future antifungal treatments, and consider evidence supporting dosage adjustments when co-administering SMKIs with triazoles. Ongoing research in model-informed precision dosing and therapeutic drug monitoring holds promise for improving the safety and efficacy of managing drug interactions with SMKI therapy. © 2023, The Author(s).

@article{mccreary.etal_2023a,
  title = {Utility of Triazole Antifungal Therapeutic Drug Monitoring: {{Insights}} from the {{Society}} of {{Infectious Diseases Pharmacists}}},
  shorttitle = {Utility of Triazole Antifungal Therapeutic Drug Monitoring},
  author = {McCreary, Erin K. and Davis, Matthew R. and Narayanan, Navaneeth and Andes, David R. and Cattaneo, Dario and Christian, Robbie and Lewis, Russell E. and Watt, Kevin M. and Wiederhold, Nathan P. and Johnson, Melissa D.},
  year = {2023},
  journal = {Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy},
  volume = {43},
  number = {10},
  pages = {1043--1050},
  issn = {1875-9114},
  doi = {10.1002/phar.2850},
  urldate = {2024-05-17},
  abstract = {AbstractTriazole antifungals (i.e., fluconazole, itraconazole, voriconazole, posaconazole, and isavuconazole) are commonly used in clinical practice to prevent or treat invasive fungal infections. Most triazole antifungals require therapeutic drug monitoring (TDM) due to highly variable pharmacokinetics, known drug interactions, and established relationships between exposure and response. On behalf of the Society of Infectious Diseases Pharmacists (SIDP), this insight describes the pharmacokinetic principles and pharmacodynamic targets of commonly used triazole antifungals and provides the rationale for utility of TDM within each agent.},
  copyright = {{\copyright} 2023 Pharmacotherapy Publications, Inc.},
  langid = {english},
  keywords = {fluconazole,isavuconazole,itraconazole,pharmacodynamics,pharmacokinetics,posaconazole,voriconazole},
  file = {/Users/russelllewis/Zotero/storage/8CK9V5A5/phar.html}
}

AbstractTriazole antifungals (i.e., fluconazole, itraconazole, voriconazole, posaconazole, and isavuconazole) are commonly used in clinical practice to prevent or treat invasive fungal infections. Most triazole antifungals require therapeutic drug monitoring (TDM) due to highly variable pharmacokinetics, known drug interactions, and established relationships between exposure and response. On behalf of the Society of Infectious Diseases Pharmacists (SIDP), this insight describes the pharmacokinetic principles and pharmacodynamic targets of commonly used triazole antifungals and provides the rationale for utility of TDM within each agent.

@article{pechacek.etal_2023,
  title = {Successful {{Treatment}} of {{Paecilomyces}} Variotii {{Pneumonia}} and {{Lupus Nephritis}} with {{Posaconazole-Cyclophosphamide Co-administration Without Drug Interaction-Induced Toxicity}}},
  author = {Pechacek, J. and Webb, T. and Ferre, E.M.N. and Schmitt, M.M. and Dimaggio, T. and Kobrin, D. and Rajasimhan, S. and Colton, B. and Lewis, R.E. and Andes, D. and Herrera, A. and Hammoud, D. and Seyedmousavi, S. and Hasni, S. and Bola{\~n}os, J. and Afzali, B. and Lionakis, M.S.},
  year = {2023},
  journal = {Open Forum Infectious Diseases},
  volume = {10},
  number = {8},
  issn = {2328-8957},
  doi = {10.1093/ofid/ofad410},
  abstract = {Paecilomyces variotii is an opportunistic mold that causes pulmonary infections in immunosuppressed humans that are often treated with triazole therapy. Lupus nephritis is a major cause of progressive kidney disease in patients with systemic lupus erythematosus, often requiring cyclophosphamide-based therapies. Triazole-cyclophosphamide co-administration is challenging as triazoles increase cyclophosphamide concentrations, which can worsen cyclophosphamide toxicity. We describe herein a patient with Paecilomyces variotii pneumonia and concomitant lupus nephritis who was successfully treated with posaconazole and echinocandin-bridged interruptions to allow for cyclophosphamide therapy. This regimen was well-tolerated without cyclophosphamide toxicity and achieved improvements in both fungal pneumonia and renal function. {\copyright} 2023 Published by Oxford University Press on behalf of Infectious Diseases Society of America.},
  langid = {english},
  keywords = {cyclophosphamide,drug-drug interactions,lupus nephritis,Paecilomyces,posaconazole},
  file = {/Users/russelllewis/Zotero/storage/RRWF3M7Z/Pechacek et al. - 2023 - Successful Treatment of Paecilomyces variotii Pneumonia and Lupus Nephritis with Posaconazole-Cyclop.pdf}
}

Paecilomyces variotii is an opportunistic mold that causes pulmonary infections in immunosuppressed humans that are often treated with triazole therapy. Lupus nephritis is a major cause of progressive kidney disease in patients with systemic lupus erythematosus, often requiring cyclophosphamide-based therapies. Triazole-cyclophosphamide co-administration is challenging as triazoles increase cyclophosphamide concentrations, which can worsen cyclophosphamide toxicity. We describe herein a patient with Paecilomyces variotii pneumonia and concomitant lupus nephritis who was successfully treated with posaconazole and echinocandin-bridged interruptions to allow for cyclophosphamide therapy. This regimen was well-tolerated without cyclophosphamide toxicity and achieved improvements in both fungal pneumonia and renal function. © 2023 Published by Oxford University Press on behalf of Infectious Diseases Society of America.

@article{tsakris.etal_2023,
  title = {Preface},
  author = {Tsakris, Athanasios and Hurley, James and Johnson, Alan and Lewis, Russell},
  year = {2023},
  month = may,
  journal = {Journal of Antimicrobial Chemotherapy},
  volume = {78},
  number = {Supplement\_1},
  pages = {i1},
  issn = {0305-7453},
  doi = {10.1093/jac/dkad084},
  urldate = {2024-05-17},
  abstract = {Streptococcus pneumoniae continues to be a major cause of morbidity and mortality worldwide, associated with invasive (e.g. bacteraemia, meningitis) and non-invasive (e.g. community-acquired respiratory tract) infections. Invasive pneumococcal disease (IPD) is an ongoing threat to global health, with severe socio-economic impacts, and MDR S. pneumoniae is a potentially emerging concern amongst IPD.This Supplement to the Journal of Antimicrobial Chemotherapy (JAC) comprises five articles that provide a comprehensive examination of the changing patterns of antimicrobial resistance, serotype distribution, genotypic relatedness and virulence of invasive S. pneumoniae isolates obtained across Canada over a 10 year period of the SAVE study. SAVE is an ongoing, annual, national study between the Canadian Antimicrobial Resistance Alliance (CARA) and the National Microbiology Laboratory, focused on characterizing invasive isolates of S. pneumoniae obtained across Canada. Some very interesting findings of this national survey, covering the period between 2011 and 2015, have been published in a previous supplement of JAC (Vol. 73, Suppl 7, July 2018).},
  file = {/Users/russelllewis/Zotero/storage/4VFCV93S/7147759.html}
}

Streptococcus pneumoniae continues to be a major cause of morbidity and mortality worldwide, associated with invasive (e.g. bacteraemia, meningitis) and non-invasive (e.g. community-acquired respiratory tract) infections. Invasive pneumococcal disease (IPD) is an ongoing threat to global health, with severe socio-economic impacts, and MDR S. pneumoniae is a potentially emerging concern amongst IPD.This Supplement to the Journal of Antimicrobial Chemotherapy (JAC) comprises five articles that provide a comprehensive examination of the changing patterns of antimicrobial resistance, serotype distribution, genotypic relatedness and virulence of invasive S. pneumoniae isolates obtained across Canada over a 10 year period of the SAVE study. SAVE is an ongoing, annual, national study between the Canadian Antimicrobial Resistance Alliance (CARA) and the National Microbiology Laboratory, focused on characterizing invasive isolates of S. pneumoniae obtained across Canada. Some very interesting findings of this national survey, covering the period between 2011 and 2015, have been published in a previous supplement of JAC (Vol. 73, Suppl 7, July 2018).

@article{bartoletti.etal_2022,
  title = {Clinical Consequences of Very Major Errors with Semi-Automated Testing Systems for Antimicrobial Susceptibility of Carbapenem-Resistant {{Enterobacterales}}},
  author = {Bartoletti, Michele and Antonelli, Alberto and Bussini, Linda and Corcione, Silvia and Giacobbe, Daniele Roberto and Marconi, Lorenzo and Pascale, Renato and Dettori, Silvia and Shbaklo, Nour and Ambretti, Simone and Gaibani, Paolo and Giani, Tommaso and Coppi, Marco and Bassetti, Matteo and De Rosa, Francesco Giuseppe and Marchese, Anna and Cavallo, Rossana and Lewis, Russell and Rossolini, Gian Maria and Viale, Pierluigi and Giannella, Maddalena},
  year = {2022},
  month = mar,
  journal = {Clinical Microbiology and Infection},
  issn = {1198-743X},
  doi = {10.1016/j.cmi.2022.03.013},
  urldate = {2022-04-30},
  abstract = {Objectives In this study we investigated the rate of susceptibility testing discrepancies between semi-automated and reference systems with carbapenem-resistant Enterobacterales (CRE) and the impact of alleged errors by semi-automated systems on guiding targeted therapy for CRE bloodstream infection (BSI). Methods This was a multicentre, retrospective study enrolling patients with monomicrobial BSI caused by CRE from January 2013 to December 2016. Nonduplicate isolates from index blood cultures tested locally with semi-automated systems were centralized at a referral laboratory and retested with a reference broth microdilution or agar dilution method. Results We enrolled 366 patients with CRE-BSI; 220 (60\%) were male, and the median age was 67~years (interquartile range, 54--76~years). When compared with the results of the reference methods, those of the semi-automated systems exhibited variable rates of very major errors (VMEs; i.e. false susceptibilities) and major errors (MEs; i.e. false resistances). The highest rates of VMEs were observed with fosfomycin (14\%) and colistin (13.9\%), and the highest rates of MEs were observed with gentamicin (21\%), fosfomycin (7.7\%), and tigecycline (34\%). Overall, VMEs and MEs led clinicians to prescribe or confirm ineffective therapy in 25 of 341 patients (7\%). Receipt of ineffective therapy supported by a misleading susceptibility test was associated with higher 30-day mortality rates by Kaplan--Meier survival curves rates compared with receipt of active therapy (56\% vs. 26\%; p~=~0.002), and the difference was confirmed after adjustment for confounders in a Cox regression model (adjusted hazard ratio: 2.91; 95\% CI, 1.62--5.22; p~{$<~$}0.001). Discussion MEs and VMEs were relatively common with semi-automated susceptibility testing systems. VMEs were associated with inappropriate use of antibiotics and poorer outcomes.},
  langid = {english},
  keywords = {Category agreement,Essential agreement,Major errors,Mortality,Very major errors},
  note = {Cited By :1
\par
Cited By :1
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022},
  file = {/Users/russelllewis/Zotero/storage/FYDKVCFJ/Bartoletti et al_2022_Clinical consequences of very major errors with semi-automated testing systems.pdf;/Users/russelllewis/Zotero/storage/EW9V8PX3/S1198743X22001525.html}
}

Objectives In this study we investigated the rate of susceptibility testing discrepancies between semi-automated and reference systems with carbapenem-resistant Enterobacterales (CRE) and the impact of alleged errors by semi-automated systems on guiding targeted therapy for CRE bloodstream infection (BSI). Methods This was a multicentre, retrospective study enrolling patients with monomicrobial BSI caused by CRE from January 2013 to December 2016. Nonduplicate isolates from index blood cultures tested locally with semi-automated systems were centralized at a referral laboratory and retested with a reference broth microdilution or agar dilution method. Results We enrolled 366 patients with CRE-BSI; 220 (60%) were male, and the median age was 67 years (interquartile range, 54–76 years). When compared with the results of the reference methods, those of the semi-automated systems exhibited variable rates of very major errors (VMEs; i.e. false susceptibilities) and major errors (MEs; i.e. false resistances). The highest rates of VMEs were observed with fosfomycin (14%) and colistin (13.9%), and the highest rates of MEs were observed with gentamicin (21%), fosfomycin (7.7%), and tigecycline (34%). Overall, VMEs and MEs led clinicians to prescribe or confirm ineffective therapy in 25 of 341 patients (7%). Receipt of ineffective therapy supported by a misleading susceptibility test was associated with higher 30-day mortality rates by Kaplan–Meier survival curves rates compared with receipt of active therapy (56% vs. 26%; p = 0.002), and the difference was confirmed after adjustment for confounders in a Cox regression model (adjusted hazard ratio: 2.91; 95% CI, 1.62–5.22; p $< $0.001). Discussion MEs and VMEs were relatively common with semi-automated susceptibility testing systems. VMEs were associated with inappropriate use of antibiotics and poorer outcomes.

@article{bruggemann.etal_2022b,
  title = {Management of Drug--Drug Interactions of Targeted Therapies for Haematological Malignancies and Triazole Antifungal Drugs},
  author = {Br{\"u}ggemann, Roger J and Verheggen, Rebecca and Boerrigter, Emmy and Stanzani, Marta and Verweij, Paul E and Blijlevens, Nicole M A and Lewis, Russell E},
  year = {2022},
  month = jan,
  journal = {The Lancet Haematology},
  volume = {9},
  number = {1},
  pages = {e58-e72},
  issn = {23523026},
  doi = {10.1016/S2352-3026(21)00232-5},
  urldate = {2022-02-25},
  langid = {english},
  keywords = {Aged,Antifungal Agents,Drug Interactions,Hematologic Neoplasms,Humans,Pharmaceutical Preparations,Triazoles},
  note = {Cited By :7
\par
Cited By :7
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022},
  file = {/Users/russelllewis/Zotero/storage/7IQW4ADS/Brüggemann et al. - 2022 - Management of drug–drug interactions of targeted t.pdf;/Users/russelllewis/Zotero/storage/XREGA4SJ/Brüggemann et al. - 2022 - Management of drug–drug interactions of targeted t.pdf}
}

@article{colombo.etal_2022,
  title = {Quandaries of Deciding When to Change First-Line Therapy in Invasive Pulmonary Aspergillosis},
  author = {Colombo, A.L. and De Almeida, J.N. and Lewis, R.E. and Kontoyiannis, D.P.},
  year = {2022},
  journal = {The Journal of antimicrobial chemotherapy},
  volume = {77},
  number = {11},
  pages = {2897--2900},
  doi = {10.1093/jac/dkac301},
  note = {Export Date: 20 November 2022
\par
Export Date: 20 November 2022}
}

@article{lamoth.etal_2022,
  title = {Investigational Antifungal Agents for Invasive Mycoses: A Clinical Perspective},
  shorttitle = {Investigational Antifungal Agents for Invasive Mycoses},
  author = {Lamoth, Frederic and Lewis, Russell E. and Kontoyiannis, Dimitrios P.},
  year = {2022},
  month = jan,
  journal = {Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America},
  pages = {ciab1070},
  issn = {1537-6591},
  doi = {10.1093/cid/ciab1070},
  abstract = {Treatment of invasive fungal infections (IFI) remains challenging, because of the limitations of the current antifungal agents (i.e. mode of administration, toxicity, drug-drug interactions), and the emergence of resistant fungal pathogens. Therefore, there is an urgent need to expand our antifungal armamentarium. Several compounds are reaching the stage of phase II or III clinical assessment. These include new drugs within the existing antifungal classes or displaying similar mechanism of activity with improved pharmacologic properties (rezafungin, ibrexafungerp) or first-in-class drugs with novel mechanisms of action (olorofim, fosmanogepix). Although critical information regarding the performance of these agents in heavily immunosuppressed patients is pending, they may provide useful additions to current therapies in some clinical scenarios, including IFI caused by azole-resistant Aspergillus or multi-resistant fungal pathogens (e.g. Candida auris, Lomentospora prolificans). However, their limited activity against Mucorales and some other opportunistic molds (e.g. some Fusarium spp.) persists as a major unmet need.},
  langid = {english},
  pmid = {34986246},
  keywords = {APX001,CD101,E1211,F901318,SCY078,VT-1129,VT-1161,VT-1598},
  note = {Cited By :5
\par
Cited By :5
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022}
}

Treatment of invasive fungal infections (IFI) remains challenging, because of the limitations of the current antifungal agents (i.e. mode of administration, toxicity, drug-drug interactions), and the emergence of resistant fungal pathogens. Therefore, there is an urgent need to expand our antifungal armamentarium. Several compounds are reaching the stage of phase II or III clinical assessment. These include new drugs within the existing antifungal classes or displaying similar mechanism of activity with improved pharmacologic properties (rezafungin, ibrexafungerp) or first-in-class drugs with novel mechanisms of action (olorofim, fosmanogepix). Although critical information regarding the performance of these agents in heavily immunosuppressed patients is pending, they may provide useful additions to current therapies in some clinical scenarios, including IFI caused by azole-resistant Aspergillus or multi-resistant fungal pathogens (e.g. Candida auris, Lomentospora prolificans). However, their limited activity against Mucorales and some other opportunistic molds (e.g. some Fusarium spp.) persists as a major unmet need.

@article{parisi.etal_2022,
  title = {Long-{{Term Outcome After Adoptive Immunotherapy With Natural Killer Cells}}: {{Alloreactive NK Cell Dose Still Matters}}},
  author = {Parisi, S. and Ruggeri, L. and Dan, E. and Rizzi, S. and Sinigaglia, B. and Ocadlikova, D. and Bontadini, A. and Giudice, V. and Urbani, E. and Ciardelli, S. and Sartor, C. and Cristiano, G. and Nanni, J. and Zannoni, L. and Chirumbolo, G. and Arpinati, M. and Lewis, R.E. and Bonifazi, F. and Marconi, G. and Martinelli, G. and Papayannidis, C. and Paolini, S. and Velardi, A. and Cavo, M. and Lemoli, R.M. and Curti, A.},
  year = {2022},
  journal = {Frontiers in Immunology},
  volume = {12},
  doi = {10.3389/fimmu.2021.804988},
  note = {Export Date: 20 November 2022
\par
Export Date: 20 November 2022},
  file = {/Users/russelllewis/Zotero/storage/KJHBJLXN/Parisi et al_2022_Long-Term Outcome After Adoptive Immunotherapy With Natural Killer Cells.pdf}
}

@article{pascale.etal_2022,
  title = {Carbapenem-Resistant Bacteria in an Intensive Care Unit during the Coronavirus Disease 2019 ({{COVID-19}}) Pandemic: {{A}} Multicenter before-and-after Cross-Sectional Study},
  author = {Pascale, R. and Bussini, L. and Gaibani, P. and Bovo, F. and Fornaro, G. and Lombardo, D. and Ambretti, S. and Pensalfine, G. and Appolloni, L. and Bartoletti, M. and Tedeschi, S. and Tumietto, F. and Lewis, R. and Viale, P. and Giannella, M.},
  year = {2022},
  journal = {Infection Control and Hospital Epidemiology},
  volume = {43},
  number = {4},
  pages = {461--466},
  doi = {10.1017/ice.2021.144},
  note = {Cited By :10
\par
Cited By :10
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022},
  file = {/Users/russelllewis/Zotero/storage/JWHP4CNC/Pascale et al_2022_Carbapenem-resistant bacteria in an intensive care unit during the coronavirus.pdf}
}

@article{stemler.etal_2022a,
  title = {Antifungal Prophylaxis in Adult Patients with Acute Myeloid Leukaemia Treated with Novel Targeted Therapies: A Systematic Review and Expert Consensus Recommendation from the {{European Hematology Association}}},
  shorttitle = {Antifungal Prophylaxis in Adult Patients with Acute Myeloid Leukaemia Treated with Novel Targeted Therapies},
  author = {Stemler, Jannik and {de Jonge}, Nick and Skoetz, Nicole and Sink{\'o}, J{\'a}nos and Br{\"u}ggemann, Roger J and Busca, Alessandro and {Ben-Ami}, Ronen and R{\'a}{\v c}il, Zden{\v e}k and Piechotta, Vanessa and Lewis, Russell and Cornely, Oliver A},
  year = {2022},
  month = may,
  journal = {The Lancet Haematology},
  volume = {9},
  number = {5},
  pages = {e361-e373},
  issn = {2352-3026},
  doi = {10.1016/S2352-3026(22)00073-4},
  urldate = {2022-04-30},
  abstract = {On the basis of improved overall survival, treatment guidelines strongly recommend antifungal prophylaxis during remission induction chemotherapy for patients with acute myeloid leukaemia. Many novel targeted agents are metabolised by cytochrome P450, but potential drug--drug interactions (DDIs) and the resulting risk--benefit ratio have not been assessed in clinical trials, leading to uncertainty in clinical management. Consequently, the European Haematology Association commissioned experts in the field of infectious diseases, haematology, oncology, clinical pharmacology, and methodology to develop up-to-date recommendations on the role of antifungal prophylaxis and management of pharmacokinetic DDIs with triazole antifungals. A systematic literature review was performed according to Cochrane methods, and recommendations were developed by use of the Grading of Recommendations Assessment, Development and Evaluation Evidence to Decision framework. We searched MEDLINE, Embase, and Cochrane Library, including Central Register of Controlled Trials, for randomised controlled trials and systematic reviews published from inception to March 10, 2020. We excluded studies that were not published in English. Evidence for any identified novel agent that is active against acute myeloid leukaemia was reviewed for the following outcomes: incidence of invasive fungal disease, prolongation of hospitalisation, days spent in intensive-care unit, mortality due to invasive fungal disease, quality of life, and potential DDIs. Recommendations and consensus statements were compiled for each targeted drug for patients with acute myeloid leukaemia and each specific setting. Evidence-based recommendations were developed for hypomethylating agents, midostaurin, and the venetoclax--hypomethylating agent combination. For all other agents, consensus statements were given for specific therapeutic settings, specifically for the management of patients with relapsed or refractory acute myeloid leukaemia, monotherapy, and combination with chemotherapy. Antifungal prophylaxis is recommended with moderate strength in most settings, and strongly recommended if the novel acute myeloid leukaemia agent is administered in combination with intensive induction chemotherapy. For ivosidenib, lestaurtinib, quizartinib, and venetoclax, we moderately recommend adjusting the dose of the antileukaemic agent during administration of triazoles. This is the first guidance supporting clinical decision making on antifungal prophylaxis in recipients of novel targeted drugs for acute myeloid leukaemia. Future studies including therapeutic drug monitoring will need to determine the role of dosage adjustment of novel antileukaemic drugs during concomitant administration of CYP3A4-inhibiting antifungals with respect to adverse effects and remission status.},
  langid = {english},
  note = {Cited By :3
\par
Cited By :3
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022},
  file = {/Users/russelllewis/Zotero/storage/I3Y7SR2L/Stemler et al_2022_Antifungal prophylaxis in adult patients with acute myeloid leukaemia treated.pdf}
}

On the basis of improved overall survival, treatment guidelines strongly recommend antifungal prophylaxis during remission induction chemotherapy for patients with acute myeloid leukaemia. Many novel targeted agents are metabolised by cytochrome P450, but potential drug–drug interactions (DDIs) and the resulting risk–benefit ratio have not been assessed in clinical trials, leading to uncertainty in clinical management. Consequently, the European Haematology Association commissioned experts in the field of infectious diseases, haematology, oncology, clinical pharmacology, and methodology to develop up-to-date recommendations on the role of antifungal prophylaxis and management of pharmacokinetic DDIs with triazole antifungals. A systematic literature review was performed according to Cochrane methods, and recommendations were developed by use of the Grading of Recommendations Assessment, Development and Evaluation Evidence to Decision framework. We searched MEDLINE, Embase, and Cochrane Library, including Central Register of Controlled Trials, for randomised controlled trials and systematic reviews published from inception to March 10, 2020. We excluded studies that were not published in English. Evidence for any identified novel agent that is active against acute myeloid leukaemia was reviewed for the following outcomes: incidence of invasive fungal disease, prolongation of hospitalisation, days spent in intensive-care unit, mortality due to invasive fungal disease, quality of life, and potential DDIs. Recommendations and consensus statements were compiled for each targeted drug for patients with acute myeloid leukaemia and each specific setting. Evidence-based recommendations were developed for hypomethylating agents, midostaurin, and the venetoclax–hypomethylating agent combination. For all other agents, consensus statements were given for specific therapeutic settings, specifically for the management of patients with relapsed or refractory acute myeloid leukaemia, monotherapy, and combination with chemotherapy. Antifungal prophylaxis is recommended with moderate strength in most settings, and strongly recommended if the novel acute myeloid leukaemia agent is administered in combination with intensive induction chemotherapy. For ivosidenib, lestaurtinib, quizartinib, and venetoclax, we moderately recommend adjusting the dose of the antileukaemic agent during administration of triazoles. This is the first guidance supporting clinical decision making on antifungal prophylaxis in recipients of novel targeted drugs for acute myeloid leukaemia. Future studies including therapeutic drug monitoring will need to determine the role of dosage adjustment of novel antileukaemic drugs during concomitant administration of CYP3A4-inhibiting antifungals with respect to adverse effects and remission status.

@article{viciani.etal_2022,
  title = {Critically Ill Patients with {{COVID-19}} Show Lung Fungal Dysbiosis with Reduced Microbial Diversity in Patients Colonized with {{Candida}} Spp.},
  author = {Viciani, E. and Gaibani, P. and Castagnetti, A. and Liberatore, A. and Bartoletti, M. and Viale, P. and Lazzarotto, T. and Ambretti, S. and Lewis, R. and Cricca, M.},
  year = {2022},
  journal = {International Journal of Infectious Diseases},
  volume = {117},
  pages = {233--240},
  doi = {10.1016/j.ijid.2022.02.011},
  note = {Cited By :5
\par
Cited By :5
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022},
  file = {/Users/russelllewis/Zotero/storage/33T5736N/Viciani et al_2022_Critically ill patients with COVID-19 show lung fungal dysbiosis with reduced.pdf}
}

@article{axell-house.etal_2021a,
  title = {Breakthrough Mucormycosis Developing on Mucorales-Active Antifungals Portrays a Poor Prognosis in Patients with Hematologic Cancer},
  author = {{Axell-House}, D.B. and Wurster, S. and Jiang, Y. and Kyvernitakis, A. and Lewis, R.E. and Tarrand, J.J. and Raad, I.I. and Kontoyiannis, D.P.},
  year = {2021},
  journal = {Journal of Fungi},
  volume = {7},
  number = {3},
  doi = {10.3390/jof7030217},
  note = {Cited By :6
\par
Cited By :6
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022},
  file = {/Users/russelllewis/Zotero/storage/2TUPYQXL/Axell-House et al_2021_Breakthrough mucormycosis developing on mucorales-active antifungals portrays a.pdf}
}

@article{bartoletti.etal_2021,
  title = {Epidemiology of {{Invasive Pulmonary Aspergillosis}} among {{Intubated Patients}} with {{COVID-19}}: {{A Prospective Study}}},
  author = {Bartoletti, M. and Pascale, R. and Cricca, M. and Rinaldi, M. and Maccaro, A. and Bussini, L. and Fornaro, G. and Tonetti, T. and Pizzilli, G. and Francalanci, E. and Giuntoli, L. and Rubin, A. and Moroni, A. and Ambretti, S. and Trapani, F. and Vatamanu, O. and Ranieri, V.M. and Castelli, A. and Baiocchi, M. and Lewis, R. and Giannella, M. and Viale, P.},
  year = {2021},
  journal = {Clinical Infectious Diseases},
  volume = {73},
  number = {11},
  pages = {E3606-E3614},
  doi = {10.1093/cid/ciaa1065},
  note = {Cited By :175
\par
Cited By :175
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022},
  file = {/Users/russelllewis/Zotero/storage/JKPE7K4P/Bartoletti et al_2021_Epidemiology of Invasive Pulmonary Aspergillosis among Intubated Patients with.pdf}
}

@article{gaibani.etal_2021a,
  title = {The Lower Respiratory Tract Microbiome of Critically Ill Patients with {{COVID-19}}},
  author = {Gaibani, P. and Viciani, E. and Bartoletti, M. and Lewis, R.E. and Tonetti, T. and Lombardo, D. and Castagnetti, A. and Bovo, F. and Horna, C.S. and Ranieri, M. and Viale, P. and Re, M.C. and Ambretti, S.},
  year = {2021},
  journal = {Scientific Reports},
  volume = {11},
  number = {1},
  doi = {10.1038/s41598-021-89516-6},
  note = {Cited By :22
\par
Cited By :22
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022},
  file = {/Users/russelllewis/Zotero/storage/V6PZPQFN/Gaibani et al_2021_The lower respiratory tract microbiome of critically ill patients with COVID-19.pdf}
}

@article{giannella.etal_2021,
  title = {Development of a {{Risk Prediction Model}} for {{Carbapenem-resistant Enterobacteriaceae Infection}} after {{Liver Transplantation}}: {{A Multinational Cohort Study}}},
  author = {Giannella, M. and Freire, M. and Rinaldi, M. and Abdala, E. and Rubin, A. and Mularoni, A. and Gruttadauria, S. and Grossi, P. and Shbaklo, N. and Tandoi, F. and Ferrarese, A. and Burra, P. and Fernandes, R. and Aranha Camargo, L.F. and Asensio, A. and Alagna, L. and Bandera, A. and Simkins, J. and Abbo, L. and Halpern, M. and Santana Girao, E. and Valerio, M. and Mu{\~n}oz, P. and Fernandez Yunquera, A. and Statlender, L. and Yahav, D. and Franceschini, E. and Graziano, E. and Morelli, M.C. and Cescon, M. and Viale, P. and Lewis, R. and Bartoletti, M. and Pascale, R. and Campoli, C. and Coladonato, S. and Cristini, F. and Tumietto, F. and Siniscalchi, A. and Laici, C. and Ambretti, S. and Romagnoli, R. and De Rosa, F.G. and Muscatello, A. and Mangioni, D. and Gori, A. and Antonelli, B. and Dondossola, D. and Rossi, G. and Invernizzi, F. and Peghin, M. and Cillo, U. and Mussini, C. and Benedetto, F.D. and Terrabuio, D.R.B. and Bittante, C.D. and Toniolo, A.D.R. and Balbi, E. and Garcia, J.H.P. and Morr{\'a}s, I. and Ramos, A. and Cruz, A.F. and Salcedo, M.},
  year = {2021},
  journal = {Clinical Infectious Diseases},
  volume = {73},
  number = {4},
  pages = {E955-E966},
  doi = {10.1093/cid/ciab109},
  note = {Cited By :7
\par
Cited By :7
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022},
  file = {/Users/russelllewis/Zotero/storage/D9GA3N85/Giannella et al_2021_Development of a Risk Prediction Model for Carbapenem-resistant.pdf}
}

@article{glampedakis.etal_2021,
  title = {Invasive {{Aspergillosis Due}} to {{Aspergillus Section Usti}}: {{A Multicenter Retrospective Study}}},
  author = {Glampedakis, E. and Cassaing, S. and Fekkar, A. and Dannaoui, E. and Bougnoux, M.-E. and Bretagne, S. and Neofytos, D. and Schreiber, P.W. and Hennequin, C. and Morio, F. and Shadrivova, O. and Bongomin, F. and {Fern{\'a}ndez-Ruiz}, M. and Bellanger, A.P. and {Arikan-Akdagli}, S. and Erard, V. and Aigner, M. and Paolucci, M. and Khanna, N. and Charpentier, E. and Bonnal, C. and Brun, S. and Gabriel, F. and Riat, A. and Zbinden, R. and Le Pape, P. and Klimko, N. and Lewis, R.E. and Richardson, M. and {\.I}nkaya, A.C. and Coste, A.T. and Bochud, P.-Y. and Lamoth, F.},
  year = {2021},
  journal = {Clinical Infectious Diseases},
  volume = {72},
  number = {8},
  pages = {1379--1385},
  doi = {10.1093/cid/ciaa230},
  note = {Cited By :12
\par
Cited By :12
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022},
  file = {/Users/russelllewis/Zotero/storage/RLFB2JWF/Glampedakis et al_2021_Invasive Aspergillosis Due to Aspergillus Section Usti.pdf}
}

@article{gudiol.etal_2021,
  title = {Chimeric Antigen Receptor {{T-cell}} Therapy for the Treatment of Lymphoid Malignancies: Is There an Excess Risk for Infection?},
  author = {Gudiol, C. and Lewis, R.E. and Strati, P. and Kontoyiannis, D.P.},
  year = {2021},
  journal = {The Lancet Haematology},
  volume = {8},
  number = {3},
  pages = {e216-e228},
  doi = {10.1016/S2352-3026(20)30376-8},
  note = {Cited By :17
\par
Cited By :17
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022}
}

@article{johnson.etal_2021,
  title = {Reply to {{Day}} et Al},
  author = {Johnson, M.D. and Lewis, R.E. and Dodds Ashley, E.S. and Perfect, J.R. and Kontoyiannis, D.P.},
  year = {2021},
  journal = {Journal of Infectious Diseases},
  volume = {224},
  number = {9},
  pages = {1627--1628},
  doi = {10.1093/infdis/jiab183},
  note = {Cited By :1
\par
Cited By :1
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022},
  file = {/Users/russelllewis/Zotero/storage/4QWI8Y9Z/Johnson et al_2021_Reply to Day et al.pdf}
}

@article{lamoth.etal_2021,
  title = {Navigating the Uncertainties of {{COVID-19}} Associated Aspergillosis ({{CAPA}}): {{A}} Comparison with Influenza Associated Aspergillosis ({{IAPA}})},
  shorttitle = {Navigating the Uncertainties of {{COVID-19}} Associated Aspergillosis ({{CAPA}})},
  author = {Lamoth, Frederic and Lewis, Russell E. and Walsh, Thomas J. and Kontoyiannis, Dimitrios P.},
  year = {2021},
  month = mar,
  journal = {The Journal of Infectious Diseases},
  pages = {jiab163},
  issn = {1537-6613},
  doi = {10.1093/infdis/jiab163},
  abstract = {Invasive pulmonary aspergillosis (IPA) is increasingly recognized as a life-threatening superinfection of severe respiratory viral infections, such as influenza. The pandemic of Coronavirus Disease 2019 (COVID-19) due to emerging SARS-CoV-2 rose concern about the eventuality of IPA complicating COVID-19 in intensive care unit mechanically-ventilated patients. While the association between severe influenza and IPA has been demonstrated, it remains unclear whether SARS-CoV-2 infection represents a specific risk factor for IPA. A variable incidence of such complication has been previously reported, which can be partly attributed to differences in diagnostic strategy and IPA definitions, and possibly local environmental/epidemiological factors. In this article, we discuss the similarities and differences between influenza-associated pulmonary aspergillosis (IAPA) and COVID-19-associated pulmonary aspergillosis (CAPA). Compared to IAPA, the majority of CAPA cases have been classified as putative rather than proven/probable IPA, in the absence of positive serum galactomannan or histopathologic evidence of angio-invasion. Discrimination between Aspergillus airways colonization and CAPA is difficult. Distinct physiopathology and cytokine profiles of influenza and COVID-19 may explain these discrepancies. Whether CAPA represents a distinct entity is still debatable and many questions remain unanswered, such as its actual incidence, the predisposing role of corticosteroids or immunomodulatory drugs, and the indications for antifungal therapy.},
  langid = {english},
  pmcid = {PMC8083649},
  pmid = {33770176},
  keywords = {acute respiratory distress syndrome,Aspergillus fumigatus,corticosteroids,flu,intensive care unit,mechanical ventilation,pneumonia,SARS-CoV-2},
  note = {Cited By :28
\par
Cited By :28
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022},
  file = {/Users/russelllewis/Zotero/storage/3FQU59WF/Lamoth et al. - 2021 - Navigating the uncertainties of COVID-19 associate.pdf;/Users/russelllewis/Zotero/storage/4LABBGTB/Lamoth et al. - 2021 - Navigating the Uncertainties of COVID-19–Associate.pdf;/Users/russelllewis/Zotero/storage/XMC3PH5K/Lamoth et al_2021_Navigating the uncertainties of COVID-19 associated aspergillosis (CAPA).pdf}
}

Invasive pulmonary aspergillosis (IPA) is increasingly recognized as a life-threatening superinfection of severe respiratory viral infections, such as influenza. The pandemic of Coronavirus Disease 2019 (COVID-19) due to emerging SARS-CoV-2 rose concern about the eventuality of IPA complicating COVID-19 in intensive care unit mechanically-ventilated patients. While the association between severe influenza and IPA has been demonstrated, it remains unclear whether SARS-CoV-2 infection represents a specific risk factor for IPA. A variable incidence of such complication has been previously reported, which can be partly attributed to differences in diagnostic strategy and IPA definitions, and possibly local environmental/epidemiological factors. In this article, we discuss the similarities and differences between influenza-associated pulmonary aspergillosis (IAPA) and COVID-19-associated pulmonary aspergillosis (CAPA). Compared to IAPA, the majority of CAPA cases have been classified as putative rather than proven/probable IPA, in the absence of positive serum galactomannan or histopathologic evidence of angio-invasion. Discrimination between Aspergillus airways colonization and CAPA is difficult. Distinct physiopathology and cytokine profiles of influenza and COVID-19 may explain these discrepancies. Whether CAPA represents a distinct entity is still debatable and many questions remain unanswered, such as its actual incidence, the predisposing role of corticosteroids or immunomodulatory drugs, and the indications for antifungal therapy.

@article{lamoth.etal_2021b,
  title = {Role and Interpretation of Antifungal Susceptibility Testing for the Management of Invasive Fungal Infections},
  author = {Lamoth, F. and Lewis, R.E. and Kontoyiannis, D.P.},
  year = {2021},
  journal = {Journal of Fungi},
  volume = {7},
  number = {1},
  pages = {1--21},
  doi = {10.3390/jof7010017},
  note = {Cited By :12
\par
Cited By :12
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022},
  file = {/Users/russelllewis/Zotero/storage/7IY7C67Y/Lamoth et al_2021_Role and interpretation of antifungal susceptibility testing for the management.pdf}
}

@article{lewis.andes_2021a,
  title = {Managing Uncertainty in Antifungal Dosing: Antibiograms, Therapeutic Drug Monitoring and Drug-Drug Interactions},
  author = {Lewis, R.E. and Andes, D.R.},
  year = {2021},
  journal = {Current opinion in infectious diseases},
  volume = {34},
  number = {4},
  pages = {288--296},
  doi = {10.1097/QCO.0000000000000740},
  note = {Cited By :2
\par
Cited By :2
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022}
}

@article{rinaldi.etal_2021,
  title = {Breakthrough Invasive Fungal Infection after Liver Transplantation in Patients on Targeted Antifungal Prophylaxis: {{A}} Prospective Multicentre Study},
  author = {Rinaldi, M. and Bartoletti, M. and Ferrarese, A. and Franceschini, E. and Campoli, C. and Coladonato, S. and Pascale, R. and Tedeschi, S. and Gatti, M. and Cricca, M. and Ambretti, S. and Siniscalchi, A. and Morelli, M.C. and Cescon, M. and Cillo, U. and Di Benedetto, F. and Burra, P. and Mussini, C. and Cristini, F. and Lewis, R. and Viale, P. and Giannella, M.},
  year = {2021},
  journal = {Transplant Infectious Disease},
  volume = {23},
  number = {4},
  doi = {10.1111/tid.13608},
  note = {Cited By :5
\par
Cited By :5
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022},
  file = {/Users/russelllewis/Zotero/storage/53N4GISU/Rinaldi et al_2021_Breakthrough invasive fungal infection after liver transplantation in patients.pdf}
}

@article{stanzani.etal_2021,
  title = {Early Low-Dose Computed Tomography with Pulmonary Angiography to Improve the Early Diagnosis of Invasive Mould Disease in Patients with Haematological Malignancies: {{A}} Pilot Study},
  author = {Stanzani, M. and Sassi, C. and Lewis, R. and Sartor, C. and Rasetto, G. and Cavo, M. and Battista, G.},
  year = {2021},
  journal = {Journal of Infection},
  volume = {83},
  number = {3},
  pages = {371--380},
  doi = {10.1016/j.jinf.2021.06.019},
  note = {Export Date: 20 November 2022
\par
Export Date: 20 November 2022}
}

@article{verweij.etal_2021,
  title = {Taskforce Report on the Diagnosis and Clinical Management of {{COVID-19}} Associated Pulmonary Aspergillosis},
  author = {Verweij, P.E. and Br{\"u}ggemann, R.J.M. and Azoulay, E. and Bassetti, M. and Blot, S. and Buil, J.B. and Calandra, T. and Chiller, T. and Clancy, C.J. and Cornely, O.A. and Depuydt, P. and Koehler, P. and Lagrou, K. and {de Lange}, D. and {Lass-Fl{\"o}rl}, C. and Lewis, R.E. and Lortholary, O. and Liu, P.-W.L. and Maertens, J. and Nguyen, M.H. and Patterson, T.F. and Rijnders, B.J.A. and Rodriguez, A. and Rogers, T.R. and Schouten, J.A. and Wauters, J. and {van de Veerdonk}, F.L. and {Martin-Loeches}, I.},
  year = {2021},
  journal = {Intensive Care Medicine},
  volume = {47},
  number = {8},
  pages = {819--834},
  doi = {10.1007/s00134-021-06449-4},
  note = {Cited By :51
\par
Cited By :51
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022},
  file = {/Users/russelllewis/Zotero/storage/ZQ89K83E/Verweij et al_2021_Taskforce report on the diagnosis and clinical management of COVID-19.pdf}
}

@article{bartoletti.etal_2020,
  title = {Prognostic {{Role}} of {{Bacterial}} and {{Fungal Infections}} in {{Patients}} with {{Liver Cirrhosis}} with and without {{Acute-on-Chronic Liver Failure}}: {{A Prospective}} 2-{{Center Study}}},
  author = {Bartoletti, M. and Baldassarre, M. and Domenicali, M. and Lewis, R.E. and Giannella, M. and Antognoli, A. and Rinaldi, M. and Zaccherini, G. and Verucchi, G. and Marconi, L. and Tam{\`e}, M. and Berardi, S. and Napoli, L. and Siniscalchi, A. and Fabbri, A. and Biselli, M. and Tufoni, M. and Pavarin, R.M. and Trevisani, F. and Viale, P. and Bernardi, M. and Caraceni, P.},
  year = {2020},
  journal = {Open Forum Infectious Diseases},
  volume = {7},
  number = {11},
  doi = {10.1093/ofid/ofaa453},
  note = {Cited By :4
\par
Cited By :4
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022},
  file = {/Users/russelllewis/Zotero/storage/G347WWLC/Bartoletti et al_2020_Prognostic Role of Bacterial and Fungal Infections in Patients with Liver.pdf}
}

@article{coppola.etal_2020,
  title = {Ceftolozane-Tazobactam Treatment of Hypervirulent Multidrug Resistant Pseudomonas Aeruginosa Infections in Neutropenic Patients},
  author = {Coppola, P.E. and Gaibani, P. and Sartor, C. and Ambretti, S. and Lewis, R.E. and Sassi, C. and Pignatti, M. and Paolini, S. and Curti, A. and Castagnetti, F. and Ursi, M. and Cavo, M. and Stanzani, M.},
  year = {2020},
  journal = {Microorganisms},
  volume = {8},
  number = {12},
  pages = {1--11},
  doi = {10.3390/microorganisms8122055},
  note = {Export Date: 20 November 2022
\par
Export Date: 20 November 2022},
  file = {/Users/russelllewis/Zotero/storage/7BSG6JRR/Coppola et al_2020_Ceftolozane-tazobactam treatment of hypervirulent multidrug resistant.pdf}
}

@article{fernandez-cruz.etal_2020,
  title = {How Long Do We Need to Treat an Invasive Mold Disease in Hematology Patients? Factors Influencing Duration of Therapy and Future Questions},
  author = {{Fern{\'a}ndez-Cruz}, A. and Lewis, R.E. and Kontoyiannis, D.P.},
  year = {2020},
  journal = {Clinical Infectious Diseases},
  volume = {71},
  number = {3},
  pages = {685--692},
  doi = {10.1093/cid/ciz1195},
  note = {Cited By :5
\par
Cited By :5
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022},
  file = {/Users/russelllewis/Zotero/storage/9APYFTMX/Fernández-Cruz et al_2020_How long do we need to treat an invasive mold disease in hematology patients.pdf}
}

@article{garcia-vidal.etal_2020,
  title = {Combination Antifungal Therapy for Breakthrough Invasive Mould Disease in Patients with Haematological Malignancies: {{When}} Management Reasoning Eclipses Evidence-Based Medicine},
  author = {{Garcia-Vidal}, C. and Lewis, R.E. and Kontoyiannis, D.P.},
  year = {2020},
  journal = {Journal of Antimicrobial Chemotherapy},
  volume = {75},
  number = {11},
  pages = {3096--3098},
  doi = {10.1093/jac/dkaa281},
  note = {Cited By :1
\par
Cited By :1
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022},
  file = {/Users/russelllewis/Zotero/storage/U7DLH5ZF/Garcia-Vidal et al_2020_Combination antifungal therapy for breakthrough invasive mould disease in.pdf}
}

@article{giannella.etal_2020a,
  title = {Follow-up Blood Cultures Are Associated with Improved Outcome of Patients with Gram-Negative Bloodstream Infections: Retrospective Observational Cohort Study},
  author = {Giannella, M. and Pascale, R. and Pancaldi, L. and Monari, C. and Ianniruberto, S. and Malosso, P. and Bussini, L. and Bartoletti, M. and Tedeschi, S. and Ambretti, S. and Lewis, R. and Viale, P.},
  year = {2020},
  journal = {Clinical Microbiology and Infection},
  volume = {26},
  number = {7},
  pages = {897--903},
  doi = {10.1016/j.cmi.2020.01.023},
  note = {Cited By :17
\par
Cited By :17
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022},
  file = {/Users/russelllewis/Zotero/storage/YQWBS8LU/Giannella et al_2020_Follow-up blood cultures are associated with improved outcome of patients with.pdf}
}

@article{lewis.kontoyiannis_2020,
  title = {Infectious Disease Consultation for Candidaemia},
  author = {Lewis, R.E. and Kontoyiannis, D.P.},
  year = {2020},
  journal = {The Lancet Infectious Diseases},
  volume = {20},
  number = {2},
  pages = {164},
  doi = {10.1016/S1473-3099(19)30682-6},
  note = {Export Date: 20 November 2022
\par
Export Date: 20 November 2022},
  file = {/Users/russelllewis/Zotero/storage/VPD6WQHT/Lewis_Kontoyiannis_2020_Infectious disease consultation for candidaemia.pdf}
}

@article{lewis.kontoyiannis_2020a,
  title = {Chimeric Antigen Receptor {{T-cell}} Immunotherapy and Need for Prophylaxis for Invasive Mold Infections},
  author = {Lewis, R.E. and Kontoyiannis, D.P.},
  year = {2020},
  journal = {Clinical Infectious Diseases},
  volume = {71},
  number = {7},
  pages = {1802--1803},
  doi = {10.1093/cid/ciaa031},
  note = {Cited By :6
\par
Cited By :6
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022},
  file = {/Users/russelllewis/Zotero/storage/ZTYFYHFC/Lewis_Kontoyiannis_2020_Chimeric antigen receptor T-cell immunotherapy and need for prophylaxis for.pdf}
}

@article{tolomelli.etal_2020,
  title = {The Timing of Plerixafor Addition to {{G-Csf}} and Chemotherapy Affects Immunological Recovery after Autologous Stem Cell Transplant in Multiple Myeloma},
  author = {Tolomelli, G. and Mancuso, K. and Tacchetti, P. and Patriarca, F. and Galli, M. and Pantani, L. and Zannetti, B. and Motta, M.R. and Rizzi, S. and Dan, E. and Sinigaglia, B. and Giudice, V. and Olmo, A. and Arpinati, M. and Chirumbolo, G. and Fanin, R. and Lewis, R.E. and Paris, L. and Bonifazi, F. and Cavo, M. and Curti, A. and Lemoli, R.M.},
  year = {2020},
  journal = {Bone Marrow Transplantation},
  volume = {55},
  number = {5},
  pages = {946--954},
  doi = {10.1038/s41409-019-0756-1},
  note = {Cited By :3
\par
Cited By :3
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022}
}

@article{verweij.etal_2020b,
  title = {Review of Influenza-Associated Pulmonary Aspergillosis in {{ICU}} Patients and Proposal for a Case Definition: An Expert Opinion},
  author = {Verweij, P.E. and Rijnders, B.J.A. and Br{\"u}ggemann, R.J.M. and Azoulay, E. and Bassetti, M. and Blot, S. and Calandra, T. and Clancy, C.J. and Cornely, O.A. and Chiller, T. and Depuydt, P. and Giacobbe, D.R. and Janssen, N.A.F. and Kullberg, B.-J. and Lagrou, K. and {Lass-Fl{\"o}rl}, C. and Lewis, R.E. and Liu, P.W.-L. and Lortholary, O. and Maertens, J. and {Martin-Loeches}, I. and Nguyen, M.H. and Patterson, T.F. and Rogers, T.R. and Schouten, J.A. and Spriet, I. and Vanderbeke, L. and Wauters, J. and {van de Veerdonk}, F.L.},
  year = {2020},
  journal = {Intensive Care Medicine},
  volume = {46},
  number = {8},
  pages = {1524--1535},
  doi = {10.1007/s00134-020-06091-6},
  note = {Cited By :166
\par
Cited By :166
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022},
  file = {/Users/russelllewis/Zotero/storage/U34ZW957/Verweij et al_2020_Review of influenza-associated pulmonary aspergillosis in ICU patients and.pdf}
}

@article{zaghi.etal_2020,
  title = {Serum Bactericidal Titres for Monitoring Antimicrobial Therapy: Current Status and Potential Role in the Management of Multidrug-Resistant {{Gram-negative}} Infections},
  author = {Zaghi, I. and Gaibani, P. and Campoli, C. and Bartoletti, M. and Giannella, M. and Ambretti, S. and Viale, P. and Lewis, R.E.},
  year = {2020},
  journal = {Clinical Microbiology and Infection},
  volume = {26},
  number = {10},
  pages = {1338--1344},
  doi = {10.1016/j.cmi.2020.04.036},
  note = {Cited By :3
\par
Cited By :3
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022},
  file = {/Users/russelllewis/Zotero/storage/MF7UQ78Y/Zaghi et al_2020_Serum bactericidal titres for monitoring antimicrobial therapy.pdf}
}

@article{adler-moore.etal_2019,
  title = {Preclinical {{Safety}}, {{Tolerability}}, {{Pharmacokinetics}}, {{Pharmacodynamics}}, and {{Antifungal Activity}} of {{Liposomal Amphotericin B}}},
  author = {{Adler-Moore}, J. and Lewis, R.E. and Br{\"u}ggemann, R.J.M. and Rijnders, B.J.A. and Groll, A.H. and Walsh, T.J.},
  year = {2019},
  journal = {Clinical Infectious Diseases},
  volume = {68},
  pages = {S244-S259},
  doi = {10.1093/cid/ciz064},
  note = {Cited By :23
\par
Cited By :23
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022},
  file = {/Users/russelllewis/Zotero/storage/6XRM4Q47/Adler-Moore et al_2019_Preclinical Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and.pdf}
}

@article{bartoletti.etal_2019,
  title = {Extended Infusion of {$\beta$}-Lactams for Bloodstream Infection in Patients with Liver Cirrhosis: {{An}} Observational Multicenter Study},
  author = {Bartoletti, M. and Giannella, M. and Lewis, R.E. and Caraceni, P. and Tedeschi, S. and Paul, M. and Schramm, C. and Bruns, T. and Merli, M. and {Cobos-Trigueros}, N. and Seminari, E. and Retamar, P. and Mu{\~n}oz, P. and Tumbarello, M. and Burra, P. and Cerenzia, M.T. and Barsic, B. and Calbo, E. and Maraolo, A.E. and Petrosillo, N. and {Galan-Ladero}, M.A. and D'Offizi, G. and {Zak-Doron}, Y. and {Rodriguez-Ba{\~n}o}, J. and Baldassarre, M. and Verucchi, G. and Domenicali, M. and Bernardi, M. and Viale, P.},
  year = {2019},
  journal = {Clinical Infectious Diseases},
  volume = {69},
  number = {10},
  pages = {1731--1739},
  doi = {10.1093/cid/ciz032},
  note = {Cited By :16
\par
Cited By :16
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022},
  file = {/Users/russelllewis/Zotero/storage/MKS8H9M3/Bartoletti et al_2019_Extended infusion of β-lactams for bloodstream infection in patients with liver.pdf}
}

@article{cornely.etal_2019a,
  title = {Global Guideline for the Diagnosis and Management of Mucormycosis: An Initiative of the {{European Confederation}} of {{Medical Mycology}} in Cooperation with the {{Mycoses Study Group Education}} and {{Research Consortium}}},
  author = {Cornely, O.A. and {Alastruey-Izquierdo}, A. and Arenz, D. and Chen, S.C.A. and Dannaoui, E. and Hochhegger, B. and Hoenigl, M. and Jensen, H.E. and Lagrou, K. and Lewis, R.E. and Mellinghoff, S.C. and Mer, M. and Pana, Z.D. and Seidel, D. and Sheppard, D.C. and Wahba, R. and Akova, M. and Alanio, A. and {Al-Hatmi}, A.M.S. and {Arikan-Akdagli}, S. and Badali, H. and {Ben-Ami}, R. and Bonifaz, A. and Bretagne, S. and Castagnola, E. and Chayakulkeeree, M. and Colombo, A.L. and {Corzo-Le{\'o}n}, D.E. and Drgona, L. and Groll, A.H. and Guinea, J. and Heussel, C.-P. and Ibrahim, A.S. and Kanj, S.S. and Klimko, N. and Lackner, M. and Lamoth, F. and Lanternier, F. and {Lass-Floerl}, C. and Lee, D.-G. and Lehrnbecher, T. and Lmimouni, B.E. and Mares, M. and Maschmeyer, G. and Meis, J.F. and Meletiadis, J. and Morrissey, C.O. and Nucci, M. and Oladele, R. and Pagano, L. and Pasqualotto, A. and Patel, A. and Racil, Z. and Richardson, M. and Roilides, E. and Ruhnke, M. and Seyedmousavi, S. and Sidharthan, N. and Singh, N. and Sinko, J. and Skiada, A. and Slavin, M. and Soman, R. and Spellberg, B. and Steinbach, W. and Tan, B.H. and Ullmann, A.J. and Vehreschild, J.J. and Vehreschild, M.J.G.T. and Walsh, T.J. and White, P.L. and Wiederhold, N.P. and Zaoutis, T. and Chakrabarti, A.},
  year = {2019},
  journal = {The Lancet Infectious Diseases},
  volume = {19},
  number = {12},
  pages = {e405-e421},
  doi = {10.1016/S1473-3099(19)30312-3},
  note = {Cited By :519
\par
Cited By :519
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022},
  file = {/Users/russelllewis/Zotero/storage/MPBX9843/Cornely et al_2019_Global guideline for the diagnosis and management of mucormycosis.pdf}
}

@article{gaibani.etal_2019,
  title = {Comparative Serum Bactericidal Activity of Meropenem-Based Combination Regimens against Extended-Spectrum Beta-Lactamase and {{KPC-producing Klebsiella}} Pneumoniae},
  author = {Gaibani, P. and Lombardo, D. and Bartoletti, M. and Ambretti, S. and Campoli, C. and Giannella, M. and Tedeschi, S. and Conti, M. and Mancini, R. and Landini, M.P. and Re, M.C. and Viale, P. and Lewis, R.E.},
  year = {2019},
  journal = {European Journal of Clinical Microbiology and Infectious Diseases},
  volume = {38},
  number = {10},
  pages = {1925--1931},
  doi = {10.1007/s10096-019-03628-6},
  note = {Cited By :5
\par
Cited By :5
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022}
}

@article{giannella.etal_2019,
  title = {Risk Factors for Treatment Failure in Patients Receiving {$\beta$}-Lactam/{$\beta$}-Lactamase Inhibitor Combinations for {{Enterobacteriaceae}} Bloodstream Infection: {{A}} Retrospective, Single-Centre, Cohort Study},
  author = {Giannella, M. and Pascale, R. and Ferraro, G. and Toschi, A. and Pancaldi, L. and Furii, F. and Bartoletti, M. and Tedeschi, S. and Ambretti, S. and Lewis, R.E. and Viale, P.},
  year = {2019},
  journal = {International Journal of Antimicrobial Agents},
  volume = {53},
  number = {5},
  pages = {574--581},
  doi = {10.1016/j.ijantimicag.2019.01.005},
  note = {Cited By :2
\par
Cited By :2
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022}
}

@article{giannella.etal_2019a,
  title = {Prognostic Utility of the New Definition of Difficult-to-Treat Resistance among Patients with Gram-Negative Bloodstream Infections},
  author = {Giannella, M. and Bussini, L. and Pascale, R. and Bartoletti, M. and Malagrin{\`o}, M. and Pancaldi, L. and Toschi, A. and Ferraro, G. and Marconi, L. and Ambretti, S. and Lewis, R. and Viale, P.},
  year = {2019},
  journal = {Open Forum Infectious Diseases},
  volume = {6},
  number = {12},
  doi = {10.1093/ofid/ofz505},
  note = {Cited By :19
\par
Cited By :19
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022},
  file = {/Users/russelllewis/Zotero/storage/VATM7IWP/Giannella et al_2019_Prognostic utility of the new definition of difficult-to-treat resistance among.pdf}
}

@article{giannella.etal_2019b,
  title = {The Impact of Carbapenemase-Producing {{Enterobacteriaceae}} Colonization on Infection Risk after Liver Transplantation: A Prospective Observational Cohort Study},
  author = {Giannella, M. and Bartoletti, M. and Campoli, C. and Rinaldi, M. and Coladonato, S. and Pascale, R. and Tedeschi, S. and Ambretti, S. and Cristini, F. and Tumietto, F. and Siniscalchi, A. and Bertuzzo, V. and Morelli, M.C. and Cescon, M. and Pinna, A.D. and Lewis, R. and Viale, P.},
  year = {2019},
  journal = {Clinical Microbiology and Infection},
  volume = {25},
  number = {12},
  pages = {1525--1531},
  doi = {10.1016/j.cmi.2019.04.014},
  note = {Cited By :22
\par
Cited By :22
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022},
  file = {/Users/russelllewis/Zotero/storage/FZVCWYWT/Giannella et al_2019_The impact of carbapenemase-producing Enterobacteriaceae colonization on.pdf}
}

@article{groll.etal_2019,
  title = {Clinical {{Pharmacokinetics}}, {{Pharmacodynamics}}, {{Safety}} and {{Efficacy}} of {{Liposomal Amphotericin B}}},
  author = {Groll, A.H. and Rijnders, B.J.A. and Walsh, T.J. and {Adler-Moore}, J. and Lewis, R.E. and Br{\"u}ggemann, R.J.M.},
  year = {2019},
  journal = {Clinical Infectious Diseases},
  volume = {68},
  pages = {S260-S274},
  doi = {10.1093/cid/ciz076},
  note = {Cited By :40
\par
Cited By :40
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022},
  file = {/Users/russelllewis/Zotero/storage/TWLY9WJW/Groll et al_2019_Clinical Pharmacokinetics, Pharmacodynamics, Safety and Efficacy of Liposomal.pdf}
}

@article{lewis.etal_2019,
  title = {Comparative in Vitro Pharmacodynamic Analysis of Isavuconazole, Voriconazole, and Posaconazole against Clinical Isolates of Aspergillosis, Mucormycosis, Fusariosis, and Phaeohyphomycosis},
  author = {Lewis, R.E. and Wurster, S. and Beyda, N.D. and Albert, N.D. and Kontoyiannis, D.P.},
  year = {2019},
  journal = {Diagnostic Microbiology and Infectious Disease},
  volume = {95},
  number = {3},
  doi = {10.1016/j.diagmicrobio.2019.06.013},
  note = {Cited By :5
\par
Cited By :5
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022}
}

@article{lewis.etal_2019a,
  title = {Using State Transition Models to Explore How the Prevalence of Subtherapeutic Posaconazole Exposures Impacts the Clinical Utility of Therapeutic Drug Monitoring for Posaconazole Tablets and Oral Suspension},
  author = {Lewis, R.E. and Kontoyiannis, D.P. and Viale, P. and Sarpong, E.M.},
  year = {2019},
  journal = {Antimicrobial Agents and Chemotherapy},
  volume = {63},
  number = {12},
  doi = {10.1128/AAC.01435-19},
  note = {Cited By :7
\par
Cited By :7
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022},
  file = {/Users/russelllewis/Zotero/storage/5DE5NALL/Lewis et al_2019_Using state transition models to explore how the prevalence of subtherapeutic.pdf}
}

@article{stanzani.etal_2019,
  title = {Development and Internal Validation of a Model for Predicting 60-Day Risk of Invasive Mould Disease in Patients with Haematological Malignancies},
  author = {Stanzani, M. and Vianelli, N. and Cavo, M. and Kontoyiannis, D.P. and Lewis, R.E.},
  year = {2019},
  journal = {Journal of Infection},
  volume = {78},
  number = {6},
  pages = {484--490},
  doi = {10.1016/j.jinf.2019.04.002},
  note = {Cited By :16
\par
Cited By :16
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022}
}

@article{stanzani.etal_2019a,
  title = {Beyond Biomarkers: {{How}} Enhanced {{CT}} Imaging Can Improve the Diagnostic-Driven Management of Invasive Mould Disease},
  author = {Stanzani, M. and Sassi, C. and Battista, G. and Lewis, R.E.},
  year = {2019},
  journal = {Medical Mycology},
  volume = {57},
  pages = {S274-S286},
  doi = {10.1093/mmy/myy125},
  note = {Cited By :1
\par
Cited By :1
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022},
  file = {/Users/russelllewis/Zotero/storage/JC8JP6NS/Stanzani et al_2019_Beyond biomarkers.pdf}
}

@article{stanzani.etal_2019b,
  title = {Saprochaete Clavata Infections in Patients Undergoing Treatment for Haematological Malignancies: {{A}} Report of a Monocentric Outbreak and Review of the Literature},
  author = {Stanzani, M. and Cricca, M. and Sassi, C. and Sutto, E. and De Cicco, G. and Bonifazi, F. and Bertuzzi, C. and Bacci, F. and Paolini, S. and Cavo, M. and Lewis, R.E.},
  year = {2019},
  journal = {Mycoses},
  volume = {62},
  number = {12},
  pages = {1100--1107},
  doi = {10.1111/myc.12978},
  note = {Cited By :12
\par
Cited By :12
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022}
}

@article{walsh.etal_2019b,
  title = {Pharmacology of {{Liposomal Amphotericin B}}: {{An Introduction}} to {{Preclinical}} and {{Clinical Advances}} for {{Treatment}} of {{Life-threatening Invasive Fungal Infections}}},
  author = {Walsh, T.J. and Lewis, R.E. and {Adler-Moore}, J.},
  year = {2019},
  journal = {Clinical Infectious Diseases},
  volume = {68},
  pages = {S241-S243},
  doi = {10.1093/cid/ciz091},
  note = {Cited By :4
\par
Cited By :4
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022},
  file = {/Users/russelllewis/Zotero/storage/IURD3WGU/Walsh et al_2019_Pharmacology of Liposomal Amphotericin B.pdf}
}

@article{welte.etal_2019,
  title = {Invasive Mould Infections in Solid Organ Transplant Patients: Modifiers and Indicators of Disease and Treatment Response},
  author = {Welte, T. and Len, O. and Mu{\~n}oz, P. and Romani, L. and Lewis, R. and Perrella, A.},
  year = {2019},
  journal = {Infection},
  volume = {47},
  number = {6},
  pages = {919--927},
  doi = {10.1007/s15010-019-01360-z},
  note = {Cited By :13
\par
Cited By :13
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022},
  file = {/Users/russelllewis/Zotero/storage/B3PAJDT6/Welte et al_2019_Invasive mould infections in solid organ transplant patients.pdf}
}

@article{wurster.etal_2019,
  title = {Preexposure to {{Isavuconazole Increases}} the {{Virulence}} of {{Mucorales}} but {{Not Aspergillus}} Fumigatus in a {{Drosophila}} Melanogaster {{Infection Model}}},
  author = {Wurster, S. and Lewis, R.E. and Albert, N.D. and Kontoyiannis, D.P.},
  year = {2019},
  journal = {Antimicrobial Agents and Chemotherapy},
  volume = {63},
  number = {2},
  doi = {10.1128/AAC.01896-18},
  note = {Cited By :8
\par
Cited By :8
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022},
  file = {/Users/russelllewis/Zotero/storage/HFPFJSZJ/Wurster et al_2019_Preexposure to Isavuconazole Increases the Virulence of Mucorales but Not.pdf}
}

@article{wurster.etal_2019a,
  title = {Live Monitoring and Analysis of Fungal Growth, Viability, and Mycelial Morphology Using the Incucyte Neurotrack Processing Module},
  author = {Wurster, S. and Kumaresan, P.R. and Albert, N.D. and Hauser, P.J. and Lewis, R.E. and Kontoyiannis, D.P.},
  year = {2019},
  journal = {mBio},
  volume = {10},
  number = {3},
  doi = {10.1128/mBio.00673-19},
  note = {Cited By :12
\par
Cited By :12
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022},
  file = {/Users/russelllewis/Zotero/storage/D3HCDNGH/Wurster et al_2019_Live monitoring and analysis of fungal growth, viability, and mycelial.pdf}
}

@article{zoran.etal_2019,
  title = {Corrigendum: {{Azole-resistance}} in Aspergillus Terreusand Related Species: {{An}} Emerging Problem or a Rare Phenomenon? ({{Frontiers}} in {{Microbiology}} (2018) 9 (516) {{DOI}}: 10.3389/Fmicb.2018.00516)},
  author = {Zoran, T. and Sartori, B. and Sappl, L. and Aigner, M. and {S{\'a}nchez-Reus}, F. and Rezusta, A. and Chowdhary, A. and {Taj-Aldeen}, S.J. and Arendrup, M.C. and Oliveri, S. and Kontoyiannis, D.P. and {Alastruey-Izquierdo}, A. and Lagrou, K. and Lo Cascio, G. and Meis, J.F. and Buzina, W. and Farina, C. and {Drogari-Apiranthitou}, M. and Grancini, A. and Tortorano, A.M. and Willinger, B. and Hamprecht, A. and Johnson, E. and Klingspor, L. and {Arsic-Arsenijevic}, V. and Cornely, O.A. and Meletiadis, J. and Prammer, W. and Tullio, V. and Vehreschild, J.-J. and Trovato, L. and Lewis, R.E. and Segal, E. and Rath, P.-M. and Hamal, P. and {Rodriguez-Iglesias}, M. and Roilides, E. and {Arikan-Akdagli}, S. and Chakrabarti, A. and Colombo, A.L. and Fern{\'a}ndez, M.S. and {Martin-Gomez}, M.T. and Badali, H. and Petrikkos, G. and Klimko, N. and Heimann, S.M. and Uzun, O. and Roudbary, M. and De La Fuente, S. and Houbraken, J. and Risslegger, B. and Sabino, R. and {Lass-Fl{\"o}rl}, C. and Lackner, M.},
  year = {2019},
  journal = {Frontiers in Microbiology},
  volume = {10},
  number = {JAN},
  doi = {10.3389/fmicb.2018.03245},
  keywords = {Aspergillus section Terrei,azoles,cryptic species,Cyp51A alterations,susceptibility profiles},
  note = {Cited By :1
\par
Cited By :1
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022},
  file = {/Users/russelllewis/Zotero/storage/JP4L3V8V/Zoran et al_2018_Corrigendum.pdf}
}

@article{bartoletti.etal_2018,
  title = {Differences in the Rate of Carbapenem-Resistant {{Enterobacteriaceae}} Colonisation or {{Clostridium}} Difficile Infection Following Frontline Treatment with Tigecycline vs. Meropenem for Intra-Abdominal Infections},
  author = {Bartoletti, M. and Tedeschi, S. and Pascale, R. and Raumer, L. and Maraolo, A.E. and Palmiero, G. and Tumietto, F. and Cristini, F. and Ambretti, S. and Giannella, M. and Lewis, R.E. and Viale, P.},
  year = {2018},
  journal = {International Journal of Antimicrobial Agents},
  volume = {51},
  number = {3},
  pages = {516--521},
  doi = {10.1016/j.ijantimicag.2018.01.010},
  note = {Cited By :1
\par
Cited By :1
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022}
}

@article{bartoletti.etal_2018a,
  title = {The Role of Extended Infusion {$\beta$}-Lactams in the Treatment of Bloodstream Infections in Patients with Liver Cirrhosis},
  author = {Bartoletti, M. and Lewis, R.E. and Giannella, M. and Tedeschi, S. and Viale, P.},
  year = {2018},
  journal = {Expert Review of Anti-Infective Therapy},
  volume = {16},
  number = {10},
  pages = {771--779},
  doi = {10.1080/14787210.2018.1523716},
  note = {Cited By :3
\par
Cited By :3
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022}
}

@article{bartoletti.etal_2018b,
  title = {A Prospective Multicentre Study of the Epidemiology and Outcomes of Bloodstream Infection in Cirrhotic Patients},
  author = {Bartoletti, M. and Giannella, M. and Lewis, R. and Caraceni, P. and Tedeschi, S. and Paul, M. and Schramm, C. and Bruns, T. and Merli, M. and {Cobos-Trigueros}, N. and Seminari, E. and Retamar, P. and Mu{\~n}oz, P. and Tumbarello, M. and Burra, P. and Torrani Cerenzia, M. and Barsic, B. and Calbo, E. and Maraolo, A.E. and Petrosillo, N. and {Galan-Ladero}, M.A. and D'Offizi, G. and Bar Sinai, N. and {Rodr{\'i}guez-Ba{\~n}o}, J. and Verucchi, G. and Bernardi, M. and Viale, P. and Campoli, C. and Siccardi, G. and Ambretti, S. and Stallmach, A. and Venditti, M. and Lucidi, C. and Ludovisi, S. and De Cueto, M. and Navarro, M.D. and Lopez Cortes, E. and Bouza, E. and Valerio, M. and Eworo, A. and Losito, R. and Senzolo, M. and Nadal, E. and Ottobrelli, A. and Varguvic, M. and Badia, C. and Borgia, G. and Gentile, I. and Buonomo, A.R. and Boumis, E. and {Beteta-Lopez}, A. and Rianda, A. and Taliani, G. and Grieco, S.},
  year = {2018},
  journal = {Clinical Microbiology and Infection},
  volume = {24},
  number = {5},
  pages = {546.e1-546.e8},
  doi = {10.1016/j.cmi.2017.08.001},
  note = {Cited By :59
\par
Cited By :59
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022},
  file = {/Users/russelllewis/Zotero/storage/KEFZNQUJ/Bartoletti et al_2018_A prospective multicentre study of the epidemiology and outcomes of bloodstream.pdf}
}

@article{cesaro.etal_2018a,
  title = {{{ECIL}} Guidelines for the Prevention, Diagnosis and Treatment of {{BK}} Polyomavirus-Associated Haemorrhagic Cystitis in Haematopoietic Stem Cell Transplant Recipients},
  author = {Cesaro, S. and Dalianis, T. and Rinaldo, C.H. and Koskenvuo, M. and Pegoraro, A. and Einsele, H. and Cordonnier, C. and Hirsch, H.H. and Akova, M. and Aljurf, M. and Averbuch, D. and Barnes, R. and Blennow, O. and Bochud, P.-Y. and Bouza, E. and Bretagne, S. and Br{\"u}ggemann, R. and Calandra, T. and Carratala, J. and Cornely, O. and {de la Camara}, R. and Donnelly, P. and Drgona, L. and Duarte, R. and Engelhard, D. and Fox, C. and Girmenia, C. and Groll, A. and Heldal, D. and {Helweg-Larsen}, J. and Herbrecht, R. and Johnson, E. and Klyasova, G. and Lagrou, K. and Lewis, R.E. and Ljungman, P. and Maertens, J. and Mikulska, M. and Nucci, M. and Padoin, C. and Pagano, L. and Pagliuca, A. and Racil, Z. and Ribaud, P. and {Rizzi-Puechal}, V. and Roilides, E. and Robin, C. and Rovira, M. and Rupp, M. and Sanchez, S. and Schellongowski, P. and Sedlacek, P. and Sinko, J. and Slavin, M. and Ferreira, I.S. and Styczynski, J. and Tissot, F. and Viscoli, C. and Ward, K. and Witschi, A.-T.},
  year = {2018},
  journal = {Journal of Antimicrobial Chemotherapy},
  volume = {73},
  number = {1},
  pages = {12--21},
  doi = {10.1093/jac/dkx324},
  note = {Cited By :87
\par
Cited By :87
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022}
}

@article{diblasi.etal_2018,
  title = {Febrile Events in Acute Lymphoblastic Leukemia: A Prospective Observational Multicentric {{SEIFEM}} Study ({{SEIFEM-2012}}/{{B ALL}})},
  author = {Di Blasi, R. and Cattaneo, C. and Lewis, R.E. and Tumbarello, M. and Angelici, L. and Dragonetti, G. and Busca, A. and Camb{\`o}, B. and Candoni, A. and Cesarini, M. and Cesaro, S. and Delia, M. and Fanci, R. and Farina, F. and Garzia, M. and Giordano, A. and Martino, B. and Melillo, L. and Nadali, G. and Perriello, V. and Picardi, M. and Quinto, A.M. and Salutari, P. and Spolzino, A. and Vacca, A. and Vetro, C. and Zancanella, M. and Nosari, A. and Aversa, F. and Pagano, L.},
  year = {2018},
  journal = {Annals of Hematology},
  volume = {97},
  number = {5},
  pages = {791--798},
  doi = {10.1007/s00277-018-3252-6},
  note = {Cited By :6
\par
Cited By :6
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022},
  file = {/Users/russelllewis/Zotero/storage/II5N5N6A/Di Blasi et al_2018_Febrile events in acute lymphoblastic leukemia.pdf}
}

@article{fernandez.etal_2018,
  title = {Acute {{Invasive Fungal Rhinosinusitis}} in {{Immunocompromised Patients}}: {{Role}} of an {{Early Diagnosis}}},
  author = {Fernandez, I.J. and Crocetta, F.M. and Dematt{\`e}, M. and Farneti, P. and Stanzani, M. and Lewis, R.E. and Fornaciari, M. and Pasquini, E. and Sciarretta, V.},
  year = {2018},
  journal = {Otolaryngology - Head and Neck Surgery (United States)},
  volume = {159},
  number = {2},
  pages = {386--393},
  doi = {10.1177/0194599818765744},
  note = {Cited By :20
\par
Cited By :20
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022}
}

@article{gaibani.etal_2018,
  title = {In Vivo Evolution of Resistant Subpopulations of {{KPC-producing Klebsiella}} Pneumoniae during Ceftazidime/Avibactam Treatment},
  author = {Gaibani, P. and Campoli, C. and Lewis, R.E. and Volpe, S.L. and Scaltriti, E. and Giannella, M. and Pongolini, S. and Berlingeri, A. and Cristini, F. and Bartoletti, M. and Tedeschi, S. and Ambretti, S.},
  year = {2018},
  journal = {Journal of Antimicrobial Chemotherapy},
  volume = {73},
  number = {6},
  pages = {1525--1529},
  doi = {10.1093/jac/dky082},
  note = {Cited By :90
\par
Cited By :90
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022}
}

@article{giannella.etal_2018,
  title = {Effect of Combination Therapy Containing a High-Dose Carbapenem on Mortality in Patients with Carbapenem-Resistant {{Klebsiella}} Pneumoniae Bloodstream Infection},
  author = {Giannella, M. and Trecarichi, E.M. and Giacobbe, D.R. and De Rosa, F.G. and Bassetti, M. and Bartoloni, A. and Bartoletti, M. and Losito, A.R. and {del Bono}, V. and Corcione, S. and Tedeschi, S. and Raffaelli, F. and Saffioti, C. and Spanu, T. and Rossolini, G.M. and Marchese, A. and Ambretti, S. and Cauda, R. and Viscoli, C. and Lewis, R.E. and Viale, P. and Tumbarello, M.},
  year = {2018},
  journal = {International Journal of Antimicrobial Agents},
  volume = {51},
  number = {2},
  pages = {244--248},
  doi = {10.1016/j.ijantimicag.2017.08.019},
  note = {Cited By :48
\par
Cited By :48
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022},
  file = {/Users/russelllewis/Zotero/storage/B9GVVWMU/Giannella et al_2018_Effect of combination therapy containing a high-dose carbapenem on mortality in.pdf}
}

@article{giannella.etal_2018a,
  title = {Treatment Duration for {{Escherichia}} Coli Bloodstream Infection and Outcomes: Retrospective Single-Centre Study},
  author = {Giannella, M. and Pascale, R. and Toschi, A. and Ferraro, G. and Graziano, E. and Furii, F. and Bartoletti, M. and Tedeschi, S. and Ambretti, S. and Lewis, R.E. and Viale, P.},
  year = {2018},
  journal = {Clinical Microbiology and Infection},
  volume = {24},
  number = {10},
  pages = {1077--1083},
  doi = {10.1016/j.cmi.2018.01.013},
  note = {Cited By :31
\par
Cited By :31
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022},
  file = {/Users/russelllewis/Zotero/storage/24WGVBL5/Giannella et al_2018_Treatment duration for Escherichia coli bloodstream infection and outcomes.pdf}
}

@article{giannella.etal_2018b,
  title = {Potential Role of {{T2Candida}} in the Management of Empirical Antifungal Treatment in Patients at High Risk of Candidaemia: {{A}} Pilot Single-Centre Study},
  author = {Giannella, M. and Paolucci, M. and Roncarati, G. and Vandi, G. and Pascale, R. and Trapani, F. and Bartoletti, M. and Tedeschi, S. and Ambretti, S. and Lewis, R. and Re, M.C. and Viale, P.},
  year = {2018},
  journal = {Journal of Antimicrobial Chemotherapy},
  volume = {73},
  number = {10},
  pages = {2856--2859},
  doi = {10.1093/jac/dky247},
  note = {Cited By :8
\par
Cited By :8
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022}
}

@article{lionakis.etal_2018,
  title = {Breakthrough Invasive Mold Infections in the Hematology Patient: {{Current}} Concepts and Future Directions},
  author = {Lionakis, M.S. and Lewis, R.E. and Kontoyiannis, D.P.},
  year = {2018},
  journal = {Clinical Infectious Diseases},
  volume = {67},
  number = {10},
  pages = {1621--1630},
  doi = {10.1093/cid/ciy473},
  note = {Cited By :75
\par
Cited By :75
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022},
  file = {/Users/russelllewis/Zotero/storage/7ZXY2VIE/Lionakis et al_2018_Breakthrough invasive mold infections in the hematology patient.pdf}
}

@article{mikulska.etal_2018a,
  title = {Fluoroquinolone Prophylaxis in Haematological Cancer Patients with Neutropenia: {{ECIL}} Critical Appraisal of Previous Guidelines},
  author = {Mikulska, M. and Averbuch, D. and Tissot, F. and Cordonnier, C. and Akova, M. and Calandra, T. and Ceppi, M. and Bruzzi, P. and Viscoli, C. and Aljurf, M. and Averbuch, D. and Barnes, R. and Blennow, O. and Bochud, P.-Y. and Bouza, E. and Bretagne, S. and Br{\"u}ggemann, R. and Carratala, J. and Cesaro, S. and Cornely, O. and Dalianis, T. and De La Camara, R. and Donnelly, P. and Drgona, L. and Duarte, R. and Einsele, H. and Engelhard, D. and Fox, C. and Girmenia, C. and Groll, A. and Heldal, D. and Larsen, J.H. and Herbrecht, R. and Hirsch, H. and Johnson, E. and Klyasova, G. and Koskuenvo, M. and Lagrou, K. and Lewis, R.E. and Ljungman, P. and Maertens, J. and Maschmeyer, G. and Nucci, M. and Padoin, C. and Pagano, L. and Pagliuca, A. and Racil, Z. and Ribaud, P. and Rinaldo, C. and Puechal, V.R. and Roilides, E. and Robin, C. and Rovira, M. and Rupp, M. and Sanchez, S. and Schellongowski, P. and Sedlacek, P. and Sinko, J. and Slavin, M. and Ferreira, I.S. and Styczynski, J. and Ward, K. and Witschi, A.-T.},
  year = {2018},
  journal = {Journal of Infection},
  volume = {76},
  number = {1},
  pages = {20--37},
  doi = {10.1016/j.jinf.2017.10.009},
  note = {Cited By :77
\par
Cited By :77
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022}
}

@article{pea.lewis_2018,
  title = {Overview of Antifungal Dosing in Invasive Candidiasis},
  author = {Pea, F. and Lewis, R.E.},
  year = {2018},
  journal = {Journal of Antimicrobial Chemotherapy},
  volume = {73},
  pages = {i33-i43},
  doi = {10.1093/jac/dkx447},
  note = {Cited By :27
\par
Cited By :27
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022}
}

@article{rizzello.etal_2018,
  title = {Successful Treatment of Bilateral Endogenous {{Fusarium}} Solani Endophthalmitis in a Patient with Acute Lymphocytic Leukaemia},
  author = {Rizzello, I. and Castagnetti, F. and Toschi, P.G. and Bertaccini, P. and Primavera, L. and Paolucci, M. and Faccioli, L. and Spinardi, L. and Lewis, R.E. and Cavo, M. and Stanzani, M.},
  year = {2018},
  journal = {Mycoses},
  volume = {61},
  number = {1},
  pages = {53--60},
  doi = {10.1111/myc.12697},
  note = {Cited By :9
\par
Cited By :9
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022}
}

@article{sassi.etal_2018,
  title = {The Utility of Contrast-Enhanced Hypodense Sign for the Diagnosis of Pulmonary Invasive Mould Disease in Patients with Haematological Malignancies},
  author = {Sassi, C. and Stanzani, M. and Lewis, R.E. and Facchini, G. and Bazzocchi, A. and Cavo, M. and Battista, G.},
  year = {2018},
  journal = {British Journal of Radiology},
  volume = {91},
  number = {1083},
  doi = {10.1259/bjr.20170220},
  note = {Cited By :7
\par
Cited By :7
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022},
  file = {/Users/russelllewis/Zotero/storage/SDB8D8CR/Sassi et al_2018_The utility of contrast-enhanced hypodense sign for the diagnosis of pulmonary.pdf}
}

@incollection{shelburne.etal_2018,
  title = {Clinical {{Approach}} to {{Infections}} in the {{Compromised Host}}},
  booktitle = {Hematology: {{Basic Principles}} and {{Practice}}},
  author = {Shelburne, S.A. and Lewis, R.E. and Kontoyiannis, D.P.},
  year = {2018},
  pages = {1447--1461},
  doi = {10.1016/B978-0-323-35762-3.00089-5},
  note = {Export Date: 20 November 2022
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022}
}

@article{stanzani.lewis_2018,
  title = {Development and Applications of Prognostic Risk Models in the Management of Invasive Mold Disease},
  author = {Stanzani, M. and Lewis, R.E.},
  year = {2018},
  journal = {Journal of Fungi},
  volume = {4},
  number = {4},
  doi = {10.3390/jof4040141},
  note = {Cited By :5
\par
Cited By :5
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022},
  file = {/Users/russelllewis/Zotero/storage/AXT4AR45/Stanzani_Lewis_2018_Development and applications of prognostic risk models in the management of.pdf}
}

@article{tam.etal_2018,
  title = {Transcriptional Profiles of Pulmonary Innate Immune Responses to Isogenic Antibiotic-Susceptible and Multidrug-Resistant {{Pseudomonas}} Aeruginosa},
  author = {Tam, V.H. and P{\'e}rez, C. and Ledesma, K.R. and Lewis, R.E.},
  year = {2018},
  journal = {Microbiology and Immunology},
  volume = {62},
  number = {4},
  pages = {291--294},
  doi = {10.1111/1348-0421.12581},
  note = {Cited By :5
\par
Cited By :5
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022},
  file = {/Users/russelllewis/Zotero/storage/ZHSW5Z92/Tam et al_2018_Transcriptional profiles of pulmonary innate immune responses to isogenic.pdf}
}

@article{ullmann.etal_2018,
  title = {Diagnosis and Management of {{Aspergillus}} Diseases: Executive Summary of the 2017 {{ESCMID-ECMM-ERS}} Guideline},
  author = {Ullmann, A.J. and Aguado, J.M. and {Arikan-Akdagli}, S. and Denning, D.W. and Groll, A.H. and Lagrou, K. and {Lass-Fl{\"o}rl}, C. and Lewis, R.E. and Munoz, P. and Verweij, P.E. and Warris, A. and Ader, F. and Akova, M. and Arendrup, M.C. and Barnes, R.A. and {Beigelman-Aubry}, C. and Blot, S. and Bouza, E. and Br{\"u}ggemann, R.J.M. and Buchheidt, D. and Cadranel, J. and Castagnola, E. and Chakrabarti, A. and {Cuenca-Estrella}, M. and Dimopoulos, G. and Fortun, J. and Gangneux, J.-P. and Garbino, J. and Heinz, W.J. and Herbrecht, R. and Heussel, C.P. and Kibbler, C.C. and Klimko, N. and Kullberg, B.J. and Lange, C. and Lehrnbecher, T. and L{\"o}ffler, J. and Lortholary, O. and Maertens, J. and Marchetti, O. and Meis, J.F. and Pagano, L. and Ribaud, P. and Richardson, M. and Roilides, E. and Ruhnke, M. and Sanguinetti, M. and Sheppard, D.C. and Sink{\'o}, J. and Skiada, A. and Vehreschild, M.J.G.T. and Viscoli, C. and Cornely, O.A.},
  year = {2018},
  journal = {Clinical Microbiology and Infection},
  volume = {24},
  pages = {e1-e38},
  doi = {10.1016/j.cmi.2018.01.002},
  note = {Cited By :638
\par
Cited By :638
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022},
  file = {/Users/russelllewis/Zotero/storage/P8Q6WWKM/Ullmann et al_2018_Diagnosis and management of Aspergillus diseases.pdf}
}

@article{zoran.etal_2018,
  title = {Azole-Resistance in {{Aspergillus}} Terreus and Related Species: {{An}} Emerging Problem or a Rare {{Phenomenon}}?},
  author = {Zoran, T. and Sartori, B. and Sappl, L. and Aigner, M. and {S{\'a}nchez-Reus}, F. and Rezusta, A. and Chowdhary, A. and {Taj-Aldeen}, S.J. and Arendrup, M.C. and Oliveri, S. and Kontoyiannis, D.P. and {Alastruey-Izquierdo}, A. and Lagrou, K. and Cascio, G.L. and Meis, J.F. and Buzina, W. and Farina, C. and {Drogari-Apiranthitou}, M. and Grancini, A. and Tortorano, A.M. and Willinger, B. and Hamprecht, A. and Johnson, E. and Klingspor, L. and {Arsic-Arsenijevic}, V. and Cornely, O.A. and Meletiadis, J. and Prammer, W. and Tullio, V. and Vehreschild, J.-J. and Trovato, L. and Lewis, R.E. and Segal, E. and Rath, P.-M. and Hamal, P. and {Rodriguez-Iglesias}, M. and Roilides, E. and {Arikan-Akdagli}, S. and Chakrabarti, A. and Colombo, A.L. and Fern{\'a}ndez, M.S. and {Martin-Gomez}, M.T. and Badali, H. and Petrikkos, G. and Klimko, N. and Heimann, S.M. and Uzun, O. and Roudbary, M. and {de la Fuente}, S. and Houbraken, J. and Risslegger, B. and {Lass-Fl{\"o}rl}, C. and Lackner, M.},
  year = {2018},
  journal = {Frontiers in Microbiology},
  volume = {9},
  number = {MAR},
  doi = {10.3389/fmicb.2018.00516},
  note = {Cited By :53
\par
Cited By :53
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022},
  file = {/Users/russelllewis/Zotero/storage/ZLDC2GZ4/Zoran et al_2018_Azole-resistance in Aspergillus terreus and related species.pdf}
}

@article{bartoletti.etal_2017,
  title = {Liver Transplantation Is Associated with Good Clinical Outcome in Patients with Active Tuberculosis and Acute Liver Failure Due to Anti-Tubercular Treatment},
  author = {Bartoletti, M. and Martelli, G. and Tedeschi, S. and Morelli, M. and Bertuzzo, V. and Tadolini, M. and Pianta, P. and Cristini, F. and Giannella, M. and Lewis, R.E. and Pinna, A.D. and Viale, P.},
  year = {2017},
  journal = {Transplant Infectious Disease},
  volume = {19},
  number = {2},
  doi = {10.1111/tid.12658},
  note = {Cited By :5
\par
Cited By :5
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022}
}

@incollection{beyda.etal_2017,
  title = {Micafungin},
  booktitle = {Kucers the {{Use}} of {{Antibiotics}}: {{A Clinical Review}} of {{Antibacterial}}, {{Antifungal}}, {{Antiparasitic}}, and {{Antiviral Drugs}}, {{Seventh Edition}}},
  author = {Beyda, N.D. and Lewis, R.E. and Kontoyiannis, D.P.},
  year = {2017},
  pages = {2681--2692},
  doi = {10.1201/9781315152110},
  note = {Export Date: 20 November 2022
\par
Export Date: 20 November 2022}
}

@article{gaibani.etal_2017,
  title = {In Vitro Interaction of Ceftazidime--Avibactam in Combination with Different Antimicrobials against {{KPC-producing Klebsiella}} Pneumoniae Clinical Isolates},
  author = {Gaibani, P. and Lewis, R.E. and Volpe, S.L. and Giannella, M. and Campoli, C. and Landini, M.P. and Viale, P. and Re, M.C. and Ambretti, S.},
  year = {2017},
  journal = {International Journal of Infectious Diseases},
  volume = {65},
  pages = {1--3},
  doi = {10.1016/j.ijid.2017.09.017},
  note = {Cited By :29
\par
Cited By :29
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022},
  file = {/Users/russelllewis/Zotero/storage/EUV8GLIN/Gaibani et al_2017_In vitro interaction of ceftazidime–avibactam in combination with different.pdf}
}

@article{giannella.etal_2017,
  title = {Risk Factors for Recurrent Carbapenem Resistant {{Klebsiella}} Pneumoniae Bloodstream Infection: A Prospective Cohort Study},
  author = {Giannella, M. and Graziano, E. and Marconi, L. and Girometti, N. and Bartoletti, M. and Tedeschi, S. and Tumietto, F. and Cristini, F. and Ambretti, S. and Berlingeri, A. and Lewis, R.E. and Viale, P.},
  year = {2017},
  journal = {European Journal of Clinical Microbiology and Infectious Diseases},
  volume = {36},
  number = {10},
  pages = {1965--1970},
  doi = {10.1007/s10096-017-3020-x},
  note = {Cited By :14
\par
Cited By :14
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022}
}

@article{heo.etal_2017a,
  title = {Changes in {{In Vitro Susceptibility Patterns}} of {{Aspergillus}} to {{Triazoles}} and {{Correlation}} with {{Aspergillosis Outcome}} in a {{Tertiary Care Cancer Center}}, 1999-2015},
  author = {Heo, S.T. and Tatara, A.M. and {Jim{\'e}nez-Ortigosa}, C. and Jiang, Y. and Lewis, R.E. and Tarrand, J. and Tverdek, F. and Albert, N.D. and Verweij, P.E. and Meis, J.F. and Mikos, A.G. and Perlin, D.S. and Kontoyiannis, D.P.},
  year = {2017},
  journal = {Clinical Infectious Diseases},
  volume = {65},
  number = {2},
  pages = {216--225},
  doi = {10.1093/cid/cix297},
  note = {Cited By :41
\par
Cited By :41
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022},
  file = {/Users/russelllewis/Zotero/storage/NHVJHFP9/Heo et al_2017_Changes in In Vitro Susceptibility Patterns of Aspergillus to Triazoles and.pdf}
}

@article{lewis_2017,
  title = {Using Carbapenems for Carbapenem-Resistant {{Klebsiella}} Pneumoniae-{{Are}} We Flogging a Dead (Work)Horse Antibiotic?},
  author = {Lewis, R.E.},
  year = {2017},
  journal = {Virulence},
  volume = {8},
  number = {1},
  pages = {13--14},
  doi = {10.1080/21505594.2016.1231756},
  note = {Export Date: 20 November 2022
\par
Export Date: 20 November 2022},
  file = {/Users/russelllewis/Zotero/storage/LGJSDUYG/Lewis_2017_Using carbapenems for carbapenem-resistant Klebsiella pneumoniae-Are we.pdf}
}

@incollection{lewis.etal_2017,
  title = {Caspofungin},
  booktitle = {Kucers the {{Use}} of {{Antibiotics}}: {{A Clinical Review}} of {{Antibacterial}}, {{Antifungal}}, {{Antiparasitic}}, and {{Antiviral Drugs}}, {{Seventh Edition}}},
  author = {Lewis, R.E. and Beyda, N.D. and Kontoyiannis, D.P.},
  year = {2017},
  pages = {2659--2680},
  doi = {10.1201/9781315152110},
  note = {Cited By :1
\par
Cited By :1
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022}
}

@incollection{lewis.etal_2017a,
  title = {Butenafine},
  booktitle = {Kucers the {{Use}} of {{Antibiotics}}: {{A Clinical Review}} of {{Antibacterial}}, {{Antifungal}}, {{Antiparasitic}}, and {{Antiviral Drugs}}, {{Seventh Edition}}},
  author = {Lewis, R.E. and Beyda, N.D. and Kontoyiannis, D.P.},
  year = {2017},
  pages = {2720--2724},
  doi = {10.1201/9781315152110},
  note = {Export Date: 20 November 2022
\par
Export Date: 20 November 2022}
}

@article{lewis.verweij_2017,
  title = {Animal Models for Studying Triazole Resistance in Aspergillus Fumigatus},
  author = {Lewis, R.E. and Verweij, P.E.},
  year = {2017},
  journal = {Journal of Infectious Diseases},
  volume = {216},
  pages = {S466-S473},
  doi = {10.1093/infdis/jix222},
  note = {Cited By :12
\par
Cited By :12
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022}
}

@article{pierro.etal_2017,
  title = {Characterization of Antibody Response in Neuroinvasive Infection Caused by {{Toscana}} Virus},
  author = {Pierro, A. and Ficarelli, S. and Ayhan, N. and Morini, S. and Raumer, L. and Bartoletti, M. and Mastroianni, A. and Prati, F. and Schivazappa, S. and Cenni, P. and Vocale, C. and Rossini, G. and Gaibani, P. and Sambri, V. and Landini, M.P. and Lewis, R.E. and Charrel, R.N. and Varani, S.},
  year = {2017},
  journal = {Clinical Microbiology and Infection},
  volume = {23},
  number = {11},
  pages = {868--873},
  doi = {10.1016/j.cmi.2017.03.017},
  note = {Cited By :13
\par
Cited By :13
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022},
  file = {/Users/russelllewis/Zotero/storage/ZBB76IJP/Pierro et al_2017_Characterization of antibody response in neuroinvasive infection caused by.pdf}
}

@article{polverelli.etal_2017,
  title = {Risk Factors for Infections in Myelofibrosis: Role of Disease Status and Treatment. {{A}} Multicenter Study of 507 Patients},
  author = {Polverelli, N. and Breccia, M. and Benevolo, G. and Martino, B. and Tieghi, A. and Latagliata, R. and Sabattini, E. and Riminucci, M. and Godio, L. and Catani, L. and Nicolosi, M. and Perricone, M. and Sollazzo, D. and Colafigli, G. and Campana, A. and Merli, F. and Vitolo, U. and Alimena, G. and Martinelli, G. and Lewis, R.E. and Vianelli, N. and Cavo, M. and Palandri, F.},
  year = {2017},
  journal = {American Journal of Hematology},
  volume = {92},
  number = {1},
  pages = {37--41},
  doi = {10.1002/ajh.24572},
  note = {Cited By :48
\par
Cited By :48
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022},
  file = {/Users/russelllewis/Zotero/storage/QXXDQ52X/Polverelli et al_2017_Risk factors for infections in myelofibrosis.pdf}
}

@article{risslegger.etal_2017,
  title = {A Prospective International {{Aspergillus}} Terreus Survey: An {{EFISG}}, {{ISHAM}} and {{ECMM}} Joint Study},
  author = {Risslegger, B. and Zoran, T. and Lackner, M. and Aigner, M. and {S{\'a}nchez-Reus}, F. and Rezusta, A. and Chowdhary, A. and {Taj-Aldeen}, S.J. and Arendrup, M.C. and Oliveri, S. and Kontoyiannis, D.P. and {Alastruey-Izquierdo}, A. and Lagrou, K. and Lo Cascio, G. and Meis, J.F. and Buzina, W. and Farina, C. and {Drogari-Apiranthitou}, M. and Grancini, A. and Tortorano, A.M. and Willinger, B. and Hamprecht, A. and Johnson, E. and Klingspor, L. and {Arsic-Arsenijevic}, V. and Cornely, O.A. and Meletiadis, J. and Prammer, W. and Tullio, V. and Vehreschild, J.-J. and Trovato, L. and Lewis, R.E. and Segal, E. and Rath, P.-M. and Hamal, P. and {Rodriguez-Iglesias}, M. and Roilides, E. and {Arikan-Akdagli}, S. and Chakrabarti, A. and Colombo, A.L. and Fern{\'a}ndez, M.S. and {Martin-Gomez}, M.T. and Badali, H. and Petrikkos, G. and Klimko, N. and Heimann, S.M. and Houbraken, J. and Uzun, O. and Edlinger, M. and Fuente, S.D.L. and {Lass-Fl{\"o}rl}, C.},
  year = {2017},
  journal = {Clinical Microbiology and Infection},
  volume = {23},
  number = {10},
  pages = {776.e1-776.e5},
  doi = {10.1016/j.cmi.2017.04.012},
  note = {Cited By :31
\par
Cited By :31
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022},
  file = {/Users/russelllewis/Zotero/storage/6RMZPZ6A/Risslegger et al_2017_A prospective international Aspergillus terreus survey.pdf}
}

@article{sassi.etal_2017,
  title = {Radiologic Findings of {{Fusarium}} Pneumonia in Neutropenic Patients},
  author = {Sassi, C. and Stanzani, M. and Lewis, R.E. and Vianelli, N. and Tarsi, A. and Poerio, A. and Cavo, M. and Battista, G.},
  year = {2017},
  journal = {Mycoses},
  volume = {60},
  number = {2},
  pages = {73--78},
  doi = {10.1111/myc.12538},
  note = {Cited By :11
\par
Cited By :11
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022}
}

@article{stanzani.etal_2017,
  title = {Retrospective Cohort Analysis of Liposomal Amphotericin b Nephrotoxicity in Patients with Hematological Malignancies},
  author = {Stanzani, M. and Vianelli, N. and Cavo, M. and Maritati, A. and Morotti, M. and Lewis, R.E.},
  year = {2017},
  journal = {Antimicrobial Agents and Chemotherapy},
  volume = {61},
  number = {9},
  doi = {10.1128/AAC.02651-16},
  note = {Cited By :12
\par
Cited By :12
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022},
  file = {/Users/russelllewis/Zotero/storage/LXST2L6J/Stanzani et al_2017_Retrospective cohort analysis of liposomal amphotericin b nephrotoxicity in.pdf}
}

@article{bartoletti.etal_2016,
  title = {Bloodstream Infections in Patients with Liver Cirrhosis},
  author = {Bartoletti, M. and Giannella, M. and Lewis, R.E. and Viale, P.},
  year = {2016},
  journal = {Virulence},
  volume = {7},
  number = {3},
  pages = {309--319},
  doi = {10.1080/21505594.2016.1141162},
  note = {Cited By :62
\par
Cited By :62
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022},
  file = {/Users/russelllewis/Zotero/storage/PTCU3DH2/Bartoletti et al_2016_Bloodstream infections in patients with liver cirrhosis.pdf}
}

@article{bellanger.etal_2016,
  title = {Statin {{Concentrations}} below the {{Minimum Inhibitory Concentration Attenuate}} the {{Virulence}} of {{Rhizopus}} Oryzae},
  author = {Bellanger, A.-P. and Tatara, A.M. and Shirazi, F. and Gebremariam, T. and Albert, N.D. and Lewis, R.E. and Ibrahim, A.S. and Kontoyiannis, D.P.},
  year = {2016},
  journal = {Journal of Infectious Diseases},
  volume = {214},
  number = {1},
  pages = {114--121},
  doi = {10.1093/infdis/jiw090},
  note = {Cited By :20
\par
Cited By :20
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022},
  file = {/Users/russelllewis/Zotero/storage/JW4D9DKL/Bellanger et al_2016_Statin Concentrations below the Minimum Inhibitory Concentration Attenuate the.pdf}
}

@article{curti.etal_2016,
  title = {Larger Size of Donor Alloreactive {{NK}} Cell Repertoire Correlates with Better Response to {{NK}} Cell Immunotherapy in Elderly Acute Myeloid Leukemia Patients},
  author = {Curti, A. and Ruggeri, L. and Parisi, S. and Bontadini, A. and Dan, E. and Motta, M.R. and Rizzi, S. and Trabanelli, S. and Ocadlikova, D. and Lecciso, M. and Giudice, V. and Fruet, F. and Urbani, E. and Papayannidis, C. and Martinelli, G. and Bandini, G. and Bonifazi, F. and Lewis, R.E. and Cavo, M. and Velardi, A. and Lemoli, R.M.},
  year = {2016},
  journal = {Clinical Cancer Research},
  volume = {22},
  number = {8},
  pages = {1914--1921},
  doi = {10.1158/1078-0432.CCR-15-1604},
  note = {Cited By :84
\par
Cited By :84
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022},
  file = {/Users/russelllewis/Zotero/storage/BMGBBSD5/Curti et al_2016_Larger size of donor alloreactive NK cell repertoire correlates with better.pdf}
}

@article{giannella.etal_2016,
  title = {Antifungal Prophylaxis in Liver Transplant Recipients: One Size Does Not Fit All},
  author = {Giannella, M. and Bartoletti, M. and Morelli, M. and Cristini, F. and Tedeschi, S. and Campoli, C. and Tumietto, F. and Bertuzzo, V. and Ercolani, G. and Faenza, S. and Pinna, A.D. and Lewis, R.E. and Viale, P.},
  year = {2016},
  journal = {Transplant Infectious Disease},
  volume = {18},
  number = {4},
  pages = {538--544},
  doi = {10.1111/tid.12560},
  note = {Cited By :25
\par
Cited By :25
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022}
}

@article{kyvernitakis.etal_2016,
  title = {Initial Use of Combination Treatment Does Not Impact Survival of 106 Patients with Haematologic Malignancies and Mucormycosis: A Propensity Score Analysis},
  author = {Kyvernitakis, A. and Torres, H.A. and Jiang, Y. and Chamilos, G. and Lewis, R.E. and Kontoyiannis, D.P.},
  year = {2016},
  journal = {Clinical Microbiology and Infection},
  volume = {22},
  number = {9},
  pages = {811.e1-811.e8},
  doi = {10.1016/j.cmi.2016.03.029},
  note = {Cited By :87
\par
Cited By :87
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022}
}

@article{maschmeyer.etal_2016,
  title = {{{ECIL}} Guidelines for Treatment of {{Pneumocystis}} Jirovecii Pneumonia in Non-{{HIV-infected}} Haematology Patients},
  author = {Maschmeyer, G. and {Helweg-Larsen}, J. and Pagano, L. and Robin, C. and Cordonnier, C. and Schellongowski, P. and Akova, M. and Aljurf, M. and Averbuch, D. and Barnes, R. and Blennow, O. and Bochud, P.-Y. and Bouza, E. and Bretagne, S. and Br{\"u}ggemann, R. and Calandra, T. and Carratal{\`a}, J. and Cesaro, S. and Cornely, O. and Dalianis, T. and De La Camara, R. and Donnelly, P. and Drgona, L. and Duarte, R. and Einsele, H. and Engelhard, D. and Fox, C. and Girmenia, C. and Groll, A. and Heldal, D. and {Helweg-Larsen}, J. and Herbrecht, R. and Hirsch, H. and Johnson, E. and Klyasova, G. and Koskuenvo, M. and Lagrou, K. and Lewis, R.E. and Ljungman, P. and Maertens, J. and Maschmeyer, G. and Mikulska, M. and Nucci, M. and Padoin, C. and Dwe, A.L.L.W. and Pagliuca, A. and Racil, Z. and Ribaud, P. and Rinaldo, C. and {Rizzi-Puechal}, V. and Roilides, E. and Robin, C. and Rovira, M. and Rupp, M. and Sanchez, S. and Schellongowski, P. and Sedlacek, P. and Sinko, J. and Slavin, M. and Ferreira, I.S. and Styczynski, J. and Tissot, F. and Viscoli, C. and Ward, K. and Witschi, A.-T.},
  year = {2016},
  journal = {Journal of Antimicrobial Chemotherapy},
  volume = {71},
  number = {9},
  pages = {2405--2413},
  doi = {10.1093/jac/dkw158},
  note = {Cited By :86
\par
Cited By :86
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022}
}

@article{potenza.etal_2016,
  title = {Mucorales-Specific {{T}} Cells in Patients with Hematologic Malignancies},
  author = {Potenza, L. and Vallerini, D. and Barozzi, P. and Riva, G. and Gilioli, A. and Forghieri, F. and Candoni, A. and Cesaro, S. and Quadrelli, C. and Maertens, J. and Rossi, G. and Morselli, M. and Codeluppi, M. and Mussini, C. and Colaci, E. and Messerotti, A. and Paolini, A. and Maccaferri, M. and Fantuzzi, V. and Del Giovane, C. and Stefani, A. and Morandi, U. and Maffei, R. and Marasca, R. and Narni, F. and Fanin, R. and Comoli, P. and Romani, L. and Beauvais, A. and Viale, P.L. and Latg{\`e}, J.P. and Lewis, R.E. and Luppi, M.},
  year = {2016},
  journal = {PLoS ONE},
  volume = {11},
  number = {2},
  doi = {10.1371/journal.pone.0149108},
  note = {Cited By :28
\par
Cited By :28
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022},
  file = {/Users/russelllewis/Zotero/storage/J5Q2HEPF/Potenza et al_2016_Mucorales-specific T cells in patients with hematologic malignancies.pdf}
}

@article{stanzani.etal_2016,
  title = {Improved {{Radiographic Imaging}} of {{Invasive Fungal Disease}}: {{The Cornerstone}} to {{Antifungal Stewardship}} in the {{Hematology Units}}?},
  author = {Stanzani, M. and Sassi, C. and Battista, G. and Cavo, M. and Lewis, R.E.},
  year = {2016},
  journal = {Current Fungal Infection Reports},
  volume = {10},
  number = {2},
  pages = {78--86},
  doi = {10.1007/s12281-016-0258-1},
  note = {Cited By :3
\par
Cited By :3
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022}
}

@article{bellanger.etal_2015,
  title = {Effect of Preexposure to Triazoles on Susceptibility and Virulence of {{Rhizopus}} Oryzae},
  author = {Bellanger, A.-P. and Albert, N.D. and Lewis, R.E. and Walsh, T.J. and Kontoyiannis, D.P.},
  year = {2015},
  journal = {Antimicrobial Agents and Chemotherapy},
  volume = {59},
  number = {12},
  pages = {7830--7832},
  doi = {10.1128/AAC.01583-15},
  note = {Cited By :8
\par
Cited By :8
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022},
  file = {/Users/russelllewis/Zotero/storage/FXM3IJW2/Bellanger et al_2015_Effect of preexposure to triazoles on susceptibility and virulence of Rhizopus.pdf}
}

@article{beyda.etal_2015,
  title = {Innate Inflammatory Response and Immunopharmacologic Activity of Micafungin, Caspofungin, and Voriconazole against Wild-Type and {{FKS}} Mutant {{Candida}} Glabrata Isolates},
  author = {Beyda, N.D. and Liao, G. and Endres, B.T. and Lewis, R.E. and Garey, K.W.},
  year = {2015},
  journal = {Antimicrobial Agents and Chemotherapy},
  volume = {59},
  number = {9},
  pages = {5405--5412},
  doi = {10.1128/AAC.00624-15},
  note = {Cited By :8
\par
Cited By :8
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022},
  file = {/Users/russelllewis/Zotero/storage/RG3T4T7M/Beyda et al_2015_Innate inflammatory response and immunopharmacologic activity of micafungin,.pdf}
}

@article{giannella.etal_2015,
  title = {High-Dose Weekly Liposomal Amphotericin {{B}} Antifungal Prophylaxis in Patients Undergoing Liver Transplantation: {{A}} Prospective Phase {{II}} Trial},
  author = {Giannella, M. and Ercolani, G. and Cristini, F. and Morelli, M. and Bartoletti, M. and Bertuzzo, V. and Tedeschi, S. and Faenza, S. and Puggioli, C. and Lewis, R.E. and Pinna, A.D. and Viale, P.},
  year = {2015},
  journal = {Transplantation},
  volume = {99},
  number = {4},
  pages = {848--854},
  doi = {10.1097/TP.0000000000000393},
  note = {Cited By :20
\par
Cited By :20
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022}
}

@article{giannella.etal_2015a,
  title = {Risk Factors for Infection with Carbapenem-Resistant {{Klebsiella}} Pneumoniae after Liver Transplantation: {{The}} Importance of Pre- and Posttransplant Colonization},
  author = {Giannella, M. and Bartoletti, M. and Morelli, M.C. and Tedeschi, S. and Cristini, F. and Tumietto, F. and Pasqualini, E. and Danese, I. and Campoli, C. and Lauria, N.D. and Faenza, S. and Ercolani, G. and Lewis, R. and Pinna, A.D. and Viale, P.},
  year = {2015},
  journal = {American Journal of Transplantation},
  volume = {15},
  number = {6},
  pages = {1708--1715},
  doi = {10.1111/ajt.13136},
  note = {Cited By :67
\par
Cited By :67
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022},
  file = {/Users/russelllewis/Zotero/storage/IBLTHD4I/Giannella et al_2015_Risk factors for infection with carbapenem-resistant Klebsiella pneumoniae.pdf}
}

@article{kontoyiannis.lewis_2015,
  title = {Treatment Principles for the Management of Mold Infections},
  author = {Kontoyiannis, D.P. and Lewis, R.E.},
  year = {2015},
  journal = {Cold Spring Harbor Perspectives in Medicine},
  volume = {5},
  number = {4},
  doi = {10.1101/cshperspect.a019737},
  note = {Cited By :20
\par
Cited By :20
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022},
  file = {/Users/russelllewis/Zotero/storage/HL4RAZEJ/Kontoyiannis_Lewis_2015_Treatment principles for the management of mold infections.pdf}
}

@article{lewis.etal_2015a,
  title = {Serum Galactomannan Diagnosis of Breakthrough Invasive Fungal Disease},
  author = {Lewis, R.E. and Giannella, M. and Viale, P.},
  year = {2015},
  journal = {Clinical Infectious Diseases},
  volume = {60},
  number = {8},
  pages = {1284},
  doi = {10.1093/cid/civ035},
  note = {Cited By :2
\par
Cited By :2
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022}
}

@incollection{lewis.fothergill_2015,
  title = {Antifungal Agents},
  booktitle = {Diagnosis and {{Treatment}} of {{Fungal Infections}}},
  author = {Lewis, R.E. and Fothergill, A.W.},
  year = {2015},
  pages = {79--97},
  doi = {10.1007/9783319130903_7},
  note = {Cited By :2
\par
Cited By :2
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022}
}

@incollection{lewis.viale_2015,
  title = {Therapeutic Drug Monitoring of Voriconazole},
  booktitle = {Voriconazole: {{Pharmacokinetics}}, {{Role}} in {{Therapeutic Drug Monitoring}} and {{Clinical Outcomes}}},
  author = {Lewis, R.E. and Viale, P.},
  year = {2015},
  pages = {155--165},
  note = {Export Date: 20 November 2022
\par
Export Date: 20 November 2022}
}

@incollection{lewis.viale_2015a,
  title = {Voriconazole Toxicology},
  booktitle = {Voriconazole: {{Pharmacokinetics}}, {{Role}} in {{Therapeutic Drug Monitoring}} and {{Clinical Outcomes}}},
  author = {Lewis, R E and Viale, P},
  year = {2015},
  pages = {145--153},
  publisher = {Nova Science Publishers, Inc.},
  isbn = {978-1-63463-313-0 978-1-63463-940-8},
  note = {Export Date: 20 November 2022
\par
Export Date: 20 November 2022}
}

@incollection{lewis.viale_2015b,
  title = {Drug Interactions with Voriconazole},
  booktitle = {Voriconazole: {{Pharmacokinetics}}, {{Role}} in {{Therapeutic Drug Monitoring}} and {{Clinical Outcomes}}},
  author = {Lewis, R E and Viale, P},
  year = {2015},
  pages = {129--139},
  publisher = {Nova Science Publishers, Inc.},
  isbn = {978-1-63463-313-0},
  note = {Export Date: 20 November 2022
\par
Export Date: 20 November 2022}
}

@article{sassi.etal_2015,
  title = {Computerized Tomographic Pulmonary Angiography Discriminates Invasive Mould Disease of the Lung from Lymphoma},
  author = {Sassi, C. and Stanzani, M. and Lewis, R.E.},
  year = {2015},
  journal = {British Journal of Haematology},
  volume = {169},
  number = {4},
  pages = {462--462},
  doi = {10.1111/bjh.13356},
  note = {Cited By :2
\par
Cited By :2
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022}
}

@article{shirazi.etal_2015a,
  title = {Micafungin Induced Apoptosis in Candida Parapsilosis Independent of Its Susceptibility to Micafungin},
  author = {Shirazi, F. and Lewis, R.E. and Kontoyiannis, D.P.},
  year = {2015},
  journal = {Microbial Cell},
  volume = {2},
  number = {11},
  pages = {445--450},
  doi = {10.15698/mic2015.11.236},
  note = {Cited By :2
\par
Cited By :2
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022},
  file = {/Users/russelllewis/Zotero/storage/XDXBT9BM/Shirazi et al_2015_Micafungin induced apoptosis in candida parapsilosis independent of its.pdf}
}

@article{stanzani.etal_2015,
  title = {High Resolution Computed Tomography Angiography Improves the Radiographic Diagnosis of Invasive Mold Disease in Patients with Hematological Malignancies},
  author = {Stanzani, M. and Sassi, C. and Lewis, R.E. and Tolomelli, G. and Bazzocchi, A. and Cavo, M. and Vianelli, N. and Battista, G.},
  year = {2015},
  journal = {Clinical Infectious Diseases},
  volume = {60},
  number = {11},
  pages = {1603--1610},
  doi = {10.1093/cid/civ154},
  note = {Cited By :62
\par
Cited By :62
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022}
}

@article{viale.etal_2015,
  title = {Impact of a Hospital-Wide Multifaceted Programme for Reducing Carbapenem-Resistant {{Enterobacteriaceae}} Infections in a Large Teaching Hospital in Northern {{Italy}}},
  author = {Viale, P. and Tumietto, F. and Giannella, M. and Bartoletti, M. and Tedeschi, S. and Ambretti, S. and Cristini, F. and Gibertoni, C. and Venturi, S. and Cavalli, M. and De Palma, A. and Puggioli, M.C. and Mosci, D. and Callea, E. and Masina, R. and Moro, M.L. and Lewis, R.E.},
  year = {2015},
  journal = {Clinical Microbiology and Infection},
  volume = {21},
  number = {3},
  pages = {242--247},
  doi = {10.1016/j.cmi.2014.10.020},
  note = {Cited By :61
\par
Cited By :61
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022},
  file = {/Users/russelllewis/Zotero/storage/K64BDYC4/Viale et al_2015_Impact of a hospital-wide multifaceted programme for reducing.pdf}
}

@article{viale.etal_2015a,
  title = {Implementation of a {{Meningitis Care Bundle}} in the {{Emergency Room Reduces Mortality Associated With Acute Bacterial Meningitis}}},
  author = {Viale, P. and Scudeller, L. and Pea, F. and Tedeschi, S. and Lewis, R. and Bartoletti, M. and Sbrojavacca, R. and Cristini, F. and Tumietto, F. and Di Lauria, N. and Fasulo, G. and Giannella, M.},
  year = {2015},
  journal = {Annals of Pharmacotherapy},
  volume = {49},
  number = {9},
  pages = {978--985},
  doi = {10.1177/1060028015586012},
  note = {Cited By :11
\par
Cited By :11
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022}
}

@article{viale.etal_2015b,
  title = {Treatment of {{MDR-Gram}} Negative Infections in the 21st Century: A Never Ending Threat for Clinicians},
  author = {Viale, P. and Giannella, M. and Tedeschi, S. and Lewis, R.},
  year = {2015},
  journal = {Current Opinion in Pharmacology},
  volume = {24},
  pages = {30--37},
  doi = {10.1016/j.coph.2015.07.001},
  note = {Cited By :36
\par
Cited By :36
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022}
}

@article{viale.etal_2015c,
  title = {Considerations {{About Antimicrobial Stewardship}} in {{Settings}} with {{Epidemic Extended-Spectrum}} {$\beta$}-{{Lactamase-Producing}} or {{Carbapenem-Resistant Enterobacteriaceae}}},
  author = {Viale, P. and Giannella, M. and Bartoletti, M. and Tedeschi, S. and Lewis, R.},
  year = {2015},
  journal = {Infectious Diseases and Therapy},
  volume = {4},
  pages = {65--83},
  doi = {10.1007/s40121-015-0081-y},
  note = {Cited By :32
\par
Cited By :32
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022},
  file = {/Users/russelllewis/Zotero/storage/TRG4MG92/Viale et al_2015_Considerations About Antimicrobial Stewardship in Settings with Epidemic.pdf}
}

@incollection{viale.lewis_2015,
  title = {Voriconazole Treatment in Invasive Candidiasis},
  booktitle = {Voriconazole: {{Pharmacokinetics}}, {{Role}} in {{Therapeutic Drug Monitoring}} and {{Clinical Outcomes}}},
  author = {Viale, P. and Lewis, R.E.},
  year = {2015},
  pages = {41--52},
  note = {Export Date: 20 November 2022
\par
Export Date: 20 November 2022}
}

@article{bartoletti.etal_2014,
  title = {Epidemiology and Outcomes of Bloodstream Infection in Patients with Cirrhosis},
  author = {Bartoletti, M. and Giannella, M. and Caraceni, P. and Domenicali, M. and Ambretti, S. and Tedeschi, S. and Verucchi, G. and Badia, L. and Lewis, R.E. and Bernardi, M. and Viale, P.},
  year = {2014},
  journal = {Journal of Hepatology},
  volume = {61},
  number = {1},
  pages = {51--58},
  doi = {10.1016/j.jhep.2014.03.021},
  note = {Cited By :91
\par
Cited By :91
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022}
}

@article{dimopoulou.etal_2014,
  title = {Anidulafungin versus Caspofungin in a Mouse Model of Candidiasis Caused by Anidulafungin-{{Susceptible}} Candida Parapsilosis Isolates with Different Degrees of Caspofungin Susceptibility},
  author = {Dimopoulou, D. and Hamilos, G. and Tzardi, M. and Lewis, R.E. and Samonis, G. and Kontoyiannis, D.P.},
  year = {2014},
  journal = {Antimicrobial Agents and Chemotherapy},
  volume = {58},
  number = {1},
  pages = {229--236},
  doi = {10.1128/AAC.01025-13},
  note = {Cited By :10
\par
Cited By :10
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022},
  file = {/Users/russelllewis/Zotero/storage/F8KGELHM/Dimopoulou et al_2014_Anidulafungin versus caspofungin in a mouse model of candidiasis caused by.pdf}
}

@article{dipaolo.etal_2014,
  title = {Different Recommendations for Daptomycin Dosing over Time in Patients with Severe Infections},
  author = {Di Paolo, A. and Polillo, M. and Tascini, C. and Lewis, R. and Menichetti, F. and Danesi, R.},
  year = {2014},
  journal = {Clinical Infectious Diseases},
  volume = {58},
  number = {12},
  pages = {1788--1789},
  doi = {10.1093/cid/ciu230},
  note = {Cited By :10
\par
Cited By :10
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022}
}

@article{gaibani.etal_2014,
  title = {In Vitro Activity and Post-Antibiotic Effects of Colistin in Combination with Other Antimicrobials against Colistin-Resistant {{KPC-producing Klebsiella}} Pneumoniae Bloodstream Isolates},
  author = {Gaibani, P. and Lombardo, D. and Lewis, R.E. and Mercuri, M. and Bonora, S. and Landini, M.P. and Ambretti, S.},
  year = {2014},
  journal = {Journal of Antimicrobial Chemotherapy},
  volume = {69},
  number = {7},
  pages = {1856--1865},
  doi = {10.1093/jac/dku065},
  note = {Cited By :61
\par
Cited By :61
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022}
}

@article{giannella.etal_2014,
  title = {Risk Factors for Carbapenem-Resistant {{Klebsiella}} Pneumoniae Bloodstream Infection among Rectal Carriers: {{A}} Prospective Observational Multicentre Study},
  author = {Giannella, M. and Trecarichi, E.M. and De Rosa, F.G. and Del Bono, V. and Bassetti, M. and Lewis, R.E. and Losito, A.R. and Corcione, S. and Saffioti, C. and Bartoletti, M. and Maiuro, G. and Cardellino, C.S. and Tedeschi, S. and Cauda, R. and Viscoli, C. and Viale, P. and Tumbarello, M.},
  year = {2014},
  journal = {Clinical Microbiology and Infection},
  volume = {20},
  number = {12},
  pages = {1357--1362},
  doi = {10.1111/1469-0691.12747},
  note = {Cited By :139
\par
Cited By :139
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022}
}

@article{giannella.etal_2014a,
  title = {Carbapenem-Resistant {{Klebsiella}} Pneumoniae Colonization at Liver Transplantation: {{A}} Management Challenge},
  author = {Giannella, M. and Morelli, M.C. and Cristini, F. and Ercolani, G. and Cescon, M. and Bartoletti, M. and Tedeschi, S. and Pasqualini, E. and Lewis, R.E. and Pinna, A.D. and Viale, P.},
  year = {2014},
  journal = {Liver Transplantation},
  volume = {20},
  number = {5},
  pages = {631--633},
  doi = {10.1002/lt.23857},
  note = {Cited By :6
\par
Cited By :6
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022}
}

@article{girometti.etal_2014,
  title = {Klebsiella Pneumoniae Bloodstream Infection Epidemiology and Impact of Inappropriate Empirical Therapy},
  author = {Girometti, N. and Lewis, R.E. and Giannella, M. and Ambretti, S. and Bartoletti, M. and Tedeschi, S. and Tumietto, F. and Cristini, F. and Trapani, F. and Gaibani, P. and Viale, P.},
  year = {2014},
  journal = {Medicine (United States)},
  volume = {93},
  number = {17},
  pages = {298--308},
  doi = {10.1097/MD.0000000000000111},
  note = {Cited By :81
\par
Cited By :81
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022},
  file = {/Users/russelllewis/Zotero/storage/36XEVE28/Girometti et al_2014_Klebsiella pneumoniae bloodstream infection epidemiology and impact of.pdf}
}

@article{gomes.etal_2014,
  title = {Incidence Density of Invasive Fungal Infections during Primary Antifungal Prophylaxis in Newly Diagnosed Acute Myeloid Leukemia Patients in a Tertiary Cancer Center, 2009 to 2011},
  author = {Gomes, M.Z.R. and Mulanovich, V.E. and Jiang, Y. and Lewis, R.E. and Kontoyiannis, D.P.},
  year = {2014},
  journal = {Antimicrobial Agents and Chemotherapy},
  volume = {58},
  number = {2},
  pages = {865--873},
  doi = {10.1128/AAC.01525-13},
  note = {Cited By :40
\par
Cited By :40
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022},
  file = {/Users/russelllewis/Zotero/storage/59W3WK7Q/Gomes et al. - 2014 - Incidence Density of Invasive Fungal Infections du.pdf}
}

@article{gomes.etal_2014a,
  title = {Effectiveness of Primary Anti-{{Aspergillus}} Prophylaxis during Remission Induction Chemotherapy of Acute Myeloid Leukemia},
  author = {Gomes, M.Z.R. and Jiang, Y. and Mulanovich, V.E. and Lewis, R.E. and Kontoyiannis, D.P.},
  year = {2014},
  journal = {Antimicrobial Agents and Chemotherapy},
  volume = {58},
  number = {5},
  pages = {2775--2780},
  doi = {10.1128/AAC.01527-13},
  note = {Cited By :30
\par
Cited By :30
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022},
  file = {/Users/russelllewis/Zotero/storage/JRW5T8VR/Gomes et al_2014_Effectiveness of primary anti-Aspergillus prophylaxis during remission.pdf}
}

@article{kontoyiannis.lewis_2014,
  title = {Reply to "{{Risk}} for Invasive Fungal Infections during Acute Myeloid Leukemia Induction Therapy: {{A}} True Association with Echinocandins?"},
  author = {Kontoyiannis, D.P. and Lewis, R.E.},
  year = {2014},
  journal = {Antimicrobial Agents and Chemotherapy},
  volume = {58},
  number = {8},
  pages = {4990--4991},
  doi = {10.1128/AAC.03224-14},
  note = {Export Date: 20 November 2022
\par
Export Date: 20 November 2022},
  file = {/Users/russelllewis/Zotero/storage/YB5RRII3/Kontoyiannis_Lewis_2014_Reply to Risk for invasive fungal infections during acute myeloid leukemia.pdf}
}

@incollection{kontoyiannis.lewis_2014a,
  title = {Agents of {{Mucormycosis}} and {{Entomophthoramycosis}}},
  booktitle = {Mandell, {{Douglas}}, and {{Bennett}}'s {{Principles}} and {{Practice}} of {{Infectious Diseases}}},
  author = {Kontoyiannis, D.P. and Lewis, R.E.},
  year = {2014},
  volume = {2},
  pages = {2909--2919},
  doi = {10.1016/B978-1-4557-4801-3.00260-5},
  note = {Cited By :18
\par
Cited By :18
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022}
}

@article{lewis.etal_2014,
  title = {Macrophage Reporter Cell Assay for Screening Immunopharmacological Activity of Cell Wall-Active Antifungals},
  author = {Lewis, R.E. and Liao, G. and Young, K. and Douglas, C. and Kontoyiannis, D.P.},
  year = {2014},
  journal = {Antimicrobial Agents and Chemotherapy},
  volume = {58},
  number = {3},
  pages = {1738--1743},
  doi = {10.1128/AAC.02408-13},
  note = {Cited By :13
\par
Cited By :13
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022},
  file = {/Users/russelllewis/Zotero/storage/2UXVPFXQ/Lewis et al_2014_Macrophage reporter cell assay for screening immunopharmacological activity of.pdf}
}

@article{lewis.etal_2014a,
  title = {Risk Factors for Early Mortality in Haematological Malignancy Patients with Pulmonary Mucormycosis},
  author = {Lewis, R.E. and Georgiadou, S.P. and Sampsonas, F. and Chamilos, G. and Kontoyiannis, D.P.},
  year = {2014},
  journal = {Mycoses},
  volume = {57},
  number = {1},
  pages = {49--55},
  doi = {10.1111/myc.12101},
  note = {Cited By :27
\par
Cited By :27
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022},
  file = {/Users/russelllewis/Zotero/storage/YNJXLHGM/Lewis et al_2014_Risk factors for early mortality in haematological malignancy patients with.pdf}
}

@article{lewis.etal_2014b,
  title = {Comparative Pharmacodynamics of Posaconazole in Neutropenic Murine Models of Invasive Pulmonary Aspergillosis and Mucormycosis},
  author = {Lewis, R.E. and Albert, N.D. and Kontoyiannis, D.P.},
  year = {2014},
  journal = {Antimicrobial Agents and Chemotherapy},
  volume = {58},
  number = {11},
  pages = {6767--6772},
  doi = {10.1128/AAC.03569-14},
  note = {Cited By :34
\par
Cited By :34
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022},
  file = {/Users/russelllewis/Zotero/storage/KESKIXU9/Lewis et al_2014_Comparative pharmacodynamics of posaconazole in neutropenic murine models of.pdf}
}

@article{tascini.etal_2014,
  title = {Oral Gentamicin Gut Decontamination for Prevention of {{KPC-producing Klebsiella}} Pneumoniae Infections: {{Relevance}} of Concomitant Systemic Antibiotic Therapy},
  author = {Tascini, C. and Sbrana, F. and Flammini, S. and Tagliaferri, E. and Arena, F. and Leonildi, A. and Ciullo, I. and Amadori, F. and Di Paolo, A. and Ripoli, A. and Lewis, R. and Rossolini, G.M. and Menichetti, F. and Lambelet, P. and Forfori, F. and Viaggi, B. and Papini, F. and Urbani, L. and Malacarne, P.},
  year = {2014},
  journal = {Antimicrobial Agents and Chemotherapy},
  volume = {58},
  number = {4},
  pages = {1972--1976},
  doi = {10.1128/AAC.02283-13},
  note = {Cited By :52
\par
Cited By :52
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022},
  file = {/Users/russelllewis/Zotero/storage/6KZI5RES/Tascini et al_2014_Oral gentamicin gut decontamination for prevention of KPC-producing Klebsiella.pdf}
}

@article{ben-ami.etal_2013,
  title = {Drosophila Melanogaster as a Model to Explore the Effects of Methicillin-Resistant {{Staphylococcus}} Aureus Strain Type on Virulence and Response to Linezolid Treatment},
  author = {{Ben-Ami}, R. and Watson, C.C. and Lewis, R.E. and Albert, N.D. and Arias, C.A. and Raad, I.I. and Kontoyiannis, D.P.},
  year = {2013},
  journal = {Microbial Pathogenesis},
  volume = {55},
  number = {1},
  pages = {16--20},
  doi = {10.1016/j.micpath.2012.11.012},
  note = {Cited By :9
\par
Cited By :9
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022}
}

@article{ben-ami.etal_2013a,
  title = {Proangiogenic Growth Factors Potentiate in Situ Angiogenesis and Enhance Antifungal Drug Activity in Murine Invasive Aspergillosis},
  author = {{Ben-Ami}, R. and Albert, N.D. and Lewis, R.E. and Kontoyiannis, D.P.},
  year = {2013},
  journal = {Journal of Infectious Diseases},
  volume = {207},
  number = {7},
  pages = {1066--1074},
  doi = {10.1093/infdis/jis940},
  note = {Cited By :19
\par
Cited By :19
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022},
  file = {/Users/russelllewis/Zotero/storage/552TYZ7H/Ben-Ami et al_2013_Proangiogenic growth factors potentiate in situ angiogenesis and enhance.pdf}
}

@article{beyda.etal_2013a,
  title = {Immunomodulatory Agents as Adjunctive Therapy for the Treatment of Resistant {{Candida}} Species},
  author = {Beyda, N.D. and Regen, S. and Lewis, R.E. and Garey, K.W.},
  year = {2013},
  journal = {Current Fungal Infection Reports},
  volume = {7},
  number = {2},
  pages = {119--125},
  doi = {10.1007/s12281-013-0132-3},
  note = {Cited By :1
\par
Cited By :1
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022}
}

@article{georgiadou.etal_2013a,
  title = {The Impact of Prior Invasive Mold Infections in Leukemia Patients Who Undergo Allo-{{SCT}} in the Era of Triazole-Based Secondary Prophylaxis},
  author = {Georgiadou, S.P. and Lewis, R.E. and Best, L. and Torres, H.A. and Champlin, R.E. and Kontoyiannis, D.P.},
  year = {2013},
  journal = {Bone Marrow Transplantation},
  volume = {48},
  number = {1},
  pages = {141--143},
  doi = {10.1038/bmt.2012.89},
  note = {Cited By :10
\par
Cited By :10
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022}
}

@article{girardis.etal_2013,
  title = {Aggressive versus Conservative Initiation of Antibiotics},
  author = {Girardis, M. and Bassetti, M. and Lewis, R.E. and Viale, P.},
  year = {2013},
  journal = {The Lancet Infectious Diseases},
  volume = {13},
  number = {5},
  pages = {387},
  doi = {10.1016/S1473-3099(13)70064-1},
  note = {Export Date: 20 November 2022
\par
Export Date: 20 November 2022},
  file = {/Users/russelllewis/Zotero/storage/GC6C2CU7/Girardis et al_2013_Aggressive versus conservative initiation of antibiotics.pdf}
}

@article{kontoyiannis.etal_2013,
  title = {Impaired Bactericidal but Not Fungicidal Activity of Polymorphonuclear Neutrophils in Patients with Chronic Lymphocytic Leukemia},
  author = {Kontoyiannis, D.P. and Georgiadou, S.P. and Wierda, W.G. and Wright, S. and Albert, N.D. and Ferrajoli, A. and Keating, M. and Lewis, R.E.},
  year = {2013},
  journal = {Leukemia and Lymphoma},
  volume = {54},
  number = {8},
  pages = {1730--1733},
  doi = {10.3109/10428194.2012.750723},
  note = {Cited By :27
\par
Cited By :27
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022},
  file = {/Users/russelllewis/Zotero/storage/DKZUUQ2J/Kontoyiannis et al_2013_Impaired bactericidal but not fungicidal activity of polymorphonuclear.pdf}
}

@article{lewis.etal_2013,
  title = {Tacrolimus Enhances the Potency of Posaconazole against {{Rhizopus}} Oryzae in Vitro and in an Experimental Model of Mucormycosis},
  author = {Lewis, R.E. and {Ben-Ami}, R. and Best, L. and Albert, N. and Walsh, T.J. and Kontoyiannis, D.P.},
  year = {2013},
  journal = {Journal of Infectious Diseases},
  volume = {207},
  number = {5},
  pages = {834--841},
  doi = {10.1093/infdis/jis767},
  note = {Cited By :43
\par
Cited By :43
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022},
  file = {/Users/russelllewis/Zotero/storage/TBNJ6SLA/Lewis et al_2013_Tacrolimus enhances the potency of posaconazole against Rhizopus oryzae in.pdf}
}

@article{lewis.etal_2013b,
  title = {High-Dose Induction Liposomal Amphotericin {{B}} Followed by de-Escalation Is Effective in Experimental {{Aspergillus}} Terreus Pneumonia},
  author = {Lewis, R.E. and Albert, N.P. and Liao, G. and Wang, W. and Prince, R.A. and Kontoyiannis, D.P.},
  year = {2013},
  journal = {Journal of Antimicrobial Chemotherapy},
  volume = {68},
  number = {5},
  pages = {1148--1151},
  doi = {10.1093/jac/dks521},
  note = {Cited By :9
\par
Cited By :9
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022}
}

@article{lewis.kontoyiannis_2013,
  title = {Epidemiology and Treatment of Mucormycosis},
  author = {Lewis, R.E. and Kontoyiannis, D.P.},
  year = {2013},
  journal = {Future Microbiology},
  volume = {8},
  number = {9},
  pages = {1163--1175},
  doi = {10.2217/fmb.13.78},
  note = {Cited By :67
\par
Cited By :67
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022}
}

@article{paolucci.etal_2013,
  title = {Routine Use of a Real-Time Polymerase Chain Reaction Method for Detection of Bloodstream Infections in Neutropaenic Patients},
  author = {Paolucci, M. and Stanzani, M. and Melchionda, F. and Tolomelli, G. and Castellani, G. and Landini, M.P. and Varani, S. and Lewis, R.E. and Sambri, V.},
  year = {2013},
  journal = {Diagnostic Microbiology and Infectious Disease},
  volume = {75},
  number = {2},
  pages = {130--134},
  doi = {10.1016/j.diagmicrobio.2012.10.012},
  note = {Cited By :35
\par
Cited By :35
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022}
}

@article{petrosillo.etal_2013,
  title = {Treatment of Carbapenem-Resistant {{Klebsiella}} Pneumoniae: {{The}} State of the Art},
  author = {Petrosillo, N. and Giannella, M. and Lewis, R. and Viale, P.},
  year = {2013},
  journal = {Expert Review of Anti-Infective Therapy},
  volume = {11},
  number = {2},
  pages = {159--177},
  doi = {10.1586/eri.12.162},
  note = {Cited By :128
\par
Cited By :128
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022}
}

@article{shirazi.etal_2013,
  title = {Hyperthermia Sensitizes {{Rhizopus}} Oryzae to Posaconazole and Itraconazole Action through Apoptosis},
  author = {Shirazi, Fazal and Pontikos, Michael A and Walsh, Thomas J and Albert, Nathaniel and Lewis, Russell E and Kontoyiannis, Dimitrios P},
  year = {2013},
  month = sep,
  journal = {Antimicrobial agents and chemotherapy},
  volume = {57},
  number = {9},
  pages = {4360--4368},
  issn = {0066-4804, 1098-6596},
  doi = {10.1128/AAC.00571-13},
  pmid = {23817366},
  note = {Cited By :18
\par
Cited By :18
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022},
  file = {/Users/russelllewis/Zotero/storage/2GG4V82V/Shirazi et al_2013_Hyperthermia sensitizes Rhizopus oryzae to posaconazole and itraconazole action.pdf}
}

@article{stanzani.etal_2013,
  title = {A {{Risk Prediction Score}} for {{Invasive Mold Disease}} in {{Patients}} with {{Hematological Malignancies}}},
  author = {Stanzani, M. and Lewis, R.E. and Fiacchini, M. and Ricci, P. and Tumietto, F. and Viale, P. and Ambretti, S. and Baccarani, M. and Cavo, M. and Vianelli, N.},
  year = {2013},
  journal = {PLoS ONE},
  volume = {8},
  number = {9},
  doi = {10.1371/journal.pone.0075531},
  note = {Cited By :49
\par
Cited By :49
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022},
  file = {/Users/russelllewis/Zotero/storage/F2FN46WD/Stanzani et al_2013_A Risk Prediction Score for Invasive Mold Disease in Patients with.pdf}
}

@article{tascini.etal_2013,
  title = {Synergistic Activity of Colistin plus Rifampin against Colistin-Resistant Kpc-Producing Klebsiella Pneumoniae},
  author = {Tascini, C. and Tagliaferri, E. and Giani, T. and Leonildi, A. and Flammini, S. and Casini, B. and Lewis, R. and Ferranti, S. and Rossolini, G.M. and Menichetti, F.},
  year = {2013},
  journal = {Antimicrobial Agents and Chemotherapy},
  volume = {57},
  number = {8},
  pages = {3990--3993},
  doi = {10.1128/AAC.00179-13},
  note = {Cited By :100
\par
Cited By :100
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022},
  file = {/Users/russelllewis/Zotero/storage/ZSNRTY8G/Tascini et al_2013_Synergistic activity of colistin plus rifampin against colistin-resistant.pdf}
}

@article{viale.etal_2013,
  title = {Predictors of Mortality in Multidrug-Resistant {{Klebsiella}} Pneumoniae Bloodstream Infections},
  author = {Viale, P. and Giannella, M. and Lewis, R. and Trecarichi, E.M. and Petrosillo, N. and Tumbarello, M.},
  year = {2013},
  journal = {Expert Review of Anti-Infective Therapy},
  volume = {11},
  number = {10},
  pages = {1053--1063},
  doi = {10.1586/14787210.2013.836057},
  note = {Cited By :68
\par
Cited By :68
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022}
}

@article{beyda.etal_2012,
  title = {Echinocandin Resistance in {{Candida}} Species: {{Mechanisms}} of Reduced Susceptibility and Therapeutic Approaches},
  shorttitle = {Resistencia a Equinocandinas En Especies de Candida: {{Mecanismos}} de Susceptibilidad Reducida y Alternativas Terap{\'e}uticas},
  author = {Beyda, N.D. and Lewis, R.E. and Garey, K.W.},
  year = {2012},
  journal = {Annals of Pharmacotherapy},
  volume = {46},
  number = {7-8},
  pages = {1086--1096},
  doi = {10.1345/aph.1R020},
  note = {Cited By :77
\par
Cited By :77
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022}
}

@article{cahuayme-zuniga.etal_2012,
  title = {Weekly Liposomal Amphotericin {{B}} as Secondary Prophylaxis for Invasive Fungal Infections in Patients with Hematological Malignancies},
  author = {{Cahuayme-Zuniga}, L. and Lewis, R.E. and Mulanovich, V.E. and Kontoyiannis, D.P.},
  year = {2012},
  journal = {Medical Mycology},
  volume = {50},
  number = {5},
  pages = {543--548},
  doi = {10.3109/13693786.2011.631152},
  note = {Cited By :14
\par
Cited By :14
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022},
  file = {/Users/russelllewis/Zotero/storage/59LHWXQD/Cahuayme-Zuniga et al_2012_Weekly liposomal amphotericin B as secondary prophylaxis for invasive fungal.pdf}
}

@article{chavan.etal_2012,
  title = {Interactions of Liposome Carriers with Infectious Fungal Hyphae Reveals the Role of {$\beta$}-Glucans},
  author = {Chavan, N.L. and Young, J.K. and Drezek, R.A. and Lewis, R. and Bikram, M.},
  year = {2012},
  journal = {Molecular Pharmaceutics},
  volume = {9},
  number = {9},
  pages = {2489--2496},
  doi = {10.1021/mp300097k},
  note = {Cited By :5
\par
Cited By :5
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022}
}

@article{chitasombat.etal_2012,
  title = {Rare Opportunistic (Non-{{Candida}}, Non-{{Cryptococcus}}) Yeast Bloodstream Infections in Patients with Cancer},
  author = {Chitasombat, M.N. and Kofteridis, D.P. and Jiang, Y. and Tarrand, J. and Lewis, R.E. and Kontoyiannis, D.P.},
  year = {2012},
  journal = {Journal of Infection},
  volume = {64},
  number = {1},
  pages = {68--75},
  doi = {10.1016/j.jinf.2011.11.002},
  note = {Cited By :104
\par
Cited By :104
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022},
  file = {/Users/russelllewis/Zotero/storage/VPAUYC3W/Chitasombat et al_2012_Rare opportunistic (non-Candida, non-Cryptococcus) yeast bloodstream infections.pdf}
}

@article{georgiadou.etal_2012,
  title = {Invasive Mold Infections in Pediatric Cancer Patients Reflect Heterogeneity in Etiology, Presentation, and Outcome: {{A}} 10-Year, Single-Institution, Retrospective Study},
  author = {Georgiadou, S.P. and Pongas, G. and Fitzgerald, N.E. and Lewis, R.E. and Rytting, M. and Marom, E.M. and Kontoyiannis, D.P.},
  year = {2012},
  journal = {Journal of the Pediatric Infectious Diseases Society},
  volume = {1},
  number = {2},
  pages = {125--135},
  doi = {10.1093/jpids/pis042},
  note = {Cited By :21
\par
Cited By :21
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022}
}

@article{julius.etal_2012,
  title = {Defining the Role of Echinocandin Catechol Functional Groups in the Development of Secondary Hepatocellular Carcinoma},
  author = {Julius, J.M. and Gaikwad, A. and Lowry, A. and Lewis, R.E. and Lozano, R.D. and Dalrymple, J.L. and Coleman, R.L. and Smith, J.A.},
  year = {2012},
  journal = {Journal of Antimicrobial Chemotherapy},
  volume = {67},
  number = {2},
  pages = {422--429},
  doi = {10.1093/jac/dkr494},
  note = {Cited By :4
\par
Cited By :4
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022}
}

@article{kontoyiannis.etal_2012,
  title = {Future Directions in Mucormycosis Research},
  author = {Kontoyiannis, D.P. and Lewis, R.E. and Lotholary, O. and Spellberg, B. and Petrikkos, G. and Roillides, E. and Ibrahim, A. and Walsh, T.J.},
  year = {2012},
  journal = {Clinical Infectious Diseases},
  volume = {54},
  number = {SUPPL. 1},
  pages = {S79-S85},
  doi = {10.1093/cid/cir886},
  note = {Cited By :31
\par
Cited By :31
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022},
  file = {/Users/russelllewis/Zotero/storage/CJSX9C2M/Kontoyiannis et al_2012_Future directions in mucormycosis research.pdf}
}

@article{lewis_2012a,
  title = {Importance of Pharmacokinetic Considerations for Selecting Therapy in the Treatment of Invasive Fungal Infections},
  author = {Lewis, R.E.},
  year = {2012},
  journal = {American Journal of Therapeutics},
  volume = {19},
  number = {1},
  pages = {51--63},
  doi = {10.1097/MJT.0b013e3181ff7e10},
  note = {Cited By :7
\par
Cited By :7
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022}
}

@article{lewis.etal_2012,
  title = {The Potential Impact of Antifungal Drug Resistance Mechanisms on the Host Immune Response to {{Candida}}},
  author = {Lewis, R.E. and Viale, P. and Kontoyiannis, D.P.},
  year = {2012},
  journal = {Virulence},
  volume = {3},
  number = {4},
  pages = {368--376},
  doi = {10.4161/viru.20746},
  note = {Cited By :35
\par
Cited By :35
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022},
  file = {/Users/russelllewis/Zotero/storage/NQM9IYN5/Lewis et al_2012_The potential impact of antifungal drug resistance mechanisms on the host.pdf}
}

@article{lewis.etal_2012a,
  title = {How Does Antifungal Pharmacology Differ for Mucormycosis versus Aspergillosis?},
  author = {Lewis, R.E. and Lortholary, O. and Spellberg, B. and Roilides, E. and Kontoyiannis, D.P. and Walsh, T.J.},
  year = {2012},
  journal = {Clinical Infectious Diseases},
  volume = {54},
  number = {SUPPL. 1},
  pages = {S67-S72},
  doi = {10.1093/cid/cir884},
  note = {Cited By :48
\par
Cited By :48
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022}
}

@article{lewis.viale_2012,
  title = {Update on Amphotericin {{B}} Pharmacology and Dosing for Common Systemic Mycoses},
  author = {Lewis, R.E. and Viale, P.},
  year = {2012},
  journal = {Current Fungal Infection Reports},
  volume = {6},
  number = {4},
  pages = {349--357},
  doi = {10.1007/s12281-012-0107-9},
  note = {Cited By :2
\par
Cited By :2
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022}
}

@article{muhammed.etal_2012,
  title = {Mouse Models for the Study of Fungal Pneumonia: {{A}} Collection of Detailed Experimental Protocols for the Study of {{Coccidioides}}, {{Cryptococcus}}, {{Fusarium}}, {{Histoplasma}} and Combined Infection Due to {{Aspergillus-Rhizopus}}},
  author = {Muhammed, M. and Feldmesser, M. and Shubitz, L.F. and Lionakis, M.S. and Sil, A. and Wang, Y. and {Glavis-Blom}, J. and Lewis, R.E. and Galgiani, J. and Casadevall, A. and Kontoyiannis, D.P. and Mylonakis, E.},
  year = {2012},
  journal = {Virulence},
  volume = {3},
  number = {3},
  pages = {15},
  note = {Cited By :11
\par
Cited By :11
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022}
}

@article{spellberg.etal_2012c,
  title = {Combination Therapy for Mucormycosis: {{Why}}, What, and How?},
  author = {Spellberg, B. and Ibrahim, A. and Roilides, E. and Lewis, R.E. and Lortholary, O. and Petrikkos, G. and Kontoyiannis, D.P. and Walsh, T.J.},
  year = {2012},
  journal = {Clinical Infectious Diseases},
  volume = {54},
  number = {SUPPL. 1},
  pages = {S73-S78},
  doi = {10.1093/cid/cir885},
  note = {Cited By :122
\par
Cited By :122
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022},
  file = {/Users/russelllewis/Zotero/storage/KBV748QF/Spellberg et al_2012_Combination therapy for mucormycosis.pdf}
}

@article{stanzani.etal_2012,
  title = {Computed Tomographic Pulmonary Angiography for Diagnosis of Invasive Mold Diseases in Patients with Hematological Malignancies},
  author = {Stanzani, M. and Battista, G. and Sassi, C. and Lewis, R.E. and Tolomelli, G. and Clissa, C. and Femia, R. and Bazzocchi, A. and Tumietto, F. and Viale, P. and Ambretti, S. and Baccarani, M. and Vianelli, N.},
  year = {2012},
  journal = {Clinical Infectious Diseases},
  volume = {54},
  number = {5},
  pages = {610--616},
  doi = {10.1093/cid/cir861},
  note = {Cited By :48
\par
Cited By :48
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022}
}

@article{ben-ami.etal_2011,
  title = {In Vitro Interactions among Echinocandins against {{Aspergillus}} Fumigatus: {{Lack}} of Concordance among Methods},
  author = {{Ben-Ami}, R. and Lewis, R.E. and Kontoyiannis, D.P.},
  year = {2011},
  journal = {Medical Mycology},
  volume = {49},
  number = {3},
  pages = {285--288},
  doi = {10.3109/13693786.2010.530300},
  note = {Cited By :8
\par
Cited By :8
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022}
}

@article{ben-ami.etal_2011a,
  title = {Fitness and Virulence Costs of {{Candida}} Albicans {{FKS1}} Hot Spot Mutations Associated with Echinocandin Resistance},
  author = {{Ben-Ami}, R. and {Garcia-Effron}, G. and Lewis, R.E. and Gamarra, S. and Leventakos, K. and Perlin, D.S. and Kontoyiannis, D.P.},
  year = {2011},
  journal = {Journal of Infectious Diseases},
  volume = {204},
  number = {4},
  pages = {626--635},
  doi = {10.1093/infdis/jir351},
  note = {Cited By :103
\par
Cited By :103
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022},
  file = {/Users/russelllewis/Zotero/storage/3F4R4K6N/Ben-Ami et al_2011_Fitness and virulence costs of Candida albicans FKS1 hot spot mutations.pdf}
}

@article{chen.etal_2011b,
  title = {Direct Effects of Non-Antifungal Agents Used in Cancer Chemotherapy and Organ Transplantation on the Development and Virulence of {{Candida}} and {{Aspergillus}} Species},
  author = {Chen, S.C.-A. and Lewis, R.E. and Kontoyiannis, D.P.},
  year = {2011},
  journal = {Virulence},
  volume = {2},
  number = {4},
  doi = {10.4161/viru.2.4.16764},
  note = {Cited By :23
\par
Cited By :23
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022},
  file = {/Users/russelllewis/Zotero/storage/EPEB799N/Chen et al_2011_Direct effects of non-antifungal agents used in cancer chemotherapy and organ.pdf}
}

@article{gomes.etal_2011,
  title = {Mucormycosis Caused by Unusual Mucormycetes, Non-{{Rhizopus}}, -{{Mucor}}, and -{{Lichtheimia}} Species},
  author = {Gomes, M.Z.R. and Lewis, R.E. and Kontoyiannis, D.P.},
  year = {2011},
  journal = {Clinical Microbiology Reviews},
  volume = {24},
  number = {2},
  pages = {411--445},
  doi = {10.1128/CMR.00056-10},
  note = {Cited By :253
\par
Cited By :253
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022},
  file = {/Users/russelllewis/Zotero/storage/774DY7H6/Gomes et al_2011_Mucormycosis caused by unusual mucormycetes, non-Rhizopus, -Mucor, and.pdf}
}

@article{kontoyiannis.lewis_2011,
  title = {How {{I}} Treat Mucormycosis},
  author = {Kontoyiannis, D.P. and Lewis, R.E.},
  year = {2011},
  journal = {Blood},
  volume = {118},
  number = {5},
  pages = {1216--1224},
  doi = {10.1182/blood-2011-03-316430},
  note = {Cited By :243
\par
Cited By :243
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022},
  file = {/Users/russelllewis/Zotero/storage/NFSK54IB/Kontoyiannis_Lewis_2011_How I treat mucormycosis.pdf}
}

@article{lewis_2011,
  title = {Pharmacokinetic-Pharmacodynamic Optimization of Triazole Antifungal Therapy},
  author = {Lewis, R.E.},
  year = {2011},
  journal = {Current Opinion in Infectious Diseases},
  volume = {24},
  number = {SUPPL. 2},
  pages = {S14-S29},
  doi = {10.1097/01.qco.0000399603.91138.e7},
  note = {Cited By :13
\par
Cited By :13
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022}
}

@article{lewis_2011a,
  title = {Cutaneous Mucormycosis in Tornado Survivors},
  author = {Lewis, R.E.},
  year = {2011},
  journal = {Current Fungal Infection Reports},
  volume = {5},
  number = {4},
  pages = {187--189},
  doi = {10.1007/s12281-011-0068-4},
  note = {Cited By :3
\par
Cited By :3
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022}
}

@article{lewis_2011b,
  title = {Current Concepts in Antifungal Pharmacology},
  author = {Lewis, R.E.},
  year = {2011},
  journal = {Mayo Clinic Proceedings},
  volume = {86},
  number = {8},
  pages = {805--817},
  doi = {10.4065/mcp.2011.0247},
  note = {Cited By :254
\par
Cited By :254
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022},
  file = {/Users/russelllewis/Zotero/storage/XTVLRDL7/Lewis_2011_Current concepts in antifungal pharmacology.pdf}
}

@article{lewis.etal_2011,
  title = {Activity of Deferasirox in {{Mucorales}}: {{Influences}} of Species and Exogenous Iron},
  author = {Lewis, R.E. and Pongas, G.N. and Albert, N. and {Ben-Ami}, R. and Walsh, T.J. and Kontoyiannis, D.P.},
  year = {2011},
  journal = {Antimicrobial Agents and Chemotherapy},
  volume = {55},
  number = {1},
  pages = {411--413},
  doi = {10.1128/AAC.00792-10},
  note = {Cited By :23
\par
Cited By :23
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022},
  file = {/Users/russelllewis/Zotero/storage/GR548H6M/Lewis et al_2011_Activity of deferasirox in Mucorales.pdf}
}

@article{lewis.etal_2011a,
  title = {Voriconazole Pre-Exposure Selects for Breakthrough Mucormycosis in a Mixed Model of {{Aspergillus}} Fumigatus-{{Rhizopus}} Oryzae Pulmonary Infection},
  author = {Lewis, R.E. and Liao, G. and Wang, W. and Prince, R.A. and Kontoyiannis, D.P.},
  year = {2011},
  journal = {Virulence},
  volume = {2},
  number = {4},
  pages = {348--355},
  doi = {10.4161/viru.2.4.17074},
  note = {Cited By :32
\par
Cited By :32
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022}
}

@article{lewis.etal_2011b,
  title = {Comparative in Vivo Dose-Dependent Activity of Caspofungin and Anidulafungin against Echinocandin-Susceptible and -Resistant {{Aspergillus}} Fumigatus},
  author = {Lewis, R.E. and Liao, G. and Hou, J. and Prince, R.A. and Kontoyiannis, D.P.},
  year = {2011},
  journal = {Journal of Antimicrobial Chemotherapy},
  volume = {66},
  number = {6},
  pages = {1324--1331},
  doi = {10.1093/jac/dkr142},
  note = {Cited By :15
\par
Cited By :15
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022}
}

@article{lewis.etal_2011c,
  title = {Efficacy of Caspofungin in Neutropenic and Corticosteroid-Immunosuppressed Murine Models of Invasive Pulmonary Mucormycosis},
  author = {Lewis, R.E. and Leventakos, K. and Liao, G. and Kontoyiannis, D.P.},
  year = {2011},
  journal = {Antimicrobial Agents and Chemotherapy},
  volume = {55},
  number = {7},
  pages = {3584--3587},
  doi = {10.1128/AAC.01812-10},
  note = {Cited By :10
\par
Cited By :10
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022},
  file = {/Users/russelllewis/Zotero/storage/ICWVNSSN/Lewis et al_2011_Efficacy of caspofungin in neutropenic and corticosteroid-immunosuppressed.pdf}
}

@article{ben-ami.etal_2010a,
  title = {Characterization of a 5-Azacytidine-Induced Developmental {{Aspergillus}} Fumigatus Variant},
  author = {{Ben-Ami}, R. and Varga, J. and Lewis, R.E. and May, G.S. and Nierman, W.C. and Kontoyiannis, D.P.},
  year = {2010},
  journal = {Virulence},
  volume = {1},
  number = {3},
  pages = {164--173},
  doi = {10.4161/viru.1.3.11750},
  note = {Cited By :14
\par
Cited By :14
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022},
  file = {/Users/russelllewis/Zotero/storage/S648GYYC/Ben-Ami et al_2010_Characterization of a 5-azacytidine-induced developmental Aspergillus fumigatus.pdf}
}

@article{ben-ami.etal_2010b,
  title = {Antifungal Activity of Colistin against {{Mucorales}} Species in Vitro and in a Murine Model of {{Rhizopus}} Oryzae Pulmonary Infection},
  author = {{Ben-Ami}, R. and Lewis, R.E. and Tarrand, J. and Leventakos, K. and Kontoyiannis, D.P.},
  year = {2010},
  journal = {Antimicrobial Agents and Chemotherapy},
  volume = {54},
  number = {1},
  pages = {484--490},
  doi = {10.1128/AAC.00956-09},
  note = {Cited By :47
\par
Cited By :47
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022},
  file = {/Users/russelllewis/Zotero/storage/PJMVX7J2/Ben-Ami et al_2010_Antifungal activity of colistin against Mucorales species in vitro and in a.pdf}
}

@article{ben-ami.etal_2010c,
  title = {Cutaneous Model of Invasive Aspergillosis},
  author = {{Ben-Ami}, R. and Lewis, R.E. and Leventakos, K. and Latg{\'e}, J.-P. and Kontoyiannis, D.P.},
  year = {2010},
  journal = {Antimicrobial Agents and Chemotherapy},
  volume = {54},
  number = {5},
  pages = {1848--1854},
  doi = {10.1128/AAC.01504-09},
  note = {Cited By :29
\par
Cited By :29
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022},
  file = {/Users/russelllewis/Zotero/storage/33UMILKW/Ben-Ami et al_2010_Cutaneous model of invasive aspergillosis.pdf}
}

@article{ben-ami.etal_2010d,
  title = {Enemy of the (Immunosuppressed) State: {{An}} Update on the Pathogenesis of {{Aspergillus}} Fumigatus Infection},
  author = {{Ben-Ami}, R. and Lewis, R.E. and Kontoyiannis, D.P.},
  year = {2010},
  journal = {British Journal of Haematology},
  volume = {150},
  number = {4},
  pages = {406--417},
  doi = {10.1111/j.1365-2141.2010.08283.x},
  note = {Cited By :91
\par
Cited By :91
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022}
}

@article{ben-ami.etal_2010e,
  title = {Lack of Galactomannan Reactivity in Dematiaceous Molds Recovered from Cancer Patients with Phaeohyphomycosis},
  author = {{Ben-Ami}, R. and LaSala, P.R. and Lewis, R.E. and Kontoyiannis, D.P.},
  year = {2010},
  journal = {Diagnostic Microbiology and Infectious Disease},
  volume = {66},
  number = {2},
  pages = {200--203},
  doi = {10.1016/j.diagmicrobio.2009.09.015},
  note = {Cited By :10
\par
Cited By :10
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022}
}

@article{ben-ami.etal_2010f,
  title = {Interstrain Variability in the Virulence of {{Aspergillus}} Fumigatus and {{Aspergillus}} Terreus in a {{Toll-deficient Drosophila}} Fly Model of Invasive Aspergillosis},
  author = {{Ben-Ami}, R. and Lamaris, G.A. and Lewis, R.E. and Kontoyiannis, D.P.},
  year = {2010},
  journal = {Medical Mycology},
  volume = {48},
  number = {2},
  pages = {310--317},
  doi = {10.3109/13693780903148346},
  note = {Cited By :25
\par
Cited By :25
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022}
}

@article{campo.etal_2010,
  title = {Invasive Fusariosis in Patients with Hematologic Malignancies at a Cancer Center: 1998-2009},
  author = {Campo, M. and Lewis, R.E. and Kontoyiannis, D.P.},
  year = {2010},
  journal = {Journal of Infection},
  volume = {60},
  number = {5},
  pages = {331--337},
  doi = {10.1016/j.jinf.2010.01.010},
  note = {Cited By :133
\par
Cited By :133
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022}
}

@article{chamilos.etal_2010a,
  title = {Exploring the Concordance of Aspergillus Fumigatus Pathogenicity in Mice and {{Toll-deficient}} Flies},
  author = {Chamilos, G. and Bignell, E.M. and Schrettl, M. and Lewis, R.E. and Leventakos, K. and May, G.S. and Haas, H. and Kontoyiannis, D.P.},
  year = {2010},
  journal = {Medical Mycology},
  volume = {48},
  number = {3},
  pages = {506--510},
  doi = {10.3109/13693780903225813},
  note = {Cited By :24
\par
Cited By :24
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022}
}

@article{evans.etal_2010,
  title = {Stimulated Innate Resistance of Lung Epithelium Protects Mice Broadly against Bacteria and Fungi},
  author = {Evans, S.E. and Scott, B.L. and Clement, C.G. and Larson, D.T. and Kontoyiannis, D. and Lewis, R.E. and Lasala, P.R. and Pawlik, J. and Peterson, J.W. and Chopra, A.K. and Klimpel, G. and Bowden, G. and H{\"o}{\"o}k, M. and Xu, Y. and Tuvim, M.J. and Dickey, B.F.},
  year = {2010},
  journal = {American Journal of Respiratory Cell and Molecular Biology},
  volume = {42},
  number = {1},
  pages = {40--50},
  doi = {10.1165/rcmb.2008-0260OC},
  note = {Cited By :82
\par
Cited By :82
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022},
  file = {/Users/russelllewis/Zotero/storage/NG5C4KYT/Evans et al_2010_Stimulated innate resistance of lung epithelium protects mice broadly against.pdf}
}

@article{evans.etal_2010a,
  title = {Toll-Deficient {{Drosophila}} Are Resistant to Infection by {{Pneumocystis}} Spp. Additional Evidence of Specificity to Mammalian Hosts},
  author = {Evans, S.E. and Leventakos, K. and {Ben-Ami}, R. and You, D. and Thakkar, S.G. and Lewis, R.E. and Kontoyiannis, D.P.},
  year = {2010},
  journal = {Virulence},
  volume = {1},
  number = {6},
  pages = {523--525},
  doi = {10.4161/viru.1.6.13903},
  note = {Cited By :6
\par
Cited By :6
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022}
}

@article{kontoyiannis.lewis_2010,
  title = {Studying {{Fungal Pathogenesis}} in {{Drosophila}}},
  author = {Kontoyiannis, D.P. and Lewis, R.E.},
  year = {2010},
  journal = {Microbe},
  volume = {5},
  number = {7},
  pages = {291--296},
  doi = {10.1128/microbe.5.291.1},
  note = {Cited By :5
\par
Cited By :5
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022}
}

@article{leventakos.etal_2010,
  title = {Fungal Infections in Leukemia Patients: {{How}} Do We Prevent and Treat Them?},
  author = {Leventakos, K. and Lewis, R.E. and Kontoyiannis, D.P.},
  year = {2010},
  journal = {Clinical Infectious Diseases},
  volume = {50},
  number = {3},
  pages = {405--415},
  doi = {10.1086/649879},
  note = {Cited By :119
\par
Cited By :119
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022}
}

@incollection{lewis_2010,
  title = {Polyene Antifungal Agents},
  booktitle = {Aspergillosis: {{From Diagnosis}} to {{Prevention}}},
  author = {Lewis, R.E.},
  year = {2010},
  pages = {281--305},
  doi = {10.1007/978-90-481-2408-4_17},
  note = {Cited By :4
\par
Cited By :4
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022}
}

@article{lewis_2010a,
  title = {Antifungal Therapeutic Drug Monitoring},
  author = {Lewis, R.E.},
  year = {2010},
  journal = {Current Fungal Infection Reports},
  volume = {4},
  number = {3},
  pages = {158--167},
  doi = {10.1007/s12281-010-0023-9},
  note = {Cited By :19
\par
Cited By :19
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022}
}

@article{lewis.etal_2010,
  title = {Comparative Pharmacodynamics of Amphotericin {{B}} Lipid Complex and Liposomal Amphotericin {{B}} in a Murine Model of Pulmonary Mucormycosis},
  author = {Lewis, R.E. and Albert, N.D. and Liao, G. and Hou, J. and Prince, R.A. and Kontoyiannis, D.P.},
  year = {2010},
  journal = {Antimicrobial Agents and Chemotherapy},
  volume = {54},
  number = {3},
  pages = {1298--1304},
  doi = {10.1128/AAC.01222-09},
  note = {Cited By :54
\par
Cited By :54
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022},
  file = {/Users/russelllewis/Zotero/storage/WBBR3BGG/Lewis et al_2010_Comparative pharmacodynamics of amphotericin B lipid complex and liposomal.pdf}
}

@article{milito.etal_2010,
  title = {Influence of Host Immunosuppression on {{CT}} Findings in Invasive Pulmonary Aspergillosis},
  author = {Milito, M.A. and Kontoyiannis, D.P. and Lewis, R.E. and Liu, P. and Mawlawi, O.R. and Truong, M.T. and Marom, E.M.},
  year = {2010},
  journal = {Medical Mycology},
  volume = {48},
  number = {6},
  pages = {817--823},
  doi = {10.3109/13693780903514872},
  note = {Cited By :36
\par
Cited By :36
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022}
}

@article{ben-ami.etal_2009,
  title = {A Clinicopathological Study of Pulmonary Mucormycosis in Cancer Patients: {{Extensive}} Angioinvasion but Limited Inflammatory Response},
  author = {{Ben-Ami}, R. and Luna, M. and Lewis, R.E. and Walsh, T.J. and Kontoyiannis, D.P.},
  year = {2009},
  journal = {Journal of Infection},
  volume = {59},
  number = {2},
  pages = {134--138},
  doi = {10.1016/j.jinf.2009.06.002},
  note = {Cited By :61
\par
Cited By :61
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022},
  file = {/Users/russelllewis/Zotero/storage/IEZG6WR7/Ben-Ami et al_2009_A clinicopathological study of pulmonary mucormycosis in cancer patients.pdf}
}

@article{ben-ami.etal_2009a,
  title = {Phaeohyphomycosis in a Tertiary Care Cancer Center},
  author = {{Ben-Ami}, R. and Lewis, R.E. and Raacl, I.I. and Kontoyiannis, D.P.},
  year = {2009},
  journal = {Clinical Infectious Diseases},
  volume = {48},
  number = {8},
  pages = {1033--1041},
  doi = {10.1086/597400},
  note = {Cited By :99
\par
Cited By :99
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022}
}

@article{ben-ami.etal_2009b,
  title = {Aspergillus Fumigatus Inhibits Angiogenesis through the Production of Gliotoxin and Other Secondary Metabolites},
  author = {{Ben-Ami}, R. and Lewis, R.E. and Leventakos, K. and Kontoyiannis, D.P.},
  year = {2009},
  journal = {Blood},
  volume = {114},
  number = {26},
  pages = {5393--5399},
  doi = {10.1182/blood-2009-07-231209},
  note = {Cited By :93
\par
Cited By :93
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022},
  file = {/Users/russelllewis/Zotero/storage/AXIIZ99T/Ben-Ami et al_2009_Aspergillus fumigatus inhibits angiogenesis through the production of gliotoxin.pdf}
}

@article{ben-ami.etal_2009c,
  title = {Invasive Mould Infections in the Setting of Hematopoietic Cell Transplantation: {{Current}} Trends and New Challenges},
  author = {{Ben-Ami}, R. and Lewis, R.E. and Kontoyiannis, D.P.},
  year = {2009},
  journal = {Current Opinion in Infectious Diseases},
  volume = {22},
  number = {4},
  pages = {376--384},
  doi = {10.1097/QCO.0b013e32832db9f3},
  note = {Cited By :28
\par
Cited By :28
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022}
}

@article{chamilos.etal_2009,
  title = {Candida Albicans {{Cas5}}, a Regulator of Cell Wall Integrity, Is Required for Virulence in Murine and Toll Mutant Fly Models},
  author = {Chamilos, G. and Nobile, C.J. and Bruno, V.M. and Lewis, R.E. and Mitchell, A.P. and Kontoyiannis, D.P.},
  year = {2009},
  journal = {Journal of Infectious Diseases},
  volume = {200},
  number = {1},
  pages = {152--157},
  doi = {10.1086/599363},
  note = {Cited By :46
\par
Cited By :46
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022},
  file = {/Users/russelllewis/Zotero/storage/GR4VMJDD/Chamilos et al_2009_Candida albicans Cas5, a regulator of cell wall integrity, is required for.pdf}
}

@article{garey.etal_2009,
  title = {Increased Bacterial Adherence and Biomass in {{Pseudomonas}} Aeruginosa Bacteria Exposed to Clarithromycin},
  author = {Garey, K.W. and Vo, Q.P. and Lewis, R.E. and Saengcharoen, W. and LaRocco, M.T. and Tam, V.H.},
  year = {2009},
  journal = {Diagnostic Microbiology and Infectious Disease},
  volume = {63},
  number = {1},
  pages = {81--86},
  doi = {10.1016/j.diagmicrobio.2008.09.007},
  note = {Cited By :14
\par
Cited By :14
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022}
}

@article{kofteridis.etal_2009,
  title = {Caspofungin-Non-Susceptible {{Candida}} Isolates in Cancer Patients},
  author = {Kofteridis, D.P. and Lewis, R.E. and Kontoyiannis, D.P.},
  year = {2009},
  journal = {Journal of Antimicrobial Chemotherapy},
  volume = {65},
  number = {2},
  pages = {293--295},
  doi = {10.1093/jac/dkp444},
  note = {Cited By :35
\par
Cited By :35
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022}
}

@article{kontoyiannis.etal_2009a,
  title = {The {{Burden}} of {{Bacterial}} and {{Viral Infections}} in {{Hematopoietic Stem Cell Transplant}}},
  author = {Kontoyiannis, D.P. and Lewis, R.E. and Marr, K.},
  year = {2009},
  journal = {Biology of Blood and Marrow Transplantation},
  volume = {15},
  number = {1 SUPPL.},
  pages = {128--133},
  doi = {10.1016/j.bbmt.2008.10.005},
  note = {Cited By :20
\par
Cited By :20
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022}
}

@article{lamaris.etal_2009,
  title = {Increased Virulence of Zygomycetes Organisms Following Exposure to Voriconazole: A Study Involving Fly and Murine Models of Zygomycosis},
  author = {Lamaris, G.A. and {Ben-Ami}, R. and Lewis, R.E. and Chamilos, G. and Samonis, G. and Kontoyiannis, D.P.},
  year = {2009},
  journal = {Journal of Infectious Diseases},
  volume = {199},
  number = {9},
  pages = {1399--1406},
  doi = {10.1086/597615},
  note = {Cited By :102
\par
Cited By :102
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022}
}

@article{leventakos.etal_2009,
  title = {Immunomodulating Effects of Antifungal Therapy},
  author = {Leventakos, K. and {Ben-Ami}, R. and Lewis, R.E. and Kontoyiannis, D.P.},
  year = {2009},
  journal = {Current Fungal Infection Reports},
  volume = {3},
  number = {4},
  pages = {243--250},
  doi = {10.1007/s12281-009-0034-6},
  note = {Cited By :3
\par
Cited By :3
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022}
}

@article{lewis_2009,
  title = {Overview of the Changing Epidemiology of Candidemia},
  author = {Lewis, R.E.},
  year = {2009},
  journal = {Current Medical Research and Opinion},
  volume = {25},
  number = {7},
  pages = {1732--1740},
  note = {Cited By :79
\par
Cited By :79
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022}
}

@article{lewis.kontoyiannis_2009,
  title = {Invasive Aspergillosis in Glucocorticoid-Treated Patients},
  author = {Lewis, R.E. and Kontoyiannis, D.P.},
  year = {2009},
  journal = {Medical Mycology},
  volume = {47},
  number = {SUPPL. 1},
  pages = {S271-S281},
  doi = {10.1080/13693780802227159},
  note = {Cited By :70
\par
Cited By :70
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022}
}

@article{pongas.etal_2009,
  title = {Voriconazole-Associated Zygomycosis: {{A}} Significant Consequence of Evolving Antifungal Prophylaxis and Immunosuppression Practices?},
  author = {Pongas, G.N. and Lewis, R.E. and Samonis, G. and Kontoyiannis, D.P.},
  year = {2009},
  journal = {Clinical Microbiology and Infection},
  volume = {15},
  number = {SUPPL. 5},
  pages = {93--97},
  doi = {10.1111/j.1469-0691.2009.02988.x},
  note = {Cited By :90
\par
Cited By :90
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022}
}

@article{pongas.etal_2009a,
  title = {Culture Medium Composition Affects the Lethality of {{Cunninghamella}} Bertholletiae in a Fly Model of Mucormycosis},
  author = {Pongas, G.N. and {Ben-Ami}, R. and Lewis, R.E. and Walsh, T.J. and Kontoyiannis, D.P.},
  year = {2009},
  journal = {Antimicrobial Agents and Chemotherapy},
  volume = {53},
  number = {10},
  pages = {4569},
  doi = {10.1128/AAC.00994-09},
  note = {Cited By :8
\par
Cited By :8
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022},
  file = {/Users/russelllewis/Zotero/storage/N6KZZMXQ/Pongas et al_2009_Culture medium composition affects the lethality of Cunninghamella.pdf}
}

@article{roussos.etal_2009,
  title = {Azoles and Antidepressants: {{A}} Mini-Review of the Tolerability of Co-Administration},
  author = {Roussos, P. and Lewis, R.E. and Kontoyiannis, D.P.},
  year = {2009},
  journal = {Mycoses},
  volume = {52},
  number = {5},
  pages = {433--439},
  doi = {10.1111/j.1439-0507.2008.01677.x},
  note = {Cited By :2
\par
Cited By :2
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022}
}

@article{sipsas.etal_2009,
  title = {Candidemia in Patients with Hematologic Malignancies in the Era of New Antifungal Agents (2001-2007): {{Stable}} Incidence but Changing Epidemiology of a Still Frequently Lethal Infection},
  author = {Sipsas, N.V. and Lewis, R.E. and Tarrand, J. and Hachem, R. and Rolston, K.V. and Raad, I.I. and Kontoyiannis, D.P.},
  year = {2009},
  journal = {Cancer},
  volume = {115},
  number = {20},
  pages = {4745--4752},
  doi = {10.1002/cncr.24507},
  note = {Cited By :213
\par
Cited By :213
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022}
}

@article{sipsas.etal_2009a,
  title = {Monotherapy with Caspofungin for Candidaemia in Adult Patients with Cancer: A Retrospective, Single Institution Study},
  author = {Sipsas, N.V. and Lewis, R.E. and Raad, I.I. and Kontoyiannis, D.P.},
  year = {2009},
  journal = {International Journal of Antimicrobial Agents},
  volume = {34},
  number = {1},
  pages = {95--98},
  doi = {10.1016/j.ijantimicag.2009.01.006},
  note = {Cited By :15
\par
Cited By :15
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022}
}

@article{tam.etal_2009,
  title = {In Vivo Dynamics of Carbapenem-Resistant {{Pseudomonas}} Aeruginosa Selection after Suboptimal Dosing},
  author = {Tam, V.H. and Ledesma, K.R. and Schilling, A.N. and Lim, T.-P. and Yuan, Z. and Ghose, R. and Lewis, R.E.},
  year = {2009},
  journal = {Diagnostic Microbiology and Infectious Disease},
  volume = {64},
  number = {4},
  pages = {427--433},
  doi = {10.1016/j.diagmicrobio.2009.03.031},
  note = {Cited By :17
\par
Cited By :17
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022}
}

@article{wiederhold.lewis_2009,
  title = {Antifungal Activity against {{Scedosporium}} Species and Novel Assays to Assess Antifungal Pharmacodynamics against Filamentous Fungi},
  author = {Wiederhold, N.P. and Lewis, R.E.},
  year = {2009},
  journal = {Medical Mycology},
  volume = {47},
  number = {4},
  pages = {422--432},
  doi = {10.1080/13693780802510224},
  note = {Cited By :31
\par
Cited By :31
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022}
}

@article{atkinson.etal_2008,
  title = {Candida Lusitaniae Fungemia in Cancer Patients: {{Risk}} Factors for Amphotericin {{B}} Failure and Outcome},
  author = {Atkinson, B.J. and Lewis, R.E. and Kontoyiannis, D.P.},
  year = {2008},
  journal = {Medical Mycology},
  volume = {46},
  number = {6},
  pages = {541--546},
  doi = {10.1080/13693780801968571},
  note = {Cited By :71
\par
Cited By :71
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022}
}

@article{ben-ami.etal_2008,
  title = {Immunopharmacology of Modern Antifungals},
  author = {{Ben-Ami}, R. and Lewis, R.E. and Kontoyiannis, D.P.},
  year = {2008},
  journal = {Clinical Infectious Diseases},
  volume = {47},
  number = {2},
  pages = {226--235},
  doi = {10.1086/589290},
  note = {Cited By :119
\par
Cited By :119
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022}
}

@article{chamilos.etal_2008a,
  title = {Genomewide Screening for Genes Associated with Gliotoxin Resistance and Sensitivity in {{Saccharomyces}} Cerevisiae},
  author = {Chamilos, G. and Lewis, R.E. and Lamaris, G.A. and Albert, N.D. and Kontoyiannis, D.P.},
  year = {2008},
  journal = {Antimicrobial Agents and Chemotherapy},
  volume = {52},
  number = {4},
  pages = {1325--1329},
  doi = {10.1128/AAC.01393-07},
  note = {Cited By :7
\par
Cited By :7
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022},
  file = {/Users/russelllewis/Zotero/storage/HISEEQV9/Chamilos et al_2008_Genomewide screening for genes associated with gliotoxin resistance and.pdf}
}

@article{chamilos.etal_2008b,
  title = {Zygomycetes Hyphae Trigger an Early, Robust Proinflammatory Response in Human Polymorphonuclear Neutrophils through Toll-like Receptor 2 Induction but Display Relative Resistance to Oxidative Damage},
  author = {Chamilos, G. and Lewis, R.E. and Lamaris, G. and Walsh, T.J. and Kontoyiannis, D.P.},
  year = {2008},
  journal = {Antimicrobial Agents and Chemotherapy},
  volume = {52},
  number = {2},
  pages = {722--724},
  doi = {10.1128/AAC.01136-07},
  note = {Cited By :70
\par
Cited By :70
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022},
  file = {/Users/russelllewis/Zotero/storage/UGKNW6PR/Chamilos et al_2008_Zygomycetes hyphae trigger an early, robust proinflammatory response in human.pdf}
}

@article{chamilos.etal_2008c,
  title = {Delaying Amphotericin {{B-based}} Frontline Therapy Significantly Increases Mortality among Patients with Hematologic Malignancy Who Have Zygomycosis},
  author = {Chamilos, G. and Lewis, R.E. and Kontoyiannis, D.P.},
  year = {2008},
  journal = {Clinical Infectious Diseases},
  volume = {47},
  number = {4},
  pages = {503--509},
  doi = {10.1086/590004},
  note = {Cited By :487
\par
Cited By :487
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022},
  file = {/Users/russelllewis/Zotero/storage/SEKWMFNV/Chamilos et al_2008_Delaying amphotericin B-based frontline therapy significantly increases.pdf}
}

@article{chamilos.etal_2008d,
  title = {Drosophila Melanogaster as a Model Host to Dissect the Immunopathogenesis of Zygomycosis},
  author = {Chamilos, G. and Lewis, R.E. and Hu, J. and Xiao, L. and Zal, T. and Gilliet, M. and Halder, G. and Kontoyiannis, D.P.},
  year = {2008},
  journal = {Proceedings of the National Academy of Sciences of the United States of America},
  volume = {105},
  number = {27},
  pages = {9367--9372},
  doi = {10.1073/pnas.0709578105},
  note = {Cited By :105
\par
Cited By :105
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022},
  file = {/Users/russelllewis/Zotero/storage/H7ZEA2WJ/Chamilos et al_2008_Drosophila melanogaster as a model host to dissect the immunopathogenesis of.pdf}
}

@article{garcia-effron.etal_2008a,
  title = {Caspofungin-Resistant {{Candida}} Tropicalis Strains Causing Breakthrough Fungemia in Patients at High Risk for Hematologic Malignancies},
  author = {{Garcia-Effron}, G. and Kontoyiannis, D.P. and Lewis, R.E. and Perlin, D.S.},
  year = {2008},
  journal = {Antimicrobial Agents and Chemotherapy},
  volume = {52},
  number = {11},
  pages = {4181--4183},
  doi = {10.1128/AAC.00802-08},
  note = {Cited By :108
\par
Cited By :108
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022},
  file = {/Users/russelllewis/Zotero/storage/FFTT68YK/Garcia-Effron et al_2008_Caspofungin-resistant Candida tropicalis strains causing breakthrough fungemia.pdf}
}

@article{kontoyiannis.etal_2008,
  title = {Calcineurin Inhibitor Agents Interact Synergistically with Antifungal Agents in Vitro against {{Cryptococcus}} Neoformans Isolates: {{Correlation}} with Outcome in Solid Organ Transplant Recipients with Cryptococcosis},
  author = {Kontoyiannis, D.P. and Lewis, R.E. and Alexander, B.D. and Lortholary, O. and Dromer, F. and Gupta, K.L. and John, G.T. and Del Busto, R. and Klintmalm, G.B. and Somani, J. and Lyon, G.M. and Pursell, K. and Stosor, V. and Mu{\v n}oz, P. and Limaye, A.P. and Kalil, A.C. and Pruett, T.L. and {Garcia-Diaz}, J. and Humar, A. and Houston, S. and House, A.A. and Wray, D. and Orloff, S. and Dowdy, L.A. and Fisher, R.A. and Heitman, J. and Albert, N.D. and Wagener, M.M. and Singh, N.},
  year = {2008},
  journal = {Antimicrobial Agents and Chemotherapy},
  volume = {52},
  number = {2},
  pages = {735--738},
  doi = {10.1128/AAC.00990-07},
  note = {Cited By :74
\par
Cited By :74
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022},
  file = {/Users/russelllewis/Zotero/storage/G4I5KDNG/Kontoyiannis et al_2008_Calcineurin inhibitor agents interact synergistically with antifungal agents in.pdf}
}

@article{lamaris.etal_2008,
  title = {Caspofungin-Mediated {$\beta$}-Glucan Unmasking and Enhancement of Human Polymorphonuclear Neutrophil Activity against {{Aspergillus}} and Non-{{Aspergillus}} Hyphae},
  author = {Lamaris, G.A. and Lewis, R.E. and Chamilos, G. and May, G.S. and Safdar, A. and Walsh, T.J. and Raad, I.I. and Kontoyiannis, D.P.},
  year = {2008},
  journal = {Journal of Infectious Diseases},
  volume = {198},
  number = {2},
  pages = {186--192},
  doi = {10.1086/589305},
  note = {Cited By :160
\par
Cited By :160
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022},
  file = {/Users/russelllewis/Zotero/storage/E9MVATLF/Lamaris et al_2008_Caspofungin-mediated β-glucan unmasking and enhancement of human.pdf}
}

@article{lamaris.etal_2008a,
  title = {Fungal Endophthalmitis in a Tertiary Care Cancer Center: {{A}} Review of 23 Cases},
  author = {Lamaris, G.A. and Esmaeli, B. and Chamilos, G. and Desai, A. and Chemaly, R.F. and Raad, I.I. and Safdar, A. and Lewis, R.E. and Kontoyiannis, D.P.},
  year = {2008},
  journal = {European Journal of Clinical Microbiology and Infectious Diseases},
  volume = {27},
  number = {5},
  pages = {343--347},
  doi = {10.1007/s10096-007-0443-9},
  note = {Cited By :42
\par
Cited By :42
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022}
}

@article{lamaris.etal_2008b,
  title = {Does Pre-Exposure of {{Aspergillus}} Fumigatus to Voriconazole or Posaconazole in Vitro Affect Its Virulence and the in Vivo Activity of Subsequent Posaconazole or Voriconazole, Respectively? {{A}} Study in a Fly Model of Aspergillosis},
  author = {Lamaris, G.A. and {Ben-Ami}, R. and Lewis, R.E. and Kontoyiannis, D.P.},
  year = {2008},
  journal = {Journal of Antimicrobial Chemotherapy},
  volume = {62},
  number = {3},
  pages = {539--542},
  doi = {10.1093/jac/dkn224},
  note = {Cited By :15
\par
Cited By :15
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022}
}

@article{lewis_2008,
  title = {What Is the "Therapeutic Range" for Voriconazole?},
  author = {Lewis, R.E.},
  year = {2008},
  journal = {Clinical Infectious Diseases},
  volume = {46},
  number = {2},
  pages = {212--214},
  doi = {10.1086/524670},
  note = {Cited By :41
\par
Cited By :41
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022}
}

@article{lewis.etal_2008,
  title = {Efficacy of Single-Dose Liposomal Amphotericin {{B}} or Micafungin Prophylaxis in a Neutropenic Murine Model of Invasive Pulmonary Aspergillosis},
  author = {Lewis, R.E. and Albert, N.D. and Kontoyiannis, D.P.},
  year = {2008},
  journal = {Antimicrobial Agents and Chemotherapy},
  volume = {52},
  number = {11},
  pages = {4178--4180},
  doi = {10.1128/AAC.00715-08},
  note = {Cited By :22
\par
Cited By :22
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022},
  file = {/Users/russelllewis/Zotero/storage/BTHJZYYG/Lewis et al_2008_Efficacy of single-dose liposomal amphotericin B or micafungin prophylaxis in a.pdf}
}

@article{lewis.etal_2008a,
  title = {Comparison of the Dose-Dependent Activity and Paradoxical Effect of Caspofungin and Micafungin in a Neutropenic Murine Model of Invasive Pulmonary Aspergillosis},
  author = {Lewis, R.E. and Albert, N.D. and Kontoyiannis, D.P.},
  year = {2008},
  journal = {Journal of Antimicrobial Chemotherapy},
  volume = {61},
  number = {5},
  pages = {1140--1144},
  doi = {10.1093/jac/dkn069},
  note = {Cited By :52
\par
Cited By :52
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022}
}

@article{chamilos.etal_2007a,
  title = {Effects of Liposomal Amphotericin {{B}} versus an Amphotericin {{B}} Lipid Complex on Liver Histopathology in Patients with Hematologic Malignancies and Invasive Fungal Infections: {{A}} Retrospective, Nonrandomized Autopsy Study},
  author = {Chamilos, G. and Luna, M. and Lewis, R.E. and Chemaly, R. and Raad, I.I. and Kontoyiannis, D.P.},
  year = {2007},
  journal = {Clinical Therapeutics},
  volume = {29},
  number = {9},
  pages = {1980--1986},
  doi = {10.1016/j.clinthera.2007.09.016},
  note = {Cited By :25
\par
Cited By :25
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022}
}

@article{chamilos.etal_2007b,
  title = {Role of Mini-Host Models in the Study of Medically Important Fungi},
  author = {Chamilos, G. and Lionakis, M.S. and Lewis, R.E. and Kontoyiannis, D.P.},
  year = {2007},
  journal = {Lancet Infectious Diseases},
  volume = {7},
  number = {1},
  pages = {42--55},
  doi = {10.1016/S1473-3099(06)70686-7},
  note = {Cited By :72
\par
Cited By :72
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022}
}

@article{chamilos.etal_2007c,
  title = {Multidrug-Resistant Endosymbiotic Bacteria Account for the Emergence of Zygomycosis: {{A}} Hypothesis},
  author = {Chamilos, G. and Lewis, R.E. and Kontoyiannis, D.P.},
  year = {2007},
  journal = {Fungal Genetics and Biology},
  volume = {44},
  number = {2},
  pages = {88--92},
  doi = {10.1016/j.fgb.2006.07.011},
  note = {Cited By :9
\par
Cited By :9
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022}
}

@article{chamilos.etal_2007d,
  title = {Paradoxical Effect of Echinocandins across {{Candida}} Species in Vitro: {{Evidence}} for {{Echinocandin-Specific}} and {{Candida}} Species-Related Differences},
  author = {Chamilos, G. and Lewis, R.E. and Albert, N. and Kontoyiannis, D.P.},
  year = {2007},
  journal = {Antimicrobial Agents and Chemotherapy},
  volume = {51},
  number = {6},
  pages = {2257--2259},
  doi = {10.1128/AAC.00095-07},
  note = {Cited By :157
\par
Cited By :157
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022},
  file = {/Users/russelllewis/Zotero/storage/XXPHHPYV/Chamilos et al_2007_Paradoxical effect of echinocandins across Candida species in vitro.pdf}
}

@article{chou.etal_2007,
  title = {Caspofungin as Primary Antifungal Prophylaxis in Stem Cell Transplant Recipients},
  author = {Chou, L.S. and Lewis, R.E. and Ippoliti, C. and Champlin, R.E. and Kontoyiannis, D.P.},
  year = {2007},
  journal = {Pharmacotherapy},
  volume = {27},
  number = {12 I},
  pages = {1644--1650},
  doi = {10.1592/phco.27.12.1644},
  note = {Cited By :61
\par
Cited By :61
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022}
}

@article{kontoyiannis.etal_2007,
  title = {Increased Bone Marrow Iron Stores Is an Independent Risk Factor for Invasive Aspergillosis in Patients with High-Risk Hematologic Malignancies and Recipients of Allogeneic Hematopoietic Stem Cell Transplantation},
  author = {Kontoyiannis, D.P. and Chamilos, G. and Lewis, R.E. and Giralt, S. and Cortes, J. and Raad, I.I. and Manning, J.T. and Han, X.},
  year = {2007},
  journal = {Cancer},
  volume = {110},
  number = {6},
  pages = {1303--1306},
  doi = {10.1002/cncr.22909},
  note = {Cited By :129
\par
Cited By :129
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022}
}

@article{kontoyiannis.etal_2007a,
  title = {Increased Culture Recovery of Zygomycetes under Physiologic Temperature Conditions},
  author = {Kontoyiannis, D.P. and Chamilos, G. and Hassan, S.A. and Lewis, R.E. and Albert, N.D. and Tarrand, J.J.},
  year = {2007},
  journal = {American Journal of Clinical Pathology},
  volume = {127},
  number = {2},
  pages = {208--212},
  doi = {10.1309/7KU5XWURYM0151YN},
  note = {Cited By :43
\par
Cited By :43
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022}
}

@article{lamaris.etal_2007,
  title = {Virulence Studies of {{Scedosporium}} and {{Fusarium}} Species in {{Drosophila}} Melanogaster},
  author = {Lamaris, G.A. and Chamilos, G. and Lewis, R.E. and Kontoyiannis, D.P.},
  year = {2007},
  journal = {Journal of Infectious Diseases},
  volume = {196},
  number = {12},
  pages = {1860--1864},
  doi = {10.1086/523765},
  note = {Cited By :33
\par
Cited By :33
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022}
}

@article{lewis_2007,
  title = {Pharmacodynamic Implications for Use of Antifungal Agents},
  author = {Lewis, R.E.},
  year = {2007},
  journal = {Current Opinion in Pharmacology},
  volume = {7},
  number = {5},
  pages = {491--497},
  doi = {10.1016/j.coph.2007.05.004},
  note = {Cited By :30
\par
Cited By :30
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022}
}

@article{lewis.etal_2007,
  title = {Comparative Analysis of Amphotericin {{B}} Lipid Complex and Liposomal Amphotericin {{B}} Kinetics of Lung Accumulation and Fungal Clearance in a Murine Model of Acute Invasive Pulmonary Aspergillosis},
  author = {Lewis, R.E. and Liao, G. and Hou, J. and Chamilos, G. and Prince, R.A. and Kontoyiannis, D.P.},
  year = {2007},
  journal = {Antimicrobial Agents and Chemotherapy},
  volume = {51},
  number = {4},
  pages = {1253--1258},
  doi = {10.1128/AAC.01449-06},
  note = {Cited By :54
\par
Cited By :54
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022},
  file = {/Users/russelllewis/Zotero/storage/UUU43B2R/Lewis et al_2007_Comparative analysis of amphotericin B lipid complex and liposomal amphotericin.pdf}
}

@article{lewis.etal_2007a,
  title = {Pretreatment with Empty Liposomes Attenuates the Immunopathology of Invasive Pulmonary Aspergillosis in Corticosteroid-Immunosuppressed Mice},
  author = {Lewis, R.E. and Chamilos, G. and Prince, R.A. and Kontoyiannis, D.P.},
  year = {2007},
  journal = {Antimicrobial Agents and Chemotherapy},
  volume = {51},
  number = {3},
  pages = {1078--1081},
  doi = {10.1128/AAC.01268-06},
  note = {Cited By :35
\par
Cited By :35
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022},
  file = {/Users/russelllewis/Zotero/storage/AP9MDXZX/Lewis et al_2007_Pretreatment with empty liposomes attenuates the immunopathology of invasive.pdf}
}

@article{mulanovich.etal_2007,
  title = {Random Plasma Concentrations of Voriconazole Decline over Time},
  author = {Mulanovich, V. and Lewis, R.E. and Raad, I.I. and Kontoyiannis, D.P.},
  year = {2007},
  journal = {Journal of Infection},
  volume = {55},
  number = {5},
  pages = {e129-e130},
  doi = {10.1016/j.jinf.2007.07.019},
  note = {Cited By :28
\par
Cited By :28
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022}
}

@article{orciuolo.etal_2007,
  title = {Effects of {{Aspergillus}} Fumigatus Gliotoxin and Methylprednisolone on Human Neutrophils: {{Implications}} for the Pathogenesis of Invasive Aspergillosis},
  author = {Orciuolo, E. and Stanzani, M. and Canestraro, M. and Galimberti, S. and Carulli, G. and Lewis, R. and Petrini, M. and Komanduri, K.V.},
  year = {2007},
  journal = {Journal of Leukocyte Biology},
  volume = {82},
  number = {4},
  pages = {839--848},
  doi = {10.1189/jlb.0207090},
  note = {Cited By :52
\par
Cited By :52
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022}
}

@article{ashley.etal_2006,
  title = {Pharmacology of Systemic Antifungal Agents},
  author = {Ashley, E.S.D. and Lewis, R. and Lewis, J.S. and Martin, C. and Andes, D.},
  year = {2006},
  journal = {Clinical Infectious Diseases},
  volume = {43},
  number = {SUPPL. 1},
  pages = {S28-S39},
  doi = {10.1086/504492},
  note = {Cited By :242
\par
Cited By :242
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022}
}

@article{chamilos.etal_2006,
  title = {Invasive Fungal Infections in Patients with Hematologic Malignancies in a Tertiary Care Cancer Center: {{An}} Autopsy Study over a 15-Year Period (1989-2003)},
  author = {Chamilos, G. and Luna, M. and Lewis, R.E. and Bodey, G.P. and Chemaly, R. and Tarrand, J.J. and Safdar, A. and Raad, I.I. and Kontoyiannis, D.P.},
  year = {2006},
  journal = {Haematologica},
  volume = {91},
  number = {7},
  pages = {986--989},
  note = {Cited By :429
\par
Cited By :429
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022}
}

@article{chamilos.etal_2006a,
  title = {Erratum: {{Drosophila}} Melanogaster as a Facile Model for Large-Scale Studies of Virulence Mechanisms and Antifungal Drug Efficacy in {{Candida}} Species ({{Journal}} of {{Infectious Diseases}} (2006) 193 (1014-1022))},
  author = {Chamilos, G. and Lionakis, M.S. and Lewis, R.E.},
  year = {2006},
  journal = {Journal of Infectious Diseases},
  volume = {194},
  number = {9},
  pages = {1342},
  doi = {10.1086/509136},
  note = {Export Date: 20 November 2022
\par
Export Date: 20 November 2022}
}

@article{chamilos.etal_2006b,
  title = {Drosophila Melanogaster as a Facile Model for Large-Scale Studies of Virulence Mechanisms and Antifungal Drug Efficacy in {{Candida}} Species},
  author = {Chamilos, G. and Lionakis, M.S. and Lewis, R.E. and {Lopez-Ribot}, J.L. and Saville, S.P. and Albert, N.D. and Halder, G. and Kontoyiannis, D.P.},
  year = {2006},
  journal = {Journal of Infectious Diseases},
  volume = {193},
  number = {7},
  pages = {1014--1022},
  doi = {10.1086/500950},
  note = {Cited By :90
\par
Cited By :90
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022}
}

@article{chamilos.etal_2006c,
  title = {Lovastatin Has Significant Activity against Zygomycetes and Interacts Synergistically with Voriconazole},
  author = {Chamilos, G. and Lewis, R.E. and Kontoyiannis, D.P.},
  year = {2006},
  journal = {Antimicrobial Agents and Chemotherapy},
  volume = {50},
  number = {1},
  pages = {96--103},
  doi = {10.1128/AAC.50.1.96-103.2006},
  note = {Cited By :101
\par
Cited By :101
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022},
  file = {/Users/russelllewis/Zotero/storage/V68US6WR/Chamilos et al_2006_Lovastatin has significant activity against zygomycetes and interacts.pdf}
}

@article{chamilos.etal_2006d,
  title = {Inhibition of {{Candida}} Parapsilosis Mitochondrial Respiratory Pathways Enhances Susceptibility to Caspofungin},
  author = {Chamilos, G. and Lewis, R.E. and Kontoyiannis, D.P.},
  year = {2006},
  journal = {Antimicrobial Agents and Chemotherapy},
  volume = {50},
  number = {2},
  pages = {744--747},
  doi = {10.1128/AAC.50.2.744-747.2006},
  note = {Cited By :32
\par
Cited By :32
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022},
  file = {/Users/russelllewis/Zotero/storage/PBWT6BPL/Chamilos et al_2006_Inhibition of Candida parapsilosis mitochondrial respiratory pathways enhances.pdf}
}

@article{dennis.etal_2006,
  title = {Effect of Amphotericin {{B}} and Micafungin Combination on Survival, Histopathology, and Fungal Burden in Experimental Aspergillosis in the P47 Phox-/- Mouse Model of Chronic Granulomatous Disease},
  author = {Dennis, C.G. and Greco, W.R. and Brun, Y. and Youn, R. and Slocum, H.K. and Bernacki, R.J. and Lewis, R. and Wiederhold, N. and Holland, S.M. and Petraitiene, R. and Walsh, T.J. and Segal, B.H.},
  year = {2006},
  journal = {Antimicrobial Agents and Chemotherapy},
  volume = {50},
  number = {2},
  pages = {422--427},
  doi = {10.1128/AAC.50.2.422-427.2006},
  note = {Cited By :63
\par
Cited By :63
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022},
  file = {/Users/russelllewis/Zotero/storage/6JGDL8SC/Dennis et al_2006_Effect of amphotericin B and micafungin combination on survival,.pdf}
}

@article{garey.etal_2006a,
  title = {Evaluation of Antifungals in the Surgical Intensive Care Unit: {{A}} Multi-Institutional Study},
  author = {Garey, K.W. and Neuhauser, M.M. and Bearden, D.T. and Cannon, J.P. and Lewis, R.E. and Gentry, L.O. and Kontoyiannis, D.P.},
  year = {2006},
  journal = {Mycoses},
  volume = {49},
  number = {3},
  pages = {226--231},
  doi = {10.1111/j.1439-0507.2006.01222.x},
  note = {Cited By :28
\par
Cited By :28
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022}
}

@article{kontoyiannis.lewis_2006,
  title = {Invasive {{Zygomycosis}}: {{Update}} on {{Pathogenesis}}, {{Clinical Manifestations}}, and {{Management}}},
  author = {Kontoyiannis, D.P. and Lewis, R.E.},
  year = {2006},
  journal = {Infectious Disease Clinics of North America},
  volume = {20},
  number = {3},
  pages = {581--607},
  doi = {10.1016/j.idc.2006.06.003},
  note = {Cited By :197
\par
Cited By :197
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022}
}

@article{lamaris.etal_2006,
  title = {Scedosporium Infection in a Tertiary Care Cancer Center: {{A}} Review of 25 Cases from 1989-2006},
  author = {Lamaris, G.A. and Chamilos, G. and Lewis, R.E. and Safdar, A. and Raad, I.I. and Kontoyiannis, D.P.},
  year = {2006},
  journal = {Clinical Infectious Diseases},
  volume = {43},
  number = {12},
  pages = {1580--1584},
  doi = {10.1086/509579},
  note = {Cited By :130
\par
Cited By :130
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022}
}

@article{lewis_2006,
  title = {Managing Drug Interactions in the Patient with Aspergillosis},
  author = {Lewis, R.E.},
  year = {2006},
  journal = {Medical Mycology},
  volume = {44},
  number = {SUPPL. 1},
  pages = {349--356},
  doi = {10.1080/13693780600835724},
  note = {Cited By :8
\par
Cited By :8
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022}
}

@article{lewis_2006a,
  title = {Decision Making in Antifungal Monotherapy versus Combination Therapy},
  author = {Lewis, R.E.},
  year = {2006},
  journal = {Pharmacotherapy},
  volume = {26},
  number = {6 II},
  pages = {61S-67S},
  doi = {10.1592/phco.26.6part2.61S},
  note = {Cited By :8
\par
Cited By :8
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022}
}

@article{lewis_2006b,
  title = {Judgments of Value, Judgments of Fact: {{The}} Ethical Dimension of Biohistorical Research},
  author = {Lewis, R.},
  year = {2006},
  journal = {Public Historian},
  volume = {28},
  number = {1},
  pages = {93--99},
  doi = {10.1525/tph.2006.28.1.93},
  note = {Cited By :2
\par
Cited By :2
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022}
}

@article{lewis.etal_2006,
  title = {In Vitro Pharmacodynamics of Rapid versus Continuous Infusion of Amphotericin {{B}} Deoxycholate against {{Candida}} Species in the Presence of Human Serum Albumin},
  author = {Lewis, R.E. and Wiederhold, N.P. and Prince, R.A. and Kontoyiannis, D.P.},
  year = {2006},
  journal = {Journal of Antimicrobial Chemotherapy},
  volume = {57},
  number = {2},
  pages = {288--293},
  doi = {10.1093/jac/dki467},
  note = {Cited By :19
\par
Cited By :19
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022}
}

@article{lionakis.etal_2006,
  title = {Pentamidine Is Active in a Neutropenic Murine Model of Acute Invasive Pulmonary Fusariosis},
  author = {Lionakis, M.S. and Chamilos, G. and Lewis, R.E. and Wiederhold, N.P. and Raad, I.I. and Samonis, G. and Kontoyiannis, D.P.},
  year = {2006},
  journal = {Antimicrobial Agents and Chemotherapy},
  volume = {50},
  number = {1},
  pages = {294--297},
  doi = {10.1128/AAC.50.1.294-297.2006},
  note = {Cited By :10
\par
Cited By :10
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022},
  file = {/Users/russelllewis/Zotero/storage/FVLYSXE8/Lionakis et al_2006_Pentamidine is active in a neutropenic murine model of acute invasive pulmonary.pdf}
}

@article{singh.etal_2006,
  title = {Combination of Voriconazole and Caspofungin as Primary Therapy for Invasive Aspergillosis in Solid Organ Transplant Recipients: {{A}} Prospective, Multicenter, Observational Study},
  author = {Singh, N. and Limaye, A.P. and Forrest, G. and Safdar, N. and Mu{\~n}oz, P. and Pursell, K. and Houston, S. and Rosso, F. and Montoya, J.G. and Patton, P. and Del Busto, R. and Aguado, J.M. and Fisher, R.A. and Klintmalm, G.B. and Miller, R. and Wagener, M.M. and Lewis, R.E. and Kontoyiannis, D.P. and Husain, S.},
  year = {2006},
  journal = {Transplantation},
  volume = {81},
  number = {3},
  pages = {320--326},
  doi = {10.1097/01.tp.0000202421.94822.f7},
  note = {Cited By :289
\par
Cited By :289
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022}
}

@article{wiederhold.etal_2006,
  title = {Pharmacodynamic Activity of Amphotericin {{B}} Deoxycholate Is Associated with Peak Plasma Concentrations in a Neutropenic Murine Model of Invasive Pulmonary Aspergillosis},
  author = {Wiederhold, N.P. and Tam, V.H. and Chi, J. and Prince, R.A. and Kontoyiannis, D.P. and Lewis, R.E.},
  year = {2006},
  journal = {Antimicrobial Agents and Chemotherapy},
  volume = {50},
  number = {2},
  pages = {469--473},
  doi = {10.1128/AAC.50.2.469-473.2006},
  note = {Cited By :85
\par
Cited By :85
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022},
  file = {/Users/russelllewis/Zotero/storage/IG342JSR/Wiederhold et al_2006_Pharmacodynamic activity of amphotericin B deoxycholate is associated with peak.pdf}
}

@article{chamilos.etal_2005,
  title = {Predictors of Pulmonary Zygomycosis versus Invasive Pulmonary Aspergillosis in Patients with Cancer},
  author = {Chamilos, G. and Marom, E.M. and Lewis, R.E. and Lionakis, M.S. and Kontoyiannis, D.P.},
  year = {2005},
  journal = {Clinical Infectious Diseases},
  volume = {41},
  number = {1},
  pages = {60--66},
  doi = {10.1086/430710},
  note = {Cited By :263
\par
Cited By :263
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022},
  file = {/Users/russelllewis/Zotero/storage/H3MUPVXS/Chamilos et al_2005_Predictors of pulmonary zygomycosis versus invasive pulmonary aspergillosis in.pdf}
}

@article{kontoyiannis.etal_2005,
  title = {Zygomycosis in a Tertiary-Care Cancer Center in the Era of {{Aspergillus-active}} Antifungal Therapy: {{A}} Case-Control Observational Study of 27 Recent Cases},
  author = {Kontoyiannis, D.P. and Lionakis, M.S. and Lewis, R.E. and Chamilos, G. and Healy, M. and Perego, C. and Safdar, A. and Kantarjian, H. and Champlin, R. and Walsh, T.J. and Raad, I.I.},
  year = {2005},
  journal = {Journal of Infectious Diseases},
  volume = {191},
  number = {8},
  pages = {1350--1360},
  doi = {10.1086/428780},
  note = {Cited By :572
\par
Cited By :572
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022},
  file = {/Users/russelllewis/Zotero/storage/ZDIHYYBC/Kontoyiannis et al_2005_Zygomycosis in a tertiary-care cancer center in the era of Aspergillus-active.pdf}
}

@article{lewis.etal_2005,
  title = {Frequency and Species Distribution of Gliotoxin-Producing {{Aspergillus}} Isolates Recovered from Patients at a Tertiary-Care Cancer Center},
  author = {Lewis, R.E. and Wiederhold, N.P. and Lionakis, M.S. and Prince, R.A. and Kontoyiannis, D.P.},
  year = {2005},
  journal = {Journal of Clinical Microbiology},
  volume = {43},
  number = {12},
  pages = {6120--6122},
  doi = {10.1128/JCM.43.12.6120-6122.2005},
  note = {Cited By :89
\par
Cited By :89
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022},
  file = {/Users/russelllewis/Zotero/storage/9IB79YH6/Lewis et al_2005_Frequency and species distribution of gliotoxin-producing Aspergillus isolates.pdf}
}

@article{lewis.etal_2005a,
  title = {In Vitro Pharmacodynamics of Amphotericin {{B}}, Itraconazole, and Voriconazole against {{Aspergillus}}, {{Fusarium}}, and {{Scedosporium}} Spp.},
  author = {Lewis, R.E. and Wiederhold, N.P. and Klepser, M.E.},
  year = {2005},
  journal = {Antimicrobial Agents and Chemotherapy},
  volume = {49},
  number = {3},
  pages = {945--951},
  doi = {10.1128/AAC.49.3.945-951.2005},
  note = {Cited By :76
\par
Cited By :76
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022},
  file = {/Users/russelllewis/Zotero/storage/T37DHEWM/Lewis et al_2005_In vitro pharmacodynamics of amphotericin B, itraconazole, and voriconazole.pdf}
}

@article{lewis.etal_2005b,
  title = {Detection of Gliotoxin in Experimental and Human Aspergillosis},
  author = {Lewis, R.E. and Wiederhold, N.P. and Chi, J. and Han, X.Y. and Komanduri, K.V. and Kontoyiannis, D.P. and Prince, R.A.},
  year = {2005},
  journal = {Infection and Immunity},
  volume = {73},
  number = {1},
  pages = {635--637},
  doi = {10.1128/IAI.73.1.635-637.2005},
  note = {Cited By :143
\par
Cited By :143
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022},
  file = {/Users/russelllewis/Zotero/storage/RNGSB8TH/Lewis et al_2005_Detection of gliotoxin in experimental and human aspergillosis.pdf}
}

@article{lewis.kontoyiannis_2005,
  title = {Micafungin in Combination with Voriconazole in {{Aspergillus}} Species: {{A}} Pharmacodynamic Approach for Detection of Combined Antifungal Activity in Vitro},
  author = {Lewis, R.E. and Kontoyiannis, D.P.},
  year = {2005},
  journal = {Journal of Antimicrobial Chemotherapy},
  volume = {56},
  number = {5},
  pages = {887--892},
  doi = {10.1093/jac/dki343},
  note = {Cited By :31
\par
Cited By :31
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022}
}

@article{lewis.wiederhold_2005,
  title = {Murine Model of Invasive Aspergillosis.},
  author = {Lewis, R.E. and Wiederhold, N.P.},
  year = {2005},
  journal = {Methods in molecular medicine},
  volume = {118},
  pages = {129--142},
  doi = {10.1385/1-59259-943-5:129},
  note = {Cited By :31
\par
Cited By :31
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022}
}

@article{lionakis.etal_2005a,
  title = {Increased Frequency of Non-Fumigatus {{Aspergillus}} Species in Amphotericin {{B-}} or Triazole-Pre-Exposed Cancer Patients with Positive Cultures for Aspergilli},
  author = {Lionakis, M.S. and Lewis, R.E. and Torres, H.A. and Albert, N.D. and Raad, I.I. and Kontoyiannis, D.P.},
  year = {2005},
  journal = {Diagnostic Microbiology and Infectious Disease},
  volume = {52},
  number = {1},
  pages = {15--20},
  doi = {10.1016/j.diagmicrobio.2005.01.001},
  note = {Cited By :74
\par
Cited By :74
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022}
}

@article{lionakis.etal_2005b,
  title = {Toll-Deficient {{Drosophila}} Flies as a Fast, High-Throughput Model for the Study of Antifungal Drug Efficacy against Invasive Aspergillosis and {{Aspergillus}} Virulence},
  author = {Lionakis, M.S. and Lewis, R.E. and May, G.S. and Wiederhold, N.P. and Albert, N.D. and Halder, G. and Kontoyiannis, D.P.},
  year = {2005},
  journal = {Journal of Infectious Diseases},
  volume = {191},
  number = {7},
  pages = {1188--1195},
  doi = {10.1086/428587},
  note = {Cited By :73
\par
Cited By :73
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022},
  file = {/Users/russelllewis/Zotero/storage/5DRQ6U6I/Lionakis et al_2005_Toll-deficient Drosophila flies as a fast, high-throughput model for the study.pdf}
}

@article{lionakis.etal_2005c,
  title = {Aspergillus Susceptibility Testing in Patients with Cancer and Invasive Aspergillosis: {{Difficulties}} in Establishing Correlation between in Vitro Susceptibility Data and the Outcome of Initial Amphotericin {{B}} Therapy},
  author = {Lionakis, M.S. and Lewis, R.E. and Chamilos, G. and Kontoyiannis, D.P.},
  year = {2005},
  journal = {Pharmacotherapy},
  volume = {25},
  number = {9},
  pages = {1174--1180},
  doi = {10.1592/phco.2005.25.9.1174},
  note = {Cited By :27
\par
Cited By :27
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022}
}

@article{lionakis.etal_2005d,
  title = {Development of a Ligand-Directed Approach to Study the Pathogenesis of Invasive Aspergillosis},
  author = {Lionakis, M.S. and Lahdenranta, J. and Sun, J. and Liu, W. and Lewis, R.E. and Albert, N.D. and Pasqualini, R. and Arap, W. and Kontoyiannis, D.P.},
  year = {2005},
  journal = {Infection and Immunity},
  volume = {73},
  number = {11},
  pages = {7747--7758},
  doi = {10.1128/IAI.73.11.7747-7758.2005},
  note = {Cited By :10
\par
Cited By :10
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022},
  file = {/Users/russelllewis/Zotero/storage/YKQVVTZE/Lionakis et al_2005_Development of a ligand-directed approach to study the pathogenesis of invasive.pdf}
}

@article{raad.etal_2005,
  title = {Vancomycin-Resistant {{Enterococcus}} Faecium: {{Catheter}} Colonization, Esp Gene, and Decreased Susceptibility to Antibiotics in Biofilm},
  author = {Raad, I.I. and Hanna, H.A. and Boktour, M. and Chaiban, G. and Hachem, R.Y. and Dvorak, T. and Lewis, R. and Murray, B.E.},
  year = {2005},
  journal = {Antimicrobial Agents and Chemotherapy},
  volume = {49},
  number = {12},
  pages = {5046--5050},
  doi = {10.1128/AAC.49.12.5046-5050.2005},
  note = {Cited By :52
\par
Cited By :52
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022},
  file = {/Users/russelllewis/Zotero/storage/AELESFKE/Raad et al_2005_Vancomycin-resistant Enterococcus faecium.pdf}
}

@article{stanzani.etal_2005,
  title = {Aspergillus Fumigatus Suppresses the Human Cellular Immune Response via Gliotoxin-Mediated Apoptosis of Monocytes},
  author = {Stanzani, M. and Orciuolo, E. and Lewis, R. and Kontoyiannis, D.P. and Martins, S.L.R. and St. John, L.S. and Komanduri, K.V.},
  year = {2005},
  journal = {Blood},
  volume = {105},
  number = {6},
  pages = {2258--2265},
  doi = {10.1182/blood-2004-09-3421},
  note = {Cited By :150
\par
Cited By :150
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022},
  file = {/Users/russelllewis/Zotero/storage/LJEUGK9X/Stanzani et al_2005_Aspergillus fumigatus suppresses the human cellular immune response via.pdf}
}

@article{tam.etal_2005a,
  title = {Pharmacodynamics of Polymyxin {{B}} against {{Pseudomonas}} Aeruginosa},
  author = {Tam, V.H. and Schilling, A.N. and Vo, G. and Kabbara, S. and Kwa, A.L. and Wiederhold, N.P. and Lewis, R.E.},
  year = {2005},
  journal = {Antimicrobial Agents and Chemotherapy},
  volume = {49},
  number = {9},
  pages = {3624--3630},
  doi = {10.1128/AAC.49.9.3624-3630.2005},
  note = {Cited By :163
\par
Cited By :163
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022},
  file = {/Users/russelllewis/Zotero/storage/W7ASLC8B/Tam et al_2005_Pharmacodynamics of polymyxin B against Pseudomonas aeruginosa.pdf}
}

@article{wiederhold.etal_2005,
  title = {Attenuation of the Activity of Caspofungin at High Concentrations against {{Candida}} Albicans: {{Possible}} Role of Cell Wall Integrity and Calcineurin Pathways},
  author = {Wiederhold, N.P. and Kontoyiannis, D.P. and Prince, R.A. and Lewis, R.E.},
  year = {2005},
  journal = {Antimicrobial Agents and Chemotherapy},
  volume = {49},
  number = {12},
  pages = {5146--5148},
  doi = {10.1128/AAC.49.12.5146-5148.2005},
  note = {Cited By :113
\par
Cited By :113
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022},
  file = {/Users/russelllewis/Zotero/storage/TPKBWUEH/Wiederhold et al_2005_Attenuation of the activity of caspofungin at high concentrations against.pdf}
}

@article{wiederhold.etal_2005a,
  title = {Antibacterial Activity of Linezolid and Vancomycin in an Vitro Pharmacodynamic Model of {{Gram-positive}} Catheter-Related Bacteraemia},
  author = {Wiederhold, N.P. and Coyle, E.A. and Raad, I.I. and Prince, R.A. and Lewis, R.E.},
  year = {2005},
  journal = {Journal of Antimicrobial Chemotherapy},
  volume = {55},
  number = {5},
  pages = {792--795},
  doi = {10.1093/jac/dki106},
  note = {Cited By :47
\par
Cited By :47
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022}
}

@article{andrews.etal_2004,
  title = {Constructing {{Ethical Guidelines}} for {{Biohistory}}},
  author = {Andrews, L.B. and Buenger, N. and Bridge, J. and Rosenow, L. and Stoney, D. and Gaensslen, R.E. and Karamanski, T. and Lewis, R. and Paradise, J. and Inlander, A. and Gonen, D.},
  year = {2004},
  journal = {Science},
  volume = {304},
  number = {5668},
  pages = {215--216},
  doi = {10.1126/science.1094372},
  note = {Cited By :14
\par
Cited By :14
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022}
}

@article{barker.etal_2004,
  title = {Genome-Wide Expression Profiling Reveals Genes Associated with Amphotericin {{B}} and Fluconazole Resistance in Experimentally Induced Antifungal Resistant Isolates of {{Candida}} Albicans},
  author = {Barker, K.S. and Crisp, S. and Wiederhold, N. and Lewis, R.E. and Bareither, B. and Eckstein, J. and Barbuch, R. and Bard, M. and Rogers, P.D.},
  year = {2004},
  journal = {Journal of Antimicrobial Chemotherapy},
  volume = {54},
  number = {2},
  pages = {376--385},
  doi = {10.1093/jac/dkh336},
  note = {Cited By :90
\par
Cited By :90
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022}
}

@article{hoffman.etal_2004,
  title = {Screening of Antibacterial and Antifungal Activities of Ten Medicinal Plants from {{Ghana}}},
  author = {Hoffman, B.R. and DelasAlas, H. and Blanco, K. and Wiederhold, N. and Lewis, R.E. and Williams, L.},
  year = {2004},
  journal = {Pharmaceutical Biology},
  volume = {42},
  number = {1},
  pages = {13--17},
  doi = {10.1080/13880200490504925},
  note = {Cited By :28
\par
Cited By :28
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022}
}

@article{kontoyiannis.lewis_2004,
  title = {Toward More Effective Antifungal Therapy: {{The}} Prospects of Combination Therapy},
  author = {Kontoyiannis, D.P. and Lewis, R.E.},
  year = {2004},
  journal = {British Journal of Haematology},
  volume = {126},
  number = {2},
  pages = {165--175},
  doi = {10.1111/j.1365-2141.2004.05007.x},
  note = {Cited By :72
\par
Cited By :72
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022}
}

@article{kontoyiannis.lewis_2004a,
  title = {Editorial Comment: {{Is}} Fluconazole the Only Factor?},
  author = {Kontoyiannis, D.P. and Lewis, R.E.},
  year = {2004},
  journal = {Infections in Medicine},
  volume = {21},
  number = {1},
  pages = {40},
  note = {Export Date: 20 November 2022
\par
Export Date: 20 November 2022}
}

@article{lewis.etal_2004,
  title = {Challenges in Designing Animal Studies to Detect Antagonism of Polyene Activity [3] (Multiple Letters)},
  author = {Lewis, R.E. and Kantoyiannis, D.P. and Najvar, L.K. and Graybill, J.R. and Cacciapuoti, A.F.},
  year = {2004},
  journal = {Antimicrobial Agents and Chemotherapy},
  volume = {48},
  number = {8},
  pages = {3211--3212},
  doi = {10.1128/AAC.48.8.3211-3212.2004},
  note = {Cited By :1
\par
Cited By :1
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022},
  file = {/Users/russelllewis/Zotero/storage/NBRCQ4WD/Lewis et al_2004_Challenges in designing animal studies to detect antagonism of polyene activity.pdf}
}

@article{lewis.kontoyiannis_2004,
  title = {Erratum: {{Challenges}} in Designing Animal Studies to Detect Antagonism of Polyene Activity ({{Antimicrobial Agents}} and {{Chemotherapy}} (2004) 48:8 (3211-3212))},
  author = {Lewis, R.E. and Kontoyiannis, D.P.},
  year = {2004},
  journal = {Antimicrobial Agents and Chemotherapy},
  volume = {48},
  number = {10},
  pages = {4072},
  doi = {10.1128/AAC.48.10.4072.2004},
  note = {Export Date: 20 November 2022
\par
Export Date: 20 November 2022},
  file = {/Users/russelllewis/Zotero/storage/TXGCQIP7/Lewis_Kontoyiannis_2004_Erratum.pdf}
}

@article{liu.etal_2004,
  title = {Extra Copies of the {{Aspergillus}} Fumigatus Squalene Epoxidase Gene Confer Resistance to Terbinafine: {{Genetic}} Approach to Studying Gene Dose-Dependent Resistance to Antifungals in {{A}}. Fumigatus},
  author = {Liu, W. and May, G.S. and Lionakis, M.S. and Lewis, R.E. and Kontoyiannis, D.P.},
  year = {2004},
  journal = {Antimicrobial Agents and Chemotherapy},
  volume = {48},
  number = {7},
  pages = {2490--2496},
  doi = {10.1128/AAC.48.7.2490-2496.2004},
  note = {Cited By :40
\par
Cited By :40
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022},
  file = {/Users/russelllewis/Zotero/storage/F9W5PITH/Liu et al_2004_Extra copies of the Aspergillus fumigatus squalene epoxidase gene confer.pdf}
}

@article{tam.etal_2004,
  title = {Novel Approach to Characterization of Combined Pharmacodynamic Effects of Antimicrobial Agents},
  author = {Tam, V.H. and Schilling, A.N. and Lewis, R.E. and Melnick, D.A. and Boucher, A.N.},
  year = {2004},
  journal = {Antimicrobial Agents and Chemotherapy},
  volume = {48},
  number = {11},
  pages = {4315--4321},
  doi = {10.1128/AAC.48.11.4315-4321.2004},
  note = {Cited By :32
\par
Cited By :32
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022},
  file = {/Users/russelllewis/Zotero/storage/RQ5MGUMN/Tam et al_2004_Novel approach to characterization of combined pharmacodynamic effects of.pdf}
}

@article{wiederhold.etal_2004,
  title = {Pharmacodynamics of Caspofungin in a Murine Model of Invasive Pulmonary Aspergillosis: {{Evidence}} of Concentration-Dependent Activity},
  author = {Wiederhold, N.P. and Kontoyiannis, D.P. and Chi, J. and Prince, R.A. and Tam, V.H. and Lewis, R.E.},
  year = {2004},
  journal = {Journal of Infectious Diseases},
  volume = {190},
  number = {8},
  pages = {1464--1471},
  doi = {10.1086/424465},
  note = {Cited By :186
\par
Cited By :186
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022}
}

@article{antoniadou.etal_2003,
  title = {Candidemia in a {{Tertiary Care Cancer Center}}: {{In}} Vitro Susceptibility and Its Association with Outcome of Initial Antifungal Therapy},
  author = {Antoniadou, A. and Torres, H.A. and Lewis, R.E. and Thornby, J. and Bodey, G.P. and Tarrand, J.J. and Han, X.-Y. and Rolston, K.V.I. and Safdar, A. and Raad, I.I. and Kontoyiannis, D.P.},
  year = {2003},
  journal = {Medicine},
  volume = {82},
  number = {5},
  pages = {309--321},
  doi = {10.1097/01.md.0000091182.93122.8e},
  note = {Cited By :114
\par
Cited By :114
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022}
}

@article{kontoyiannis.etal_2003,
  title = {Combination of Caspofungin with Inhibitors of the Calcineurin Pathway Attenuates Growth in Vitro in {{Aspergillus}} Species},
  author = {Kontoyiannis, D.P. and Lewis, R.E. and Osherov, N. and Albert, N.D. and May, G.S.},
  year = {2003},
  journal = {Journal of Antimicrobial Chemotherapy},
  volume = {51},
  number = {2},
  pages = {313--316},
  doi = {10.1093/jac/dkg090},
  note = {Cited By :106
\par
Cited By :106
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022}
}

@article{kontoyiannis.etal_2003a,
  title = {Sequential Exposure of {{Aspergillus}} Fumigatus to Itraconazole and Caspofungin: {{Evidence}} of Enhanced in Vitro Activity},
  author = {Kontoyiannis, D.P. and Lewis, R.E. and Lionakis, M.S. and Albert, N.D. and May, G.S. and Raad, I.I.},
  year = {2003},
  journal = {Diagnostic Microbiology and Infectious Disease},
  volume = {47},
  number = {2},
  pages = {415--419},
  doi = {10.1016/S0732-8893(03)00136-6},
  note = {Cited By :15
\par
Cited By :15
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022}
}

@article{kontoyiannis.etal_2003b,
  title = {Efficacy and Toxicity of Caspofungin in Combination with Liposomal Amphotericin {{B}} as Primary or Salvage Treatment of Invasive Aspergillosis in Patients with Hematologic Malignancies},
  author = {Kontoyiannis, D.P. and Hachem, R. and Lewis, R.E. and Rivero, G.A. and Torres, H.A. and Thornby, J. and Champlin, R. and Kantarjian, H. and Bodey, G.P. and Raad, I.I.},
  year = {2003},
  journal = {Cancer},
  volume = {98},
  number = {2},
  pages = {292--299},
  doi = {10.1002/cncr.11479},
  note = {Cited By :268
\par
Cited By :268
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022}
}

@article{kontoyiannis.lewis_2003,
  title = {Combination Chemotherapy for Invasive Fungal Infections: {{What}} Laboratory and Clinical Studies Tell Us so Far},
  author = {Kontoyiannis, D.P. and Lewis, R.E.},
  year = {2003},
  journal = {Drug Resistance Updates},
  volume = {6},
  number = {5},
  pages = {257--269},
  doi = {10.1016/j.drup.2003.08.003},
  note = {Cited By :52
\par
Cited By :52
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022}
}

@article{lewis.wiederhold_2003,
  title = {The Solubility Ceiling: {{A}} Rationale for Continuous Infusion Amphotericin {{B}} Therapy? [9]},
  author = {Lewis, R.E. and Wiederhold, N.P.},
  year = {2003},
  journal = {Clinical Infectious Diseases},
  volume = {37},
  number = {6},
  pages = {871--872},
  doi = {10.1086/377279},
  note = {Cited By :38
\par
Cited By :38
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022}
}

@article{lionakis.etal_2003,
  title = {Pentamidine Is Active in Vitro against {{Fusarium}} Species},
  author = {Lionakis, M.S. and Lewis, R.E. and Samonis, G. and Kontoyiannis, D.P.},
  year = {2003},
  journal = {Antimicrobial Agents and Chemotherapy},
  volume = {47},
  number = {10},
  pages = {3252--3259},
  doi = {10.1128/AAC.47.10.3252-3259.2003},
  note = {Cited By :24
\par
Cited By :24
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022},
  file = {/Users/russelllewis/Zotero/storage/UHBYNLSD/Lionakis et al_2003_Pentamidine is active in vitro against Fusarium species.pdf}
}

@article{liu.etal_2003,
  title = {Attenuation of {{Itraconazole Fungicidal Activity}} Following {{Preexposure}} of {{Aspergillus}} Fumigatus to {{Fluconazole}}},
  author = {Liu, W. and Lionakis, M.S. and Lewis, R.E. and Wiederhold, N. and May, G.S. and Kontoyiannis, D.P.},
  year = {2003},
  journal = {Antimicrobial Agents and Chemotherapy},
  volume = {47},
  number = {11},
  pages = {3592--3597},
  doi = {10.1128/AAC.47.11.3592-3597.2003},
  note = {Cited By :17
\par
Cited By :17
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022},
  file = {/Users/russelllewis/Zotero/storage/CSCY7GLS/Liu et al_2003_Attenuation of Itraconazole Fungicidal Activity following Preexposure of.pdf}
}

@article{rogers.etal_2003,
  title = {The Activity of Amphotericin {{B}} against {{Candida}} Albicans Is Not Directly Associated with Extracellular Calcium Concentration},
  author = {Rogers, P.D. and Kramer, R.E. and Crews, J.K. and Lewis, R.E.},
  year = {2003},
  journal = {Journal of Antimicrobial Chemotherapy},
  volume = {51},
  number = {2},
  pages = {305--312},
  doi = {10.1093/jac/dkg075},
  note = {Cited By :3
\par
Cited By :3
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022}
}

@article{torres.etal_2003,
  title = {Aspergillosis Caused by Non-Fumigatus {{Aspergillus}} Species: {{Risk}} Factors and in Vitro Susceptibility Compared with {{Aspergillus}} Fumigatus},
  author = {Torres, H.A. and Rivero, G.A. and Lewis, R.E. and Hachem, R. and Raad, I.I. and Kontoyiannis, D.P.},
  year = {2003},
  journal = {Diagnostic Microbiology and Infectious Disease},
  volume = {46},
  number = {1},
  pages = {25--28},
  doi = {10.1016/S0732-8893(03)00013-0},
  note = {Cited By :55
\par
Cited By :55
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022}
}

@article{wiederhold.etal_2003,
  title = {Invasive {{Aspergillosis}} in {{Patients}} with {{Hematologic Malignancies}}},
  author = {Wiederhold, N.P. and Lewis, R.E. and Kontoyiannis, D.P.},
  year = {2003},
  journal = {Pharmacotherapy},
  volume = {23},
  number = {12 I},
  pages = {1592--1610},
  doi = {10.1592/phco.23.15.1592.31965},
  note = {Cited By :51
\par
Cited By :51
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022}
}

@article{wiederhold.lewis_2003,
  title = {The Echinocandin Antifungals: {{An}} Overview of the Pharmacology, Spectrum and Clinical Efficacy},
  author = {Wiederhold, N.P. and Lewis, R.E.},
  year = {2003},
  journal = {Expert Opinion on Investigational Drugs},
  volume = {12},
  number = {8},
  pages = {1313--1333},
  doi = {10.1517/13543784.12.8.1313},
  note = {Cited By :127
\par
Cited By :127
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022}
}

@article{kontoyiannis.etal_2002,
  title = {Pulmonary Candidiasis in Patients with Cancer: {{An}} Autopsy Study},
  author = {Kontoyiannis, D.P. and Reddy, B.T. and Torres, H.A. and Luna, M. and Lewis, R.E. and Tarrand, J. and Bodey, G.P. and Raad, I.I.},
  year = {2002},
  journal = {Clinical Infectious Diseases},
  volume = {34},
  number = {3},
  pages = {400--403},
  doi = {10.1086/338404},
  note = {Cited By :86
\par
Cited By :86
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022}
}

@article{kontoyiannis.etal_2002a,
  title = {Aspergillus Nidulans Is Frequently Resistant to Amphotericin {{B}}},
  author = {Kontoyiannis, D.P. and Lewis, R.E. and May, G.S. and Osherov, N. and Rinaldi, M.G.},
  year = {2002},
  journal = {Mycoses},
  volume = {45},
  number = {9-10},
  pages = {406--407},
  doi = {10.1046/j.1439-0507.2002.00797.x},
  note = {Cited By :64
\par
Cited By :64
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022}
}

@article{kontoyiannis.lewis_2002,
  title = {Antifungal Drug Resistance of Pathogenic Fungi},
  author = {Kontoyiannis, D.P. and Lewis, R.E.},
  year = {2002},
  journal = {Lancet},
  volume = {359},
  number = {9312},
  pages = {1135--1144},
  doi = {10.1016/S0140-6736(02)08162-X},
  note = {Cited By :347
\par
Cited By :347
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022}
}

@article{lewis_2002,
  title = {Pharmacotherapy of {{Candida}} Bloodstream Infections: {{New}} Treatment Options, New Era},
  author = {Lewis, R.E.},
  year = {2002},
  journal = {Expert Opinion on Pharmacotherapy},
  volume = {3},
  number = {8},
  pages = {1039--1057},
  doi = {10.1517/14656566.3.8.1039},
  note = {Cited By :6
\par
Cited By :6
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022}
}

@article{lewis.etal_2002,
  title = {Itraconazole Preexposure Attenuates the Efficacy of Subsequent Amphotericin {{B}} Therapy in a Murine Model of Acute Invasive Pulmonary Aspergillosis},
  author = {Lewis, R.E. and Prince, R.A. and Chi, J. and Kontoyiannis, D.P.},
  year = {2002},
  journal = {Antimicrobial Agents and Chemotherapy},
  volume = {46},
  number = {10},
  pages = {3208--3214},
  doi = {10.1128/AAC.46.10.3208-3214.2002},
  note = {Cited By :78
\par
Cited By :78
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022},
  file = {/Users/russelllewis/Zotero/storage/T628IXBT/Lewis et al_2002_Itraconazole preexposure attenuates the efficacy of subsequent amphotericin B.pdf}
}

@article{lewis.etal_2002a,
  title = {Lack of Catheter Infection by the Efg1/Efg1 Cph1/Cph1 Double-Null Mutant, a {{Candida}} Albicans Strain That Is Defective in Filamentous Growth},
  author = {Lewis, R.E. and Lo, H.-J. and Raad, I.I. and Kontoyiannis, D.P.},
  year = {2002},
  journal = {Antimicrobial Agents and Chemotherapy},
  volume = {46},
  number = {4},
  pages = {1153--1155},
  doi = {10.1128/AAC.46.4.1153-1155.2002},
  note = {Cited By :53
\par
Cited By :53
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022},
  file = {/Users/russelllewis/Zotero/storage/PDRFGM2W/Lewis et al_2002_Lack of catheter infection by the efg1-efg1 cph1-cph1 double-null mutant, a.pdf}
}

@article{lewis.etal_2002b,
  title = {Antifungal Activity of Amphotericin {{B}}, Fluconazole, and Voriconazole in an in Vitro Model of {{Candida}} Catheter-Related Bloodstream Infection},
  author = {Lewis, R.E. and Kontoyiannis, D.P. and Darouiche, R.O. and Raad, I.I. and Prince, R.A.},
  year = {2002},
  journal = {Antimicrobial Agents and Chemotherapy},
  volume = {46},
  number = {11},
  pages = {3499--3505},
  doi = {10.1128/AAC.46.11.3499-3505.2002},
  note = {Cited By :88
\par
Cited By :88
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022},
  file = {/Users/russelllewis/Zotero/storage/ZRZWPL33/Lewis et al_2002_Antifungal activity of amphotericin B, fluconazole, and voriconazole in an in.pdf}
}

@article{lewis.etal_2002c,
  title = {Comparison of {{Etest}}, Chequerboard Dilution and Time-Kill Studies for the Detection of Synergy or Antagonism between Antifungal Agents Tested against {{Candida}} Species},
  author = {Lewis, R.E. and Diekema, D.J. and Messer, S.A. and Pfaller, M.A. and Klepser, M.E.},
  year = {2002},
  journal = {Journal of Antimicrobial Chemotherapy},
  volume = {49},
  number = {2},
  pages = {345--351},
  doi = {10.1093/jac/49.2.345},
  note = {Cited By :166
\par
Cited By :166
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022}
}

@article{roling.etal_2002,
  title = {Antifungal Activities of Fluconazole, Caspofungin ({{MK0991}}), and Anidulafungin ({{LY}} 303366) Alone and in Combination against {{Candida}} Spp. and {{Crytococcus}} Neoformans via Time-Kill Methods},
  author = {Roling, E.E. and Klepser, M.E. and Wasson, A. and Lewis, R.E. and Ernst, E.J. and Pfaller, M.A.},
  year = {2002},
  journal = {Diagnostic Microbiology and Infectious Disease},
  volume = {43},
  number = {1},
  pages = {13--17},
  doi = {10.1016/S0732-8893(02)00361-9},
  note = {Cited By :99
\par
Cited By :99
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022}
}

@article{keele.etal_2001,
  title = {Evaluation of Amphotericin {{B}} and Flucytosine in Combination against {{Candida}} Albicans and {{Cryptococcus}} Neoformans Using Time-Kill Methodology},
  author = {Keele, D.J. and DeLallo, V.C. and Lewis, R.E. and Ernst, E.J. and Klepser, M.E.},
  year = {2001},
  journal = {Diagnostic Microbiology and Infectious Disease},
  volume = {41},
  number = {3},
  pages = {121--126},
  doi = {10.1016/S0732-8893(01)00297-8},
  note = {Cited By :31
\par
Cited By :31
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022}
}

@article{klepser.etal_2001,
  title = {Multi-Center Evaluation of Antifungal Time-Kill Methods},
  author = {Klepser, M.E. and Lewis, R.E. and Ernst, E.J. and Rosemarie Petzold, C. and Bailey, E.M. and Burgess, D.S. and Carver, P.L. and Lacy, M.K. and Mercier, R.-C. and Nicolau, D.P. and Zhanel, G.G. and Pfaller, M.A.},
  year = {2001},
  journal = {Journal of Infectious Disease Pharmacotherapy},
  volume = {5},
  number = {2},
  pages = {29--41},
  doi = {10.1300/J100v05n02_04},
  note = {Cited By :7
\par
Cited By :7
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022}
}

@article{kontoyiannis.etal_2001a,
  title = {Progressive Disseminated Aspergillosis in a Bone Marrow Transplant Recipient: Response with a High-Dose Lipid Formulation of Amphotericin {{B}}.},
  author = {Kontoyiannis, D.P. and Andersson, B.S. and Lewis, R.E. and Raad, I.I.},
  year = {2001},
  journal = {Clinical infectious diseases : an official publication of the Infectious Diseases Society of America},
  volume = {32},
  number = {5},
  pages = {E94-96},
  doi = {10.1086/319208},
  note = {Cited By :16
\par
Cited By :16
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022}
}

@article{lewis.kontoyiannis_2001,
  title = {Rationale for Combination Antifungal Therapy},
  author = {Lewis, R.E. and Kontoyiannis, D.P.},
  year = {2001},
  journal = {Pharmacotherapy},
  volume = {21},
  number = {8 SUPPL. 2},
  pages = {149S-164S},
  doi = {10.1592/phco.21.12.149s.34505},
  note = {Cited By :97
\par
Cited By :97
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022}
}

@article{pietrucha-dilanchian.etal_2001,
  title = {Candida Lusitaniae Catheter-Related Sepsis},
  author = {{Pietrucha-Dilanchian}, P. and Lewis, R.E. and Ahmad, H. and Lechin, A.E.},
  year = {2001},
  journal = {Annals of Pharmacotherapy},
  volume = {35},
  number = {12},
  pages = {1570--1574},
  doi = {10.1345/aph.1A077},
  note = {Cited By :11
\par
Cited By :11
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022}
}

@article{klepser.etal_2000,
  title = {Evaluation of Voriconazole Pharmacodynamics Using Time-Kill Methodology},
  author = {Klepser, M.E. and Malone, D. and Lewis, R.E. and Ernst, E.J. and Pfaller, M.A.},
  year = {2000},
  journal = {Antimicrobial Agents and Chemotherapy},
  volume = {44},
  number = {7},
  pages = {1917--1920},
  doi = {10.1128/AAC.44.7.1917-1920.2000},
  note = {Cited By :97
\par
Cited By :97
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022},
  file = {/Users/russelllewis/Zotero/storage/XKU4J9BY/Klepser et al_2000_Evaluation of voriconazole pharmacodynamics using time-kill methodology.pdf}
}

@article{kontoyiannis.etal_2000b,
  title = {Itraconazole-Amphotericin {{B}} Antagonism in {{Aspergillus}} Fumigatus: {{An E-test-based}} Strategy},
  author = {Kontoyiannis, D.P. and Lewis, R.E. and Sagar, N. and May, G. and Prince, R.A. and Rolston, K.V.I.},
  year = {2000},
  journal = {Antimicrobial Agents and Chemotherapy},
  volume = {44},
  number = {10},
  pages = {2915--2918},
  doi = {10.1128/AAC.44.10.2915-2918.2000},
  note = {Cited By :68
\par
Cited By :68
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022},
  file = {/Users/russelllewis/Zotero/storage/V5GYVGEX/Kontoyiannis et al_2000_Itraconazole-amphotericin B antagonism in Aspergillus fumigatus.pdf}
}

@article{lewis.etal_2000,
  title = {In Vitro Pharmacodynamic Characteristics of Flucytosine Determined by Time-Kill Methods},
  author = {Lewis, R.E. and Klepser, M.E. and Pfaller, M.A.},
  year = {2000},
  journal = {Diagnostic Microbiology and Infectious Disease},
  volume = {36},
  number = {2},
  pages = {101--105},
  doi = {10.1016/S0732-8893(99)00125-X},
  note = {Cited By :39
\par
Cited By :39
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022}
}

@article{lewis.etal_2000a,
  title = {Comparison of Oral Immediate-Release ({{IR}}) and Extended-Release ({{ER}}) Metronidazole Bactericidal Activity against {{Bacteroides}} Spp. Using an in Vitro Model of Infection},
  author = {Lewis, R.E. and Klepser, M.E. and Ernst, E.J. and Snabes, M.A. and Jones, R.N.},
  year = {2000},
  journal = {Diagnostic Microbiology and Infectious Disease},
  volume = {37},
  number = {1},
  pages = {51--55},
  doi = {10.1016/S0732-8893(00)00120-6},
  note = {Cited By :9
\par
Cited By :9
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022}
}

@article{lewis.etal_1999,
  title = {Combination Systemic Antifungal Therapy for Cryptococcosis, Candidiasis, and Aspergillosis},
  author = {Lewis, R.E. and Klepser, M.E. and Pfaller, M.A.},
  year = {1999},
  journal = {Journal of Infectious Disease Pharmacotherapy},
  volume = {3},
  number = {4},
  pages = {61--83},
  doi = {10.1300/j100v03n04_04},
  note = {Cited By :18
\par
Cited By :18
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022}
}

@article{lewis.etal_1999a,
  title = {Evaluation of Low-Dose, Extended-Interval Clindamycin Regimens against {{Staphylococcus}} Aureus and {{Streptococcus}} Pneumoniae Using a Dynamic in Vitro Model of Infection},
  author = {Lewis, R.E. and Klepser, M.E. and Ernst, E.J. and Lund, B.C. and Biedenbach, D.J. and Jones, R.N.},
  year = {1999},
  journal = {Antimicrobial Agents and Chemotherapy},
  volume = {43},
  number = {8},
  pages = {2005--2009},
  doi = {10.1128/aac.43.8.2005},
  note = {Cited By :21
\par
Cited By :21
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022},
  file = {/Users/russelllewis/Zotero/storage/EMIFV58K/Lewis et al_1999_Evaluation of low-dose, extended-interval clindamycin regimens against.pdf}
}

@article{lewis.klepser_1999,
  title = {The Changing Face of Nosocomial Candidemia: {{Epidemiology}}, Resistance, and Drug Therapy},
  author = {Lewis, R.E. and Klepser, M.E.},
  year = {1999},
  journal = {American Journal of Health-System Pharmacy},
  volume = {56},
  number = {6},
  pages = {525--536},
  doi = {10.1093/ajhp/56.6.525},
  note = {Cited By :44
\par
Cited By :44
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022}
}

@article{klepser.etal_1998,
  title = {Therapy of {{Candida}} Infections: {{Susceptibility}} Testing, Resistance, and Therapeutic Options},
  author = {Klepser, M.E. and Lewis, R.E. and Pfaller, M.A.},
  year = {1998},
  journal = {Annals of Pharmacotherapy},
  volume = {32},
  number = {12},
  pages = {1353--1361},
  doi = {10.1345/aph.18166},
  note = {Cited By :22
\par
Cited By :22
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022}
}

@article{klepser.etal_1998a,
  title = {Influence of Test Conditions on Antifungal Time-Kill Curve Results: {{Proposal}} for Standardized Methods},
  author = {Klepser, M.E. and Ernst, E.J. and Lewis, R.E. and Ernst, M.E. and Pfaller, M.A.},
  year = {1998},
  journal = {Antimicrobial Agents and Chemotherapy},
  volume = {42},
  number = {5},
  pages = {1207--1212},
  doi = {10.1128/aac.42.5.1207},
  note = {Cited By :232
\par
Cited By :232
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022},
  file = {/Users/russelllewis/Zotero/storage/HHSUJL8I/Klepser et al_1998_Influence of test conditions on antifungal time-kill curve results.pdf}
}

@article{lewis.etal_1998,
  title = {Assessment of Antifungal Activities of Fluconazole and Amphotericin b Administered Alone and in Combination against {{Candida}} Albicans by Using a Dynamic in Vitro Mycotic Infection Model},
  author = {Lewis, R.E. and Lund, B.C. and Klepser, M.E. and Ernst, E.J. and Pfaller, M.A.},
  year = {1998},
  journal = {Antimicrobial Agents and Chemotherapy},
  volume = {42},
  number = {6},
  pages = {1382--1386},
  doi = {10.1128/aac.42.6.1382},
  note = {Cited By :82
\par
Cited By :82
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022},
  file = {/Users/russelllewis/Zotero/storage/5FL52KD7/Lewis et al_1998_Assessment of antifungal activities of fluconazole and amphotericin b.pdf}
}

@article{lewis.etal_1998a,
  title = {Update on Clinical Antifungal Susceptibility Testing for {{Candida}} Species},
  author = {Lewis, R.E. and Klepser, M.E. and Pfaller, M.A.},
  year = {1998},
  journal = {Pharmacotherapy},
  volume = {18},
  number = {3},
  pages = {509--515},
  note = {Cited By :12
\par
Cited By :12
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022}
}

@article{lewis.klepser_1998,
  title = {Update on Clindamycin: {{New}} Pharmacokinetic and Pharmacodynamic Data},
  author = {Lewis, R.E. and Klepser, M.E.},
  year = {1998},
  journal = {Infections in Medicine},
  volume = {15},
  number = {10},
  pages = {726--731},
  note = {Cited By :3
\par
Cited By :3
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022}
}